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Abstract
Bioactive glasses (BGs) are amorphous materials exhibiting biocompatibility properties,
gaining great interest as biomaterials for regenerative medicine. This work comprises two
parts. First, the bioactivity properties that fluoridated phosphate-based bioactive glasses
(F-PBGs) exhibit once implanted, for dental repair applications, was studied. Second,
the experimental design of cardiac patches, containing 45S5 bioactive glasses for cardiac
tissue engineering, was undertaken.
Recently, the role played by fluoride ions on the bioactivity of F-PBGs has been debated
in the literature and previous studies have concluded opposite results. Bioactivity and
structure are closely related, so classical molecular dynamics (MD) simulations were used
to accurately describe the atomistic structure of F-PBGs. To improve the modelling of F-
containing bioactive phosphate, a conceptually advanced approach based on polarisation
effects of both the oxygen and fluorine atoms was developed. The MD simulations were
performed on the following systems P2O5(50−x) CaO(50−x)CaF2(x); x=0,2,5. In the compo-
sition with 2% and 5% of CaF2, no bonding between the phosphorus and fluorine atoms
was observed and the atomistic visualisation highlighted the presence of Ca/F clusters.
The main effect of fluoride addition was the bonding of the calcium with the fluorine.
This bonding led to a re-polymerization of the network and the formation of F-rich and
F-poor regions which, overall, decreased the bioactivity of the glass. Presence of clustering
ultimately decreased the bioactivity of F-PBGs. Indeed, the ionic-rich regions dissolve
at a higher rate than the network-rich regions leading to an uneven fluoro-apatite layer
formation, which reduces F-PBGs’s suitability for biomedical applications.
It would have been ideal to back up the computational data with experiments, but the
synthesis of FPBGs was not feasible in the laboratory available. The experimental sec-
tion was therefore orientated toward to study of commercially available 45S5 silicate-based
bioactive glasses (Si-BGs).
Si-BGs are gaining more and more interest for soft tissue engineering applications. In
particular, the use of Si-BGs/polymeric composite scaffold for cardiac tissue regeneration
was shown to be promising but has not yet been addressed extensively. In this project,
BGs-polymers composite cardiac patches for myocardial tissue regeneration exhibiting
tunable degradation properties have been designed. Two techniques were combined:
three-dimensional printing and electrospinning both using two highly biocompatible and
i
bioresorbable biopolymers: poly(glycerol sebacate) and poly(caprolactone). The designed
scaffold was shown to be a promising device for cardiac tissue engineering. The manufac-
tured cardiac patches are bioresorbable and biocompatible with a controllable degradation
depending on the composition. The addition of BGs had beneficial effects on cell pro-
liferation by helping to regulate the pH and hence, providing a suitable environment for
their growth and proliferation. BGs degradation in the PCL-PGS scaffolds, also led to
the formation of an open three-dimensional porosity network within the scaffold. This
is beneficial for cell growth, flow transport of nutrients and metabolic waste. Finally,
mechanical properties showed high values of more than 200% of the myocardium’s which
will be beneficial for a healthy recovery of the heart scarred tissue.
This project gathered modelling and experimental data that helped better understand
the use of bioactive glasses for biomedical applications, including personalised treatments
for patients.
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Chapter 1
Introduction
1.1 Bioactive Glasses: a bus ride through history...
Before the invention of bioactive glasses, biomaterials, in the 1960s, were mostly composed
of stainless steel hip implants pioneered by Dr. McKee1,2 and the use of cement-based
materials to afford better fixation3. During this time, the biomaterials community focused
on researching inert materials for medical devices such as high-strength metallic implants
or fixation materials such as cement or fasteners (e.g. pins and screws).4,5
Biocompatibility, at this point in time, was closely linked with low reactive materials and
minimal interaction of the implant with the body and surrounding tissues.6,7 However,
significant failures for these implants were reported and attributed to the materials used
and/or the mechanical design. Indeed, it was observed that such metallic implants are
susceptible to corrosion, leading to implant failures and a limited lifetime in the body.8
It is in this context that, in 1967, a young professor made an encounter that would
revolutionise the field of biomaterials. During a bus ride, Professor Larry Hench met
a Colonel in the Medical Command who confided in him his frustration with the lack
of technical advances in the medical field, while tremendous advances were witnessed
in weapons and other areas of materials. The Colonel then raised the question of why
couldn’t amputee soldiers coming back from Vietnam be helped? Larry and the Colonel
then discussed the composition of the bones made primarily of hydroxyapatite - a ceramic
compound. The conversation awoke Hench’s scientific mind and he began researching
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more compatible materials. Metals and polymers were discarded as they were made
of molecules and atoms not normally found in the body. Following this logic, L.Hench
focused his research on calcium phosphate-based materials which are the main components
of bones. The first bioactive glass was developed in 1969 by L.Hench9 and composed of
46.1 SiO2, 2.6 P2O5, 24.4 Na2O, 26.9 CaO (in mol%). Studies showed that it could form
a bond with bones so strong that it was impossible to be removed without damaging and
breaking the bone10 and it has been clinically used since 1985. Bioactive glasses were first
referred to as ’Ceramic Prosthetic Materials’ demonstrating that the concept of bioactive
compounds was not yet fully adopted, and it was not until 1973 when the term ’bioactive
glass’ first appeared.
Nowadays, bioactive glasses are defined as inorganic biomedical material, and are often
used for bone and teeth tissue engineering, as they have been shown to stimulate bone
regeneration.11–13 Alternatively they have recently gained more interest as a use for soft
tissue engineering such as cardiac tissue and nerve regeneration, lung tissue repair and
wound healing applications.14–17 The term ’bioactive’ defines any substances or materials
that induce a beneficial biological response from the host body. Many of the bioactive
glasses, used and studied, are derived from L.Hench’s first bioactive glasses, as shown in
Table 1.1.9,18,19
Bioactive glasses belong to a larger groups of materials triggering appropriate response
from the body called biomaterials. Biomaterials are defined by the American National
Institute of Health as “any substance or combination of substances, other than drugs, syn-
thetic or natural in origin, which can be used for any period of time, which augments or
replaces partially or totally any tissue, organ or function of the body, in order to maintain
or improve the quality of life of the individual”.20 In other words, these materials are used
to manufacture artificial organs, rehabilitation devices or implants replacing natural tis-
sues in the body. Such materials can be implanted in the body to replace or repair failing
tissue with the aim of bettering the quality of patients’ lives by being placed in close or
direct contact with the body. The definition of biomaterials also includes materials used
in drug-delivery applications, biosensors and any external device that interacts with the
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body e.g. artificial heart systems.21,22. To fulfil their role, biomaterials should exhibit the
following properties: in vivo and in vitro biocompatibility, controllable biodegradability
and biostability.23 Biomaterials can be sub-divided into four main categories; (a) natural
or synthetic polymers, (b) metals, (c) composites and (d) ceramics including bioactive
glasses.
When a bioactive glass is put in contact with an aqueous solution it starts dissolving and
releasing ions such as calcium, sodium and phosphate. The release of these ions leads to
the formation of an apatite surface layer which plays a crucial role in the bioactivity. The
mechanism through which a bioactive glass dissolves was first proposed by Hench (Figure
2.2)24.
Figure 1.1: Sequence of interfacial reactions involved in forming a bond between bone
and a bioactive glass.24 (1998) Reproduced with permission of John Wiley and Sons.
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Table 1.1: Selected bioactive glasses composition (mol%)18
Name SiO2 P2O5 Na2O CaO CaF2 K2O MgO NCSi
45S5 46.1 2.6 24.4 26.9 - - - 2.11
45S5F 46.1 2.6 24.4 13.45 13.4 - - 2.70
S53P4 53..9 1.7 22.7 21.8 - - - 2.54
13-93 54.6 1.7 6 22.1 - 7.9 7.7 2.59[a]
6P61 61.0 2.5 10 13.5 - 2.4 10.7 3.05[a]
6P55 54.1 2.5 11.5 15.9 - 3.4 12.6 2.6[a]
6P50 49.4 2.5 14.9 16.6 - 3.5 13.2 2.36[a]
ICIE1 49.46 1.07 26.38 23.08 - - - 2.11
ICIE16 49.46 1.07 6.6 36.27 - 6.6 - 2.11
a the values were calculated assuming MgO acts as modifiers
NC represent the network connectivity which is defined in section 2.1.1 which
is page 9.18 (2015) Reproduced with permission of John Wiley and Sons.
1.2 Fluoridated-phosphate based glasses for hard tis-
sue engineering
Phosphate-based bioglasses (PBGs) are mainly based on P2O5, Na2O and CaO enti-
ties.25 They are used in many different biomedical fields such as orthopaedic and dental
surgery.26,27 These type of glasses can be manufactured in various shapes such as discs28,
microtubes29, microspheres30,31 and fibres32,33, hence the use of PBGs in various appli-
cations; fibres can be used as cell transportation device32, nerve conduct27 or muscle
regeneration34.
Glasses are not as dependent on a specific stoichiometry as crystals are, therefore they
allow more flexibility in composition.18 Over the last years, an increasing number of
bioactive glasses have been developed, most of them with incorporated ions exhibiting
potential therapeutic effects.15,32,35–44
Fluoride is a component of high interest for dental applications as it prevents caries.45,46
Indeed, fluoride in dentistry presents three main benefits which are:
• The enhancement of tooth enamel remineralisation47
• The inhibition of enamel demineralisation47
• The inhibition of bacterial enzymes48,49
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1.3 Silicate-based glasses for soft tissue engineering
Since the discovery of the first bioactive glass 45S5 by L. Hench in 19699, a significant
amount of research has focused on hard tissue engineering applications such as bone tissue
and enamel regeneration, as discussed in the previous section.9–11,50–54 Recently BGs have
attracted increasing interest for their interaction with soft tissues.14,55 More studies are
being published (Figure 1.2), focusing on using BGs in innovative approaches such as
regeneration of soft tissues and for various clinical needs.56 This is due to the enormous
potential BGs exhibit in soft tissue repair. Indeed, promising results have been obtained
in terms of angiogenesis (formation of blood vessel)57–61 and wound healing62–66 properties
but also in nerve67–70, gastro intestinal71–74, laryngeal14,75, lung tissue repair76–79 and more
interestingly, cardiac tissue repair80–82.
Figure 1.2: Number of papers published per year in the fields of ’bioactive glass’ and
’tissue engineering’ (according to Web of Science; literature search carried out in June
2019)
Cardiac tissue repair is necessary when the heart suffers what is known as myocardial in-
farction or heart attack. The latter occurs after a sudden blockage of blood vessels leads
to the formation of scar tissue, which impairs the efficient functioning of the heart. To
meet this challenge, cardiac tissue engineering has emerged as an highly promising field,
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developing efficient and innovative treatments to target cardiac tissue repair.83 Through
this approach, the aim is to mimic the extracellular matrix (ECM) using natural or syn-
thetic polymeric materials.81 The ECM is an important component of all tissues and
organs within the body, as this non-cellular constituent ensures the initiation of crucial
biochemical and biomechanical cues needed in various tissue processes e.g morphogenesis,
differentiation and homeostasis. Additionally, the ECM acts as a vital physical scaffold
for cells and cells’ constituents.84
1.4 Aims of the project
The research in this work is focused on the use of bioactive glasses as a biomaterial for
soft and hard tissue engineering. To do so, both modelling and experimental methods
are used in order to gain better understanding of their properties for tissue engineering
applications. Bioactive glasses represent a promising class of amorphous materials whose
wide range of compositions allows for use in many different fields.
The focus in this project is set on BGs for hard tissue engineering with fluoridated
phosphate-based glasses for dentistry, and soft tissue engineering with silicate-based glasses
for cardiac tissue engineering. To do so, modelling techniques, with the use of molecular
dynamics, are used to better understand how the addition of fluorine affects the bioactiv-
ity of phosphate-based glasses through the development of a polarisable force field. The
experimental part of the project was initially set to be focused on studying the chemical
structure of synthesised fluoridated phosphate-based glasses. However, due to missing lab
equipment such synthesis was not feasible during the project. To overcome this issue,
it was decided to study commercially available bioactive glasses, 45S5 BGs, exhibiting
promising interactions with soft tissues. Experimental techniques such as 3D printing
and electrospinning are used to design cardiac patches presenting suitable mechanical
properties and surface chemistry to support cardiac tissue regeneration. The following
chapters present a detailed description on how such results and data were obtained.
Chapter 2
Literature Review
Every year increasing numbers of patients are seen suffering from tissue and organ failures,
along with an increase of health care costs .85 To face these current challenges, researchers’
interests around the world have focused on the development of new, innovative, and/or
improved treatments as there is a growing need for solutions.21 To achieve such improve-
ments, emphasis is being directed toward to development of materials able to assist or
enhance the body’s repairing processes.86 Such materials can be synthetic (organic and
inorganic), natural or a combination of both. Ultimately, they should exhibit in vivo and
in vitro biocompatibility, controllable biodegradability and biostability. Such materials
can be referred to as biomaterials.23
Biocompatibility refers to the ability of a material to perform its specific application with
appropriate host response. In other words, exposure to a physiological environment should
not prevent the material from performing its role.87 A biodegradable material degrades
and moves away from the site of action in the body but is not necessarily removed from
the later. A bioresorbable material will completely eliminate itself and its degradation
products from the body with no residual side effects.88 Biostability refers to the chemical
and physical stability of a biomaterial in a physiological environment as function of time.
In others words, no physiological interactions change the material’s property and trigger
loss of function during the service life of the biomedical material.89
Since the first bioactive glass developed in 1969 by L.Hench9, composed of 46.1 SiO2, 2.6
P2O5, 24.4 Na2O, 26.9 CaO (in mol%), many of the bioglasses
18,19 used and studied are
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derived from this composition.9 Inorganic biomedical materials have been used for hard
and soft tissue engineering such as bone repair, cardiac tissue and nerve regeneration,
lung tissue repair and wound healing applications.14 Bioactive glasses belong to the third
generation of biomedical materials.90 The first generation of biomaterials is constituted of
synthetic materials, manufactured to match the physical properties of the replaced tissue
and to be biologically inert. The second generation of biomaterials was engineered to
interact with the biological environment to enhance the biological response. They are re-
sorbable materials with the ability to degrade whilst regenerating new tissues. The third
generation of biomaterials simultaneously aims at having bioresorbable and bioactive ac-
tions, so they help the body heal when implanted, along with the ability to activate genes
that stimulate the regeneration of tissue.91,92
2.1 General structural properties on bioactive glasses
2.1.1 Glass Composition and structure
Unlike crystalline solids18 (Figure 2.1 a), bioactive glasses are amorphous materials with-
out any long range periodic structure (Figure 2.1 b-d). The atomistic structure of bio-
glasses is based on a tetrahedron formed of network formers (phosphorus, silica or borate)
linked to oxygen atoms. The oxygen atoms present can have two different roles.18,93 They
can be referred to as bridging oxygen when they link two building units in the network
forming, for instance, a Si-O-Si or P-O-P bond. They can also be referred to as non-
bridging oxygen when they do not participate in building the network.
The glass structure can be described by three main components94:
• The network formers are the backbone of the glass. They form a network with no
need of additional components. Typical network formers are P2O5, SiO2 or B2O3.
95
• The network modifiers, as opposed to the network formers, alter the glass struc-
ture by linking to the non-terminal or bridging oxygen atom, and thereby turning
them into terminal or non-bridging ones, by creating a predominantly ionic linkage.
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Typical examples are the calcium or sodium ions.96
• The intermediate oxides can act as network modifiers or network formers and
can be aluminium, titanium, carbon, tungsten, gallium or vanadium.
These PO4 tetrahedral building units are commonly referred to as Qn units, where n is the
number of bridging oxygen atoms linked to the tetrahedron.18 The network connectivity
(NC)97 represents the mean value of the number of bridging oxygen atoms per network
former e.g Si for silicate-based glass or P for phosphate based-glasses. The network
connectivity affects the solubility and degradation rates of the glass. The NC reflects the
structural properties beyond the short range distances and shows interesting correlation
with the glass bioactivity. It gives a notion of the average polymerisation of the network
and is the main structural parameter affecting the bioactivity of the PBGs.98,99 The NC
represents a precious tool for predicting glass properties such as crystallisation tendency,
bioactivity and glass transition temperature.100
Bioactive glasses are also characterised by their thermal behaviour101 which is described
by a glass transition range (Tg). This range marks the temperature interval within which
the system goes from supercooled liquid to a solid glass. Furthermore, when heated,
bioactive glasses show a slow decrease of viscosity over several orders of magnitude, which
allows them to be processed into various shapes.
Bioactive glasses can be produced through two common methods. One consists of melting
the precursors (inorganic oxides, carbonates, fluorides and others) at a temperature going
up to 1500◦C depending on the composition of the glasses. The subsequent cooling should
be rapid enough so that no crystallization occurs. The other synthesis method is a poly-
condensation reaction from organic precursors (alkoides such as tetraethyl orthosilicate):
the produced glasses are referred to as sol-gel derived glasses.102–104
2.1.2 What makes glasses bioactic¸ve?
When immersed in an aqueous solution, bioactive glasses start dissolving and releasing
calcium, sodium and phosphate ions leading to the formation of an apatite surface layer.
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Figure 2.1: Structure of a) crystalline and b) vitreous silica (only three oxygen atoms
are shown per SiO4 tetrahedron, with the fourth lying above or below the image plane),
c) atomic-resolution scanning tunnelling microscopy image of a vitreous SiO2 film, and
d) the same image superimposed with a schematic representation of oxygen and silicon
.18,95,105 (1932 and 2015) Reproduced with permission of John Wiley and Sons and the
American Chemical Society.
As L.Hench showed in proposed dissolution mechanism24, this apatite layer plays a crucial
role in the bioactivity. Bioactive glasses are typically referred to as second generation
biomaterials; however, the use of BGs in medical implants, developed for tissue engineering
applications (e.g. cardiac patches), belongs to the third generation of biomaterials.106,107
2.1.2.1 Link between glass structure and solubility
The open network of bioactive glasses allows the water molecules to penetrate the glass
network easily.18 The mechanism through which a bioactive glass dissolves was first pro-
posed by Hench (Figure 2.2)24 and then illustrated with Molecular Dynamics (MD) simu-
lations.108,109 Those simulations highlighted not only the importance of an open network
for water penetration, but also some important surface features such as the modifier
cations or non-bridging oxygen atoms. Indeed, when a bioglass is put in contact with
water, an ion exchange occurs between the glass surface and the water: modifier ions
such as Na+ are exchanged with some protons from the solution. MD simulations showed
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that modifier cations act as Lewis acids, activating the dissociation of H2O and steady-
ing the HO− ions.108 Therefore, these sites allow a strong interaction between the glass
and the water. Regarding the bridging oxygen atoms, MD simulations showed that they
tend to exhibit hydrophobic properties and no significant interactions with the aqueous
environment.
Figure 2.2: Sequence of interfacial reactions involved in forming a bond between bone
and a bioactive glass.24 (1998) Reproduced with permission of John Wiley and Sons.
The immersion of a bioglass in an aqueous environment is also accompanied by the forma-
tion of an apatite layer at the surface of the glass.110 The apatite surface layer is key to the
bioactivity of the glasses. Apatite is a term used to classify groups of calcium orthophos-
phate (e.g. hydroxyapatite Ca5(PO4)3OH)
111,112) and is one the main components of
mineralized human tissues such as dentine, enamel and bones. Since the composition of
apatite is similar to mineral tissues, it interacts with them. For instance, hydroxyapatite
is said to interact with collagen fibrils to bond with the host bone.113
Diffraction methods experiments114 showed that this apatite formation starts with the
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development of an octacalcium phosphate layer, which thereafter endures various recrys-
tallizations. This is due to the nucleation rates of octacalcium phosphate being higher at
physiological pH values than hydroxyapatite, which is more stable at pH values between
5 and 10.111
The formation of apatite depends on the network connectivity: a more polymerised glass
will have a slower apatite formation due to a smaller release of ions from the glass.97
The limit point for the formation of an apatite layer is a network connectivity of 2.4.97
At this value, the network is too rigid to allow any glass dissolution or significant ion
release. These glasses are therefore classified as not bioactive enough. However, some
exceptions exist; indeed some glasses with a network connectivity higher than 2.4 exhibit
bioactive properties in vitro (e.g. 13-93115 and S53P4116 ), albeit at a very slow rate. To
understand that, it should be borne in mind that the network connectivity represents a
mere average value. The sites which show a lower local connectivity network (referred
to as floppy regions) allow the water to penetrate and ions to be released, leading to an
apatite surface layer formation. This process happens until there are no floppy regions
left. At this point, apatite is no longer formed and bioactivity goes down to zero.
The rate at which the apatite layer is formed has been shown to depend on many factors.
If the network connectivity is maintained, the apatite layer formation can be accelerated
by an increase of the phosphate content.117,118 The substitution of calcium by strontium
also increases apatite formation through the formation of a strontium-substituted ap-
atite.119,120 Studies also show that the presence of alkali metal ions such as Na+, K+, does
not necessarily enhance bioactivity, since alkali-free bioactive glasses have been shown to
form apatite at a similar rate to bioactive glasses containing them.118,121 Indeed, the high
amount of calcium present in the glass is enough to precipitate the apatite.
How the glass structure and the release of ions affect the apatite formation are important
factors when studying the dissolution behaviour of a glass that will exhibit slow apatite
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formation (e.g. non mineralising glasses for cartilage repair) or a fast one (e.g. for dental
application). Several types of bioactive glasses have been engineered depending on their
targeted applications: the ’conventional’ silicates such as Bioglass 45S5, phosphate-based
and borate-based glasses.
Figure 2.3: Rate of apatite formation of silicate based-glasses (t−1Ap, where tAp is the time
of first apatite formation in a simulated body fluid.18,122) (1990 and 2015) Reproduced
with permission of John Wiley and Sons.
2.1.2.2 Biological response induced by the dissolution of a bioactive glass
Once implanted in the body, bioactive glasses show osteoconductive properties; they are
able to bond to both soft and hard tissues, along with angiogenesis properties (in vivo and
in vitro), antibacterial and anti-inflammatory properties. This is summarised in Figure
2.4.46,60,123–125
Angiogenesis
Silicate and phosphate-based glasses Silicate-based glasses induce angiogenic differ-
entiation of different types of mesenchymal stem cells by influencing genes up-regulating
the angiogenesis such as genes encoding for vascular endothelial growth factor (VEGF)
and fibroblast growth factor.60,123
Concerning phosphate-based glasses, a high concentration of phosphate ions triggers an-
giogenesis processes in the lungs in mice.126 Indeed, phosphate ions induce an over expres-
sion of a type IV collagenase enzyme (matrix metalloproteinase-2; MMP2) which plays an
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Figure 2.4: Summary of the biological responses induced by the dissolution of a bio-
glass46,60,123–125
important role in the formation and growth of new blood vessels, the repair of damaged
tissues and inflammation.124 Finally, phosphate ions also induce an over expression of
fibroblast growth factor.126
Doped Glasses Among additive ions used as dopant for bioactive glasses, copper and
cobalt ions have been shown to have a positive effect on the angiogenesis properties of
glasses. Copper influences various factors inducing angiogenesis127,128 such as VEGF and
collagenase, which are important in all stages of the development of new blood vessels
and in the regulation of the blood vessel formation. Copper activates transcription factors
responsible for the initiation of angiogenesis.129
1% Cu-doped 45S5 Bioglass increases the formation of new blood vessels when tested on
rat arteries in comparison with Cu-free 45S5 composition.130 Cu-doped borate-based BGs
showed interesting results in terms of in situ healing of skin wounds in rats.131
Magnesium in bioglasses has been shown to stimulate the proliferation and migration of
microvascular cells.132–135 However, additional studies would be necessary to gain further
understanding of the effect of magnesium over angiogenesis.
Cobalt-doped bioglasses induce the over expression of angiogenic factors VEGF and fi-
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Table 2.1: Compositions (wt%) of 45S5, 13-93, 13-93-B1,
and 13-93-B3 Bioactive Glasses as used in the work of Bi et
al.153,154, Gu et al.155 and Wang et al.156
Name SiO2 P2O5 Na2O CaO K2O MgO B2O3
45S5 46.1 2.6 24.4 26.9 - - -
13-93 54.6 1.7 6 22.1 7.9 7.7 -
13-93B1 34.4 3.9 5.8 19.5 11.6 4.9 20.0
13-93B2 18.0 2.0 6 22.0 8.0 8.0 36.0
13-93B3 - 3.7 5.5 18.5 11.1 4.6 56.6
broblast growth factor.136,137 The use of doped-glass represents an interesting tool for
optimising the angiogenesis of a given glass or biomaterial.
Melt-derived silicate and phosphate-based glasses Studies, carried out to opti-
mise the bone regeneration properties of 45S5 glasses, have revealed the importance of
various factors such as the fabrication method, the inner microstructure, pore of the scaf-
fold and their composition.138
Porous BG scaffolds exhibit osteoconductive properties with a degradation rate of the scaf-
fold matching the bone formation rate.139–142 To control the porosity of the scaffold, some
studies used 3D printing manufacturing (indirect selective laser sintering) and developed
bioactive glass-containing 3D scaffolds.143–146 Those 3D scaffolds represent a promising
solution for the treatment of large bone defects.
Many different types of melt-derived silicate glasses have been developed and studied for
regeneration properties, using different manufacturing processes and have led to bioactive
glass fibres with different dimensions.147–151
Phosphate-based glasses are an interesting group of materials as their dissolution be-
haviour can be tailored by their composition and the addition of metal oxide such as
TiO2, CuO, NiO, MnO, and Fe2O3.
54,152 Calcium phosphate-based glasses can therefore
be tailored so that their composition matches that of the bones.152
Antibacterial Properties
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Bioactive glasses and body fluids When bioactive glasses are immersed into a physi-
ological environment, they start dissolving following various dissolution stages summarized
by L. Hench24 as shown in Figure 2.2. This dissolution is accompanied by the release of
various ions such as Na+, K+, Ca2+ which are exchanged with ions present in the body
(H+ or H3O
+). This exchange of ions leads to an increase in the local pH from 7 up
to 10 rendering the local environment alkaline. Additionally, the release of ions from
the BG surface increases the salt concentration and hence the osmotic pressure.157 These
two mechanisms ensure the inhibition of bacterial growth and their potential subsequent
adhesion and contamination of implants.158 The sudden increase of pH induces a lot of
stress for a bacteria, which tries to survive by changing its morphology and structure,
triggering a modification of numerous genes and proteins patterns.159
Following the dissolution of the glass, the pH increases due to the observed liberation
of sodium ions.160 In parallel, a decrease of bacterial activity is observed until the pH
reaches a neutral value. This suggests the importance of the dissolution mechanism in
the control of bacteria development.161 However, the effect is diminished in vivo because
of the buffering media used. Various bioactive glasses (in composition, size and shapes)
have been tested against many bacteria. They have shown efficiency in killing bacteria
and inhibiting biofilm growth.162–170
Doped glasses Several ions have been shown to exhibit antibacterial properties such
as copper (Cu), phosphate (P), strontium (Sr), zinc (Zn) and have been incorporated
into the structure of glasses. They have been shown to enhance antimicrobial effect in
glasses.171,172
2.2 Bioactive fluoridated phosphate-based glasses for
hard tissue engineering
Phosphate-based bioglasses (PBGs) are used in many different biomedical fields such as
orthopaedic and dental surgery.26,27 It has been shown that depending on the formulation
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of the glass, they are able to enhance bone cell growth and antigen expression.46 This
type of glasses is mainly based on P2O5, Na2O and CaO entities.
25 Modifying oxides
can be added depending on the targeted applications: CuO for antibacterial properties35,
TiO2 and SrO to improve degradation properties
36,37, Ag2O to enhance antibacterial
properties38, Fe2O3 to increase the chemical durability and enhance cell attachment and
differentiation32, and TiO2 to enhance cell viability
41.
PBGs can be manufactured in various shapes such as discs28, microtubes29, microspheres30,31
and fibres32,33. Hence the use of PBGs in various applications: fibres can be used as cell
transportation device32, nerve conduct27 or muscle regeneration34. Microtubes can eas-
ily be incorporated in bio-polymers and used for soft and hard tissue regeneration. The
morphology of microsphere represents an ideal environment for cells to attach and prolif-
erate.36 This feature also helps to prevent tissue damage and haemorrhage hence the use
of the latter in radiotherapy application.173
2.2.1 Phosphate-based glasses
PBGs present many properties27,94, the most interesting of which would be the complete
dissolution of phosphate glasses in an aqueous environment. This feature is of high interest
in the biomedical field. Additionally, the dissolution behaviour can easily be controlled by
the glass composition and chemistry. Interestingly, these glasses can be synthesised with
ions that can usually be found in the body. PBGs represent a unique group of materials
that differ greatly from the silicate-based ones.
The chemistry of phosphate compounds leads to interesting structural differences in glass
formation compared to silica starting network forming oxide, as illustrated in Figure
2.5.174 In vitreous P2O5, the tetrahedral network is not fully polymerised unlike in the
silica network. This property is due to the non-bridging and terminal oxygen atoms
(double bonded) found in the vitreous P2O5.
The most commonly used oxides in phosphate bioactive glasses are the sodium oxide
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Figure 2.5: Illustration of the basic silicate and phosphate tetrahedra.
(Na2O) and the calcium oxide (CaO). These oxides have different effects on the glass
structure, as shown in Figure 2.6174, where the calcium ions adopt a chelating structure,
as they have the potential to bond with the oxygen atoms of two different chains of the
phosphate glass and therefore render the glass more resistant to dissolution. This is due
to the calcium ions’ higher field strength which leads calcium ions to bond preferably to
non-bridging oxygen at the expense of Na.174 According to the Dietzel definition, the field
strength F can be defined as F = Z/a2, where Z represents the charge of the modifier ion
and a the length of the modifier oxygen bond in a tetrahedron.175 Figure 2.7 spotlights
the three main building blocks which can be found in phosphate based glasses with the Q1
or end unit, the Q2 or middle unit and the Q3 or branching unit. The structure of phos-
phate glasses still needs to be better understood and it generally depends on the [O]/[P]
ratio. However, previous works176–178 have helped gain understanding on their complex
structure. In the work of Hoppe176 it was found that a binary system, only constituted
with P2O5 as network formers, initially presents a substantial excess of terminal oxygen
atoms in comparison with bridging oxygen atoms. As the metal (M) is added, it will first
occupy positions with a high coordination number which are the terminal oxygen atoms
forming an M-O-P link. When all of these sites are occupied and if the content of M is
further increased, a modified random network is developed. This point is reached when
the content of metal oxide exceeds 30 mol%.
Concerning the glass composition (Na2 O)0.55-x(CaO)-x(P2O5)0.45, the basic dissolution
characteristics were investigated.18,94,179,180 The work of Knowles et al.94 does not present
an exhaustive analysis of the dissolution-composition relationship but the main relation-
ships have been studied. As shown in Figure 2.8, the weight loss per unit area against
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Figure 2.6: Schematic representation of difference between the bonding of Na and Ca
in phosphate glasses. The work of Christie et al.174 shows that this schematic is an
oversimplification. (2013) Reproduced with permission of the American Chemical Society.
Figure 2.7: Main building blocks94 (2003) Reproduced with permission of the American
Chemical Society.
both time and CaO content was studied at a constant amount of P2O5 of 45%.
Generally, the more the CaO content is increased, the lower the dissolution rate.94,179,180
The dissolution rate also appears linear in comparison to time. This property of phosphate-
based glasses is very important as silicate-based glasses do not exhibit it. Indeed they
have different dissolution mechanisms. For this reason, the linear dissolution rate in PBGs
is a real advantage when the release of therapeutic elements must be controlled.
However, between a CaO content of 32 and 40 mol%, the non-linear dissolution rate in-
dicates a two-staged degradation process.94 Initially, a high dissolution rate is observed,
the latter decreasing significantly after 10-20 hours. This two-staged degradation process
is due to the ion release’s profile.
Analysis of the ion release showed that sodium ions are released at a very high concen-
tration, in the case of high dissolution rate glasses, and during the early stage of the
dissolution as shown in Figure 2.9. This is also observed for glasses with a high level of
Na2O (which tend to exhibit the highest dissolution rate). These observations suggest a
preferential release mechanism during the early stage of degradation. These values were
supported by pH measurements which presented a rapid increase for all compositions.
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This suggests that Na+ release leads to a migration of H+ back into the glass to ensure
charge balancing and leaving an excess of OH− anions. Concerning calcium ions, the
opposite is observed, with glasses containing the lowest amount of calcium (the highest
dissolution rate glasses) exhibiting the highest release of Ca2+ (Figure 2.10).
Figure 2.8: Effect of CaO content on the weight loss per unit area against time between
CaO content of 24 and 40 mol% and inset an enlargement of the region from 32 to 40
mol%.27,94,180Reproduced with permission of the American Chemical Society.
Figure 2.9: Change in sodium ion concentration in distilled water with time for glasses
with 8, 24 and 40 mol% CaO (45 mol% P2O5 and the balance is Na2O)
94Reproduced with
permission of the American Chemical Society.
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Figure 2.10: Change in calcium ion concentration in distilled water with time for glasses
with 8, 24 and 40 mol% CaO (45 mol% P2O5 and the balance is Na2O)
94Reproduced with
permission of the American Chemical Society.
2.2.1.1 Fluoridated phosphate-based glasses
Over the last few years, an increasing number of bioactive glasses have been developed,
most of them with incorporated ions exhibiting potential therapeutic effects. Examples
are calcium ions which favour osteoblast differentiation and apatite precipitation42, stron-
tium ions which stimulate bone forming cells43 and silver ions which exhibit antibacterial
properties39,40. Zinc ions are known to be bactericidal and essential for wound healing
at the right concentration15 and also stimulate bone formation44, and fluoride ions are of
high interest for dental applications18,46.
Glasses are not as dependent on a specific stoichiometry as crystals are, therefore they
allow more flexibility in composition.18 A various concentration of ions, with physiological
activity and/or therapeutic properties, can therefore be incorporated.
Therapeutic ion release According to in vitro cell culture studies, it has been shown
that ionic dissolution products from bioactive glasses affect cell proliferation, mineralisa-
tion and gene expression.18,46 These ions are released during the dissolution process to
perform their therapeutic action in the human body. The great advantage of ions re-
leased locally and from an implant (rather than administrated medication) is that they
have a targeted action on the desired site. The therapeutic effect is therefore optimised
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and the side effects are minimised. Furthermore, the continuous glass degradation gives
the opportunity for the ions to be released continuously and the therapeutic effect to be
sustained. As mentioned in the section 2.1.2.1, the released rate can be adjusted, studied
through variation of the glass network and type of modifiers or intermediate ions, and
with the accurate study of the structure of these bioglasses using molecular dynamics
simulations.
Interest of fluoridated bioactive glasses in biomedical applications Fluoride is a
component of high interest in dental application as it prevents caries.45,46 Indeed, fluoride
in dentistry presents three main benefits:
• The enhancement of tooth enamel remineralisation47
• The inhibition of enamel demineralisation47
• The inhibition of bacterial enzymes48,49
CaF2 has been shown to inhibit the formation of alveolar cavities.
181 Moreover, it has
been shown that fluoride-containing bioactive glasses form fluoroapatite in physiological
solutions.47,118,121 This fluoridated form of hydroxyapatite, which is the main component
of the tooth, is more stable against acid attacks than hydroxyapatite.182 Additionally,
the composition of phosphate-based bioglass which is similar to tooth’s composition helps
reduce hypersensitivity by filling the microtubule of the teeth.183 A toothpaste containing
very fine Bioglass 45S5 particulates is commercialised. The latter is a fluoride-containing
toothpaste where the common abrasive additive in toothpaste, alumina particles, is re-
placed by Bioglass 45S5 which is a silicate-based glass. Clinical studies show that the Bio-
glass 45S5 particles adhere to the dentine and form an hydroxycarbonate apatite (HCA)
layer that is similar in composition to tooth enamel and blocks the tubules, which are
approximately l µm in diameter, relieving the pain for longer periods. Figure 2.11 shows
the results obtained with Sensodyne Repair and Protect toothpaste R©.184
Furthermore, studies have shown the efficiency of fluoride in promoting bone forma-
tion and, with the right concentration, in preventing osteoporosis-related fractures.185,186
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Figure 2.11: (a) Photograph of Sensodyne Repair and Protect toothpaste R©, which
contains NovaMin R©, a fine particulate of Bioglass 45S5 R©. (b) SEM image of
NovaMin R©particles (bar = 20 lm). (c–f) SEM micrographs of human dentine (bar =
1 lm): (c) untreated, (d) immediately after application of NovaMin in artificial saliva
(AS); (e) 24 h after application of NovaMin R©in AS; (f) 5 days after application. SEM
images modified from Earl et al.184 (2002) Reproduced with permission of John Wiley
and Sons.
Fluoride-releasing bioglasses have therefore been used in bone-regeneration applications
as well as for dentistry.
2.2.1.2 Unsuitability of silicate-based glasses
Fluoride-containing silicate-based bioactive glasses have been synthesised and used in
toothpaste to treat dentine hypersensitivity as shown in Figure 2.11.18,184 In the past,
fluoride atoms were assumed to replace oxygen atoms in silicate glass by forming a Si-F
bond.105 However, recent studies show that in reality, clusters of fluoride/modifiers cations
are formed, with no Si-F bond detectable. This was determined by 19F MAS-Nuclear
Magnetic resonance (NMR) and Molecular Dynamics simulations.93,187–189 As shown in
Figure 2.12, fluoridated silicate-based glasses show a very small amount of Si-F bonding.
The conclusion was that the incorporation of fluoride leads to the formation of modifier
cations, and fluoride rich regions which are highly soluble, and silicate rich regions which
are poorly soluble in a physiological environment. This ion clustering reduces bioactivity.
24 Chapter 2. Literature Review
It was concluded that the addition of fluoride in silicate BGs decreased bioactivity and
the resulted fluoridated BGs are unsuitable for a use as biomaterials, as the ion clustering
will lead to a discontinuous hydroxyapatite layer formation on the surface of the bioglass
in contact with water.190
Figure 2.12: Fluoride environment in a bioactive glass (45S5 with 15% of CaO replaced
by CaF2) obtained by MD simulation: the area in the white circle is enriched in fluoride
ions (green), charge-balanced by calcium (pink) and sodium (blue) cations.190 (2008)
Reproduced with permission of the American Chemical Society.
2.2.2 Study of the bioactivity of phosphate-based glasses through
experimental data and its limitations
As shown in the example above (Section 2.2.1.2), bioactivity and structure are closely
related. Therefore, to study the bioactivity of a given glass, it is essential to study its
chemical structure. Many different techniques can be used to help analyse the structure
of glasses36, such as X-ray, Fourier Transform Infrared (FTIR), Raman spectroscopy or
Nuclear Magnetic Resonance(NMR).
Probing the structure of phosphate-based glasses: Analytical techniques X-
Ray diffraction analysis provides information on the disordered and amorphous global
structure.36,191,192 It is a useful and important tool to help prove the absence of any crys-
tal structures within the glasses.192,193 The amorphous nature of a glass is an important
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feature that is critically linked to its biological behaviour and degradation.194–196 Addition-
ally, bioactive glasses have by definition an amorphous structure, whereas glass-ceramics
have partial crystalline structures197, hence the necessity to characterise the structure
using XRD, where a crystal structure would be signalled by the presence of one or more
sharp peaks.
FTIR provides information on the type of atom bonds and local coordination.198 This
high energy diffraction method can be used in complement with Raman spectroscopy.199
These techniques help analyse the structure on the length scale of the nearest neighbour
and have been frequently used to probe the structure of glasses.69,117,192,193,200–203 They
are based on both absorption and scattering of electromagnetic radiations. These radia-
tions obtained have different wave-numbers which are corresponding to the vibration of
different chemical groups of a molecule.
NMR is also a commonly used method as it is element specific.204,205 More particularly,
solid state NMR can provide a lot of information on glass structure, as 31P is one of
the most receptive nucleus due to its large magnetic moment.206 NMR is usually used in
conjunction with magic angle spinning (MAS)207 with solid power being rotated rapidly
at 54.7◦ to the main magnetic field, which cancels the effect of anisotropy and greatly
improves the resolution. Under these conditions, the Qn species can be observed due
to the differing isotropic chemical shifts.16,121,177,187,208–211 MAS NMR has been used on
binary, ternary and more complex systems.94,189,212–214 Other methods such as absorption
spectroscopy (XAS)215 and neutron scattering can be used in more specific cases to obtain
accurate structure analysis.
Experimental study of fluoridated phosphate-based glasses Fluoridated phosphate-
based glasses have been experimentally studied and more specially, the role of fluoride
has been underlined in phospho-silicate (glasses containing both silicate and phospho-
rus as network formers)216, alkali phosphate217 and tin phosphate glasses218. Concerning
phospho-silicate glasses216, 19F and 29Si MAS NMR have helped to show that the addition
of CaF2 leads to the formation of calcium sodium fluoride species and no Si-F bonding was
observed. 23Na MAS NMR highlighted the presence of sites where the coordination num-
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ber between Na and F augments with the increase of CaF2.
31P MAS NMR demonstrated
the presence of orthophosphate with no Si-O-P bond present. Finally, it was observed
that the glass transition decreases with the addition of CaF2 and this can be explained
by the hypothetical presence of CaF+ as no Si-F bonding was observed.
In alkali-phosphate glass, 19F, 27Al and 31P MAS NMR have been used to study the influ-
ence of fluoride in the Na-P-O and Na-Al-P-O bondings.217 In sodium phosphate-based
glasses, this study observed the formation of a P-F bonding where F replaces the oxygen
in the phosphate tetrahedra. However, in aluminium glass, MAS NMR revealed the for-
mation of F-Al bonding.217
High resolution X-ray photoelectrons spectroscopy and Raman microscopies have been
used to investigate the structure of 50SnF2-20SnO-30P2O5 glass.
218 The results showed
a high non-bridging oxygen amount. However, to complement these experimental re-
sults, theoretical calculations have been implemented. Indeed, experimental study has its
limitation that can be complemented by computational calculations.
Limits of the experimental data Computational simulation methods such as molec-
ular dynamics219–223, ab-initio93,93,224–228 or density functional theory (DFT)
189,218,226 can be used as a complement to experimental data. Indeed, experimental data
often lacks precise information with regards to the atomistic and microscopic structure
within the glass, and how network modifiers affect its structure.218 Molecular dynamics
simulations have often been used as a complement to experimental data by showing dif-
ferent effects109,222,223,225,229–231 which are linkable to the bioactivity, such as the tendency
of modifiers to form clusters, the coordination environment of network formers, inho-
mogeneities and the existence of chain and ring nano-structures. Additionally, in some
cases the acquisition of experimental measurements has proven to be complicated, time
consuming or even unattainable.226,227 Therefore, simulations appeared an efficient and
reliable way to map out relevant structural features and link the composition of PBGs to
their structure and solubility. Some bonds are not visible through MAS NMR, an example
would be the Si-F bond in fluoridated silicate-based glasses.189
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2.2.3 Study of the bioactivity through computational simula-
tions : computational techniques and previous works
Atomistic computational models are powerful tools that aim to mimic the behaviour of
a large and complex system. To do so, these models are programmed to explicitly take
into account the smallest constituent of the system. In materials science and chemistry,
an atomistic model is based on precise calculations that model of the atomistic structure
of larger systems e.g molecules and crystals.
2.2.3.1 Polarisable force field development and potential models
The use of polarisable force fields is crucial to obtain a correct description of medium
range structure and hence the bioactivity of a bioactive glass.227 The role of the force
field is to model accurately the atomistic structure of a studied system. The potential
model represents the most important part of a simulation. Indeed, the reliability and
accuracy of the calculated structures and energies rely on the quality and accuracy of the
potential model used. The potential model aims to describe the interactions between the
atoms within the systems. The energy of a system is sometimes written as an expansion
of interatomic potential, as shown in the equation 2.1. In principle the internal energy
of a solid is a many-body quantity. The later depends on the position and momenta of
all electrons and nuclei. This makes the problem impossible to solve, and therefore some
approximations must be made to simplify the calculations. For this reason, the energy
of the electron is presumed to be mostly embedded into its corresponding atom, and the
energy can be decomposed into an expansion in terms of interactions between different
subsets of the total number of atoms, N :
V =
N∑
i=1
Vi +
1
2
N∑
i=1
N∑
j=1
Vij +
1
6
N∑
i=1
N∑
j=1
N∑
k=1
Vijk (2.1)
where i, j and k are atoms. The first term represents the self-energy of the atoms, the
second the two-body interaction, etc. In order to keep this decomposition as accurate as
possible, it has to be performed at a high enough order, bearing in mind that the contri-
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bution from higher order terms is smaller for most systems. In that sense, when reaching
a certain order, terms above it are neglected. To compensate, a degree of parametrisation
for the remaining terms is introduced. Since the further apart two atoms are, the weaker
the interactions, a cut-off distance can be introduced to simplify the computational task.
The interactions between the atoms can be expressed by many different potential func-
tions, the form of which are usually chosen based on the physical insight of the nature of
the forces between the particles.
Long range energy contribution
Coulomb summation In ionic material, the Coulomb forces can represent up to 90%
of the total energy depending on the type of material. It is therefore by far the most
dominant term, expressed by the following Coulomb’s law:
UCoulombij =
qiqj
4piorij
(2.2)
where q is the charge of the ions i or j, o is the vacuum permittivity and rij is the distance
between the ions. To sum the interactions between the numerous ions , a summation
technique which is called the ’Ewald summation’ was used.232
Ewald summation The Ewald summation enables the computation of long range in-
teractions within a periodic system. Since the coulombic part is a long range interaction,
the summation is non-convergent when carried out in real space. Additionally, the con-
vergence depends on the number of atoms in the summation. The Ewald summation232
provides a solution to this problem. To do so, in small to moderate-sized systems, the
electrostatic energy is evaluated through the Ewald summation: the inverse distance is
rewritten using Laplace transform technique and then split into two rapidly convergent
series: one is summed in real space and the other in reciprocal space. A reciprocal lattice
is a Fourier transformation of another space. The first lattice is a periodic spatial func-
tion in real space. The electrostatic potential of an ion can be resolved into two parts.
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Therefore, the resulting energy can be expressed using the expressions:
Erecip =
1
2
· 4pi
V
∑
G
exp(−G2/4η)
G2
·
∑
i
∑
j
qiqjexp(−iGrij)
Ereal =
1
2
·
∑
i
∑
j
qiqjerfc(η
1/2rij)
rij
(2.3)
where η is the parameter controlling the distribution of the summation between real and
reciprocal-space, q is the ion charge, G is the reciprocal lattice vector and V is the unit
cell volume. The optimal value for η is described as follows233:
ηopt =
(
nwpi3
V 2
)1/3
(2.4)
where w is the relative computational expense for the operations involved, n is the number
of species in the unit cell, including shells, and V is the unit cell volume.234 Values for w
have been studied in order to obtain the optimal value.233,235.
Representation of the ion charges
Rigid Ion Model The rigid ion model was proposed by Kellerman in 1940236 for the
calculation of lattice dynamics of NaCl. Later on, a modified rigid ion model (M.R.I)
was developed. In this model, fixed partial charges are used and the ionic polarisability is
neglected.237 Nowadays, some more realistic approximations are used such as the deforma-
tion model238, the breathing shell model239 and the shell model240. The shell model has
been proven to provide more accurate representation of medium range structure compared
to rigid ion model.227 In this work, only the latter will be discussed.
Electronic polarisability of ions: Shell Model The shell model was first developed
by Dick and Overhauser.240 This model takes into account the electronic polarisation of
the atoms. An atom is polarisable if it develops a dipole moment when placed in an
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electric field. This dipole moment is commonly expressed by the equation:
µ = αE (2.5)
where µ is the induced dipole, E is the electric field and α is the polarisability.
In a static shell model, the ion is split into a core and a massless shell, hereafter called
the core-shell unit. In this simple mechanical description, the core can be represented by
the nucleus of the atom. The core contains the mass of the ion and a charge Q. The shell
approximately represents the valence electrons and is also attributed a charge q. The total
charge of the sum (Q + q) is always equal to the total charge of the atoms. Figure 2.13
shows a schematic representation of this shell model. There is no electrostatic interaction
(i.e self interaction) between the core and the shell of the same atom. Non-coulombic
interactions arise from the shell alone. Finally, the core and shell are connected by a
Figure 2.13: Schematic representation of the shell model
harmonic spring with a constant k, hence the following interaction energy :
U(ri) =
1
2
kir
2
i (2.6)
where k represents the force constant of the harmonic spring, and r the distance between
the core and the shell. The position of the core is important as it gives the exact ion
position in the lattice, unlike the shell position which has no physical meaning. At the
beginning of the simulation, core and shell are usually given the same position. The
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electric field aims at separating the core and the shell, giving rise to a polarisation dipole.
The short-range forces affect the polarisability which becomes environment-dependent.
When a static equilibrium is reached, the polarisability can be expressed through the
equation:
α = (2q2s − q2c )/k (2.7)
where qs and qc are the shell and core charges and k is the force constant of the harmonic
spring.
In an adiabatic method, the shell is attributed a fraction of the atomic mass, in order
to have a dynamical description. This fraction of mass m is chosen according to the fre-
quency of vibration of the harmonic spring (equation 2.8), which has to be much larger
than the frequency of vibration of the whole atom in the bulk system. This condition
should be respected in order to avoid any exchange of kinetic energy between the core-shell
unit and the rest of the system. Indeed, two core-shell units are linked with a harmonic
bond. Therefore, the core-shell units should have a negligible internal vibrational energy,
compared to the vibrational energy of the bond linking the two atoms. This should re-
main throughout the whole simulation in order to maintain a net polarisation. However,
during the simulation, there is a slow leakage of kinetic energy into the core-shell units,
but this represent a negligible amount of the total kinetic energy and can be corrected by
a frictional term. The polarisation of the ion is described in terms of displacement of its
shell with respect to the core.
µ =
1
2pi
(
k
x(1− x)m
)1/2
(2.8)
where x is the displacement. In DL POLY ( the code used to run the simulation), the
adiabatic method is used.
Short range two-bodied potential functions To run an accurate molecular dynam-
ics simulation, an exact potential function must be defined. A potential function describes
the energy with which the particles will interact. Indeed, the functional form and param-
eter sets are used to describe the potential energy of the system. This potential function
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can also be referred to as an interatomic potential or a force field. For an interatomic
potential, the functional term includes a bonded term, for covalently linked atoms, and
a non-bonded (or not covalent) term, comprising long-ranged electrostatic and Van Der
Waals forces:
VTOTAL = VBONDED + VNON−BONDED (2.9)
Bond Stretching term
VBONDED =
∑
BONDED
1
2
kB(r − req)2 (2.10)
Where kB is the force constant of the bond, r the bond length and req the equilibrium bond
length. However, in the case of this project, only ionic solid ionic solids are discussed,
therefore this term was neglected.
Van der Waals The Van Der Waals forces describe the residual attractive and repulsive
forces between the atoms. Depending on the type of bond between the two atoms, the Van
Der Waals terms can be expressed by different equations: Lennard-Jones potential241,Born
Mayer potential242, Morse Potential243, Buckingham potential244, Born-Huggins-Meyer
potential245, Hydrogen-bond (12 - 10) potential246, Shifted force n - m potential247 and
others. Those of relevance to this study which are the Buckingham, Morse and Lennard-
Jones potentials and will be discussed here.
Lennard-Jones potential For large systems, the Lennard-Jones potential241 provides
an accurate description of the interactions between non-bonded ions. The potential func-
tion, shown below, can be decomposed into an attractive term, usually − 1
r6
which predom-
inates at a long distance r and a repulsive term which usually is 1
r12
which predominates
at a short distance r.
V (uij) =
A
r12ij
− B
rij6
(2.11)
where A = 4σ12 and B = 4σ6 with  being the depth of the potential well or more
practically representing the attraction strength of two particles, σ, the finite distance
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where the two-body potential is equal to zero and r being the distance between the
particle.
Buckingham potential The Buckingham potential244 is one of the most commonly
used potential for two body non-bonded interactions in ionic solids. The potential is
expressed as follows:
V (rij) = Aije
−rij
ρij − Cij
r6ij
(2.12)
where Aij, ρij and Cij are the Buckingham potential parameters for interactions between
the atoms i and j. The short-range repulsion is represented by the first term and the long
range attraction, which dominates at larger separation, is represented by the second term.
The inclusion of the exponential term makes the use of this potential more computationally
expensive. However, this exponential function is a more accurate estimate of the repulsive
term.
Morse potential The Morse potential243 is a function which accurately describes the
interactions between two atoms where a dissociation is possible. Thie potential is useful
in the case where interactions at bond distance display a non-harmonic oscillator, such
as OH bond in hydroxy group or for the P-O interaction in the PO4 tetrahedron group.
The Morse potential realistically takes into account that dissociation can occur unlike the
Harmonic potential, and can be expressed by the following expression:
V (rij) = D(1− e[−α(rij−ro)])2 −D (2.13)
where D is the bond energy, ro is the equilibrium separation and α is a variable that can
be determined by spectroscopic data and represents the slope of the potential energy well.
The Morse potential can also include a subtraction of the Coulomb interaction as follows:
V (rij) = D(1− e[−α(rij−ro)])2 −D − Cqiqj
r
(2.14)
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where qi and qj are the charges of the ions i and j respectively, C is the fraction of the
Coulombic subtraction, and the value of 1.0 means that no Coulombic interactions exists
between the atoms. For a value of C = 0, the equation reduces to the original Morse
potential with full Coulombic interaction.
Three body potential function The three body potential is used to describe the
interactions between three atoms , as shown in Figure 2.14, where j and k are linked in
the middle by a third atom i. The energy of the system is proportional to the deviation
of the angle from the equilibrium angle, θijk. This three body potential also known as the
’bond bending term’ introduces an energy penalty for any deviation from the equilibrium
bond angle θ0, and is written as follows:
V =
1
2
kijk(θijk − θ0)2 (2.15)
Figure 2.14: Schematic representation of the three body interaction.
where kijk is the bond bending force constant between the bond ij and ik.
Potential Derivation The potential functions, shown above, are used to accurately de-
scribe the energy of a system. However, they all require some parameters to be set. These
parameters can be evaluated by two different methods : an empirical derivation fitting or
a direct calculation method. These methods are detailed in the following sections.
Empirical fitting Empirical fitting is a way to determine the potential parameters of a
given potential function.248 To do this, the structural and lattice properties of bulk crystals
of interest are used. The aim of empirical fitting is to allow the potential parameters
to vary one or more at a time, and to calculate crystals properties such as elastic and
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dielectric constants, phonon dispersion curves, vibrational frequencies, and structural and
lattice properties. The aim is to reproduce as closely as possible the data from the crystals.
To evaluate the accuracy of the fit, the sum of squares is often calculated (Equation 2.16).
The parameters are considered satisfactory when the sum of squares is at its lowest value,
which means that the parameters set lead to the calculated properties closest to the initial
data.
F =
∑
all−observables
w(fcalc − fobs)2 (2.16)
where fcalc and fobs are respectively the calculated and observed quantities used for the
fitting, and w is the weighting factor. This weighting factor depends on different param-
eters, such as the relative magnitude of the quantities and reliability of the data. For
instance, the lattice parameters are generally given a higher weighting factor as they can
be measured more accurately than other properties. As an infinite number of possible fits
exist, depending of the weighting factors, there are multiple fits possible. It is important
to use sufficient experimental data when fitting a potential function by using multiple
structures.233
Direct calculation method The direct calculation method of deriving potential pa-
rameters is based on quantum mechanical calculation, either by electron gas methods or
ab initio calculation249, local density approximation methods or with embedded atoms
methods (EAM).
The interaction energy between a periodic array of atoms can be calculated for a range
of distances, and resulting potential energy curve is fitted to a suitable functional form.
This method can calculate potentials for any interaction, but it may be dependent on the
availability of suitable basis sets.
Such a method would not be adequate for the type of study conducted here. Indeed, the
size of the system studied would require a colossal amount of computer time to be able
to apply any quantum mechanical calculations.
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2.2.3.2 Classical molecular dynamics simulations
Classical molecular dynamics219,220 (MD) is a computational simulation technique. This
method was originally developed for the field of theoretical physics in the late 1950s.250,251
In this model, the ions in the crystal interact via long-range and short-range electrostatic
forces, including the repulsions and the Van der Waals attractions between neighbouring
electron charge clouds. The time evolution of a set of interacting particles can be calcu-
lated by integrating Newton’s second law. If we consider the example of one particle in
movement and under the influence of a force ~F (~r) :
m
d2~r
dt2
= ~F (~r) (2.17)
where for N interacting particles the classical equation of motion is
m
d2~r
dt2
= Fi(r1, r2, ....., ri, ...., rN), i = 1, N (2.18)
Verlet scheme This algorithm252 is the most commonly used to integrate the equations
of motion. This algorithm was initially adopted by Verlet and relies on a direct solution
of a second-order equation:
mir¨i = fi (2.19)
where mi is the mass of the atom, i, ri is the Cartesian coordinate, and fi is the force
on the atom i. This method is based on the position r(t), the accelerations a(t), and the
positions r(t − δt) for each particle form the previous step. The equation for advancing
the position is:
r(t+ δt) = 2r(t)− r(t− δt) + δt2a(t) (2.20)
In this equation the velocities do not appear. They have been eliminated by the addition
of the equations obtained by Taylor expansion about r(t)
r(t+ δt) = r(t) + δtv(t) + (1/2)δt2a(t) + ... (2.21)
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r(t− δt) = r(t)− δtv(t) + (1/2)δt2a(t)− ...
They are useful to estimate the kinetic energy and hence the total energy of the system.
This can be obtained through the formula:
v(t) =
r(t+ δt)− r(t− δt)
2δt
(2.22)
where the error of velocities in the equation 2.22 is of the order of δt2 and the error of the
equation is of error of δt4.
Calculation step In molecular dynamics, the simulation period is divided into a set of
calculations, each occurring over very short time steps ∆t, which are typically between
10−16−10−15 sec. During these time steps, the forces of each atom are computed, and the
accelerations are calculated to generate a new set of positions for the atoms and initial
velocities for the next step. Then the atoms are moves to new positions and the pattern
is repeated again. Small time intervals are usually selected, so that the forces can be
considered as constant.
At the end of the simulation, a dynamical trajectory is generated. These data describe
the time evolution of the dynamic variable ~pi and ~ri for each particle and over the simu-
lation time. The microscopic dynamical behaviour of the system is described by a set of
trajectories constituted of each particle in the system.
Born Model of solids In this model242,253, it is presumed that the energy and its
derivatives can be calculated by summing all the interactions between the atoms in the
system. This summation results in the development of a total interaction and total net
force acting on each atom towards each other. This method relies on the calculation of the
total energy of the lattice. The energy interaction of each atom to the others is expressed
as follows:
Ui =
1
2
∑
j
(
qiqj
4pi0(rij)
+ φijrij) +
1
3
∑
jk
φijk(rijk) +
1
4
∑
jkl
φijkl(rijkl) + ... (2.23)
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The first term represents the long range Coulomb energy and the short range interaction
between two atoms. The second and third characterise the interaction between three or
four atoms, referred to as three or four body interactions. φij is the short-range energy
between the ions i and j, rij is the distance between the atoms i and j respectively and
qi and qj represent the charges on them. As for the lattice energy of the system, it can
be calculated with the following expression:
Ulatt =
∑
Lij
(
qiqj
4pi0
(rijL) + φijLrijL) +
∑
Lijk
φLijk(rirjrk) +
∑
Ljkl
φLijk(rirjrkrl) + ... (2.24)
where L is a set of lattice vectors representing the periodicity of the lattice itself in three
dimensions. For instance, this changes rij to rij + L and similarly for rijk.
Statistical mechanics
Boundaries and ensemble In computer simulations, the studied material can be rep-
resented by a model. This model should ideally be as large as possible; however, the size of
the model is limited by the computational expenses. The more atoms the model contains,
the more expensive the simulation is. To tackle this issue, hundreds up to thousands of
atoms are put in a bo, known as a simulation box. All the structure calculations are
carried out within this box. Thereafter, the box is duplicated in every direction to give an
infinite lattice, as shown in Figure 2.15. As a particle moves during the simulation which
is due to the influence of interatomic forces from the neighbouring atoms, the replica of
this particle undergoes the same interatomic forces and therefore the same movement.
This applies even if the particle happens to leave the initial simulation box; its image will
enter the box through the opposite side so that the number of particles within the box
is conserved. Periodic boundaries conditions are introduced to avoid modelling too many
atoms on a surface at any one time, which would be computationally expensive, and also
to avoid the appearance of any surface atoms.
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Figure 2.15: Schematic representation of the simulation boxes in 2D. Particle trajectories
shown in the central simulation box (yellow) are replicated in every directions.254
Ensembles There are different thermodynamic conditions, under which a simulation
box can be run; these are known as ensembles.255 The common ensembles under which
simulations are run ar as follows:
- Micro-canonical ensemble (NVE): in this thermodynamic state the number of atoms N,
the volume V and the total energy of the system E are fixed.
- Canonical ensemble (NVT): in this ensemble, the number of atoms N, the volume V and
the temperature T, and therefore the kinetic energy, are fixed.
- Isothermal-isobaric ensemble (NPT): this thermodynamic state is characterised by a
fixed number of atoms N, pressure P and temperature T.
- Grand-canonical ensemble (µVT): this thermodynamic state is characterised by a fixed
chemical potential µ , a fixed volume V and a fixed temperature T.
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The choice of the ensemble is based on the simulated systems and on the targeted com-
puted properties.
2.2.3.3 Ab initio Molecular Dynamics
Ab-initio Molecular Dynamics224(AIMD) can be presented as a combination of quantum
mechanical electronic structure calculation and classical molecular dynamics calculation.
Ab-initio Molecular Dynamics does not rely on the development of an accurate potential
force field, but combines electronic structure calculation with finite temperature dynamics
to describe events involved in chemical transformations. This method is more expensive
but provides more accurate results.
There are three ab-initio molecular dynamics approaches which all rely on the Born Op-
penheimer approximation: Ehrenfest MD, Born-Oppenheimer MD and Car-Parrinello
MD.
The Born-Oppenheimer MD is based on the Born Oppenheimer approximation, which
assumes that the position of the atoms is a function of the propagated forces.256
Ab-initio has not been used in this research due to the size of the model studied. Simu-
lating such a large model would lead to significant computational expenses and time.
2.2.3.4 Previous works: the debated role of fluoride ions in PBGs
Both ab-initio and molecular dynamics have been used to model the atomistic structure
of fluoridated phosphate-based glasses. The two methods led to opposite results casting
ambiguity over the influence of the addition of fluoride to PBGs.
Ab-initio MD of structural changes associated with the incorporation of flu-
oride in BGs Christie et al.225 used first-principles Born Oppenheimer Molecular Dy-
namics (MD) simulation to create accurate models of two phosphate glass compositions
with different fluoride contents (Table 2.2). The atomic forces were computed from a
quantum mechanical representation of the electronic structure. This expensive method
is limited to small models, but provides highly accurate results that do not rely on the
generation of an empirical force field. The aim of this work was to characterise the atomic
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Table 2.2: Simulated Compositions, their densities and size. The fluoride-free F0 com-
position is included as reference225
Composition P2O5 Na2O CaO CaF2 Density Number Cell size
mol % mol % mol % mol % (g.cm−3) of atoms (A˚ )
F0 50.0 20.0 30.0 0.0 2.585 Not simulated
F2 49.0 19.6 29.4 2.0 2.593 363 17.0718
F6 47.0 18.8 28.2 6.0 2.610 167 13.9227
structure of fluoridated phosphate-based glasses and the effect of the addition of fluoride
on the bioactivity of the glass. The underlying purpose of this study was to verify if as
in silicate-BGs, clusters were formed.
Figure 2.16: Views of the (a) F2 and (b) F6 compositions. The colours are: phosphorus
(brown), oxygen (red), sodium (dark blue), calcium (light blue), fluoride (yellow).225
Figure 2.16 shows the resulted simulations for the two compositions F2 and F6 (Table
2.2). The incorporation of fluoride has two effects on the bioactivity of the phosphate
glasses. The first is the replacement of an oxygen atom in the PO4 tetrahedron by a
non-bridging fluoride atom (Figure 2.17). Indeed, there is a significant P-F bonding, and
the tetrahedral structure around the phosphorus is therefore preserved. The change in
the structure leads to a decrease in the network connectivity. This is due to the fact
that bridging oxygen of the network is replaced by non-bridging fluoride ions, as shown
in the schematic Figure 2.18. In other terms, the network chain lengths are reduced with
the incorporation of fluoride. A decrease of the network connectivity leads to an increase
of the bioactivity of the glass, since the network is more fragmented and therefore more
soluble.
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The second effect observed with the incorporation of fluoride is the formation of a sig-
nificant number of clusters in the glass of modifier rich regions and network rich regions.
A moderate amount of fluoride tends to bond to modifiers atoms (sodium and calcium),
which would tend to create highly soluble regions (modifiers rich region) and poorly sol-
uble ones (network rich regions). However, it has also been observed that this effect is
insignificant, since an equal amount of fluoride bonds to the phosphorus.
This study concluded that the addition of fluoride in phosphate-based glasses does not
lead to a decrease of bioactivity which is not the case with silicate-based glasses. For this
reason, fluoridated phosphate-based glasses were deemed suitable for use as biomaterials
based on the results published in this paper.225
Figure 2.17: Partial pair-correlation functions (a)gPO(r) and (b) gPF (r) for the F2 (black)
and F6 (red) compositions.225
Classical MD simulation of the structure of fluoridated phosphate bioactive
glasses In the work of Shaharyar et al.210, MD simulations with the DL POLY code257
are used to obtain atomic-scale models of the glasses. The force field developed and
used is based on existing works, and the shell model theory227,240,258, which is explained
in section 2.2.3.1. Oxygen atoms are represented as core-shell units (Os), connected by
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Figure 2.18: Schematic representation of an bridging oxygen replaced by a non-bridging
fluoride.225
Table 2.3: Simulated Compositions.210
x P2O5 Na2O CaO CaF2
mol % mol % mol % mol %
0 45 10.0 45.0 0.0
5 45 10.0 40.0 5.0
10 45 10.0 35.0 10.0
a harmonic spring. The interactions between the oxygen atoms and the others such as
P, Na and Ca259 are described using the Buckingham potential, as explained in section
2.2.3.1. The interactions between fluoride atoms and Os, P, Na and Ca are fitted to the
crystalline structure of fluoroapatite, difluorophosdphoric acid anhydride, sodium fluoride
and calcium difluoride. A three-body harmonic potential is used to control the tetrahe-
dral angle Os-P-Os in the phosphate group but no arbitrary constraints are placed in the
inter-tetrahedral structure.
Two compositions are modelled in this study; (45−x)CaO−10Na2O−45P2O5−xCaF2)
where is x = 5 and x = 10. For each composition (Table 2.3), the simulation is started
with a random atom configuration containing approximately 3000 atoms. For x = 5 the
simulation contains 68 fluoride atoms and 136 for x = 10. A reference without fluoride is
also included in this study.
The radial distribution function (Figure 2.19 ) and the Table 2.4 show that the fluoride
tends to predominantly bond with the modifiers ions. Only a relatively small amount of
fluoride bonds to phosphorus atoms, with a tendency that increases with the amount of
CaF2 incorporated, and this bonding to P does not affect the tetrahedral structure around
the phosphorus. It should also be noted that this amount of P-F bonding is initially higher
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Figure 2.19: Radial Distribution function of the interaction between the oxygen, phos-
phorus, calcium, sodium and fluoride atoms.210
Table 2.4: Qn distribution function with the
corresponding NC.210
x Q0 Q1 Q2 Q3 Q4 NC
0 0.08 26.6 68.9 4.4 0 1.78
5 0.58 19.25 73.25 6.9 0 1.87
10 0.61 13.5 77.8 8.0 0.05 1.93
(at higher temperature) which suggests that the system slowly converges to an equilib-
rium. A much higher amount of fluoride is found coordinated with calcium and sodium, as
shown by the sharp peaks in the Ca-F rdfs in Figure 2.19 and the smaller in the Na-F rdfs.
The incorporation of fluoride ions leads to a re-polymerisation of the network by removing
the cations from the glass network. Indeed, fluoride tends to associate with the network
modifier cations to form alkali/alkine aggregates. The chemical dissolution of the glass is
in that sense slowed for a time: until the glass network is broken down by the attack of
hydroxy ions and water molecules. At this stage, phosphate-based glasses degrade con-
tinuously and the fluoride content no longer has an impact on the chemical durability any
more. This work presents very different results from the ab-initio study225: they suggest
this difference is due to the cooling rate used. However, this observation appears unlikely
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since similar cooling rates were used to do ab-initio MD of fluoridated silicate227 and phos-
phate225 glass, and reliable results have been obtained with similar cooling rate.219–223 One
can therefore assume that if results are satisfactory for fluoridated silicate, it should be
no different for fluoridated phosphate. Additionally, the article does not mention the po-
tential and parameters used to develop the MD model described in the work of Shaharyar
et al..210
2.2.3.5 The role of fluoride ions in bioactive glasses
Preliminary modelling experiments using both molecular dynamics and ab-initio have
concluded with opposite results , and there is therefore some uncertainty about the be-
haviour of fluorine in bioactive phosphate glasses. Such ambiguity should be eliminated
as fluoridated PBGs are promising materials for dentistry, as they prevent tooth decay,
enhance tooth enamel remineralisation and inhibit bacterial infections. It is, therefore,
crucial to provide a clear answer on the influence of fluoride ions in PBGs using modelling
techniques.
2.3 Bioactivity of silicate-based glasses for cardiac
tissue engineering
Since the discovery of the first bioactive glass 45S5 by L. Hench9, BGs have gained interest
for their interaction with soft tissues.14,55 due to the significant potential BGs exhibit in
soft tissue repair.57–70,80–82
2.3.1 Silicate based-glasses for biomaterial applications
Since 1969, extensive improvements of the glass composition have been led to the pro-
curement of highly viable materials for the human body; materials performing without
forming any scar tissue and enhancing their bonding properties.50 From those studies, a
Na2O-CaO-SiO2 ternary state diagram emerged, as shown in Figure 2.20.
45S5 BGs have often been used in built up composite structures, which aim to mimic the
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extracellular matrix of the targeted tissue.9 To do this, various materials can be used such
as natural, elastomeric or synthetic polymers. 45S5 glasses composition sits within the
range of suitable composition for soft tissue bonding. They, therefore demonstrate poten-
tial applications in soft tissue repair and more specifically, in cardiac tissue engineering,
, a field of application that has not yet been addressed extensively.
Figure 2.20: Compositional diagram representing the type of tissue bonding properties of
bioactive glasses.9 The name Bioglass R© referred to the inital 45S5 glass. (2006) Repro-
duced with permission of Springer Nature.
2.3.2 Myocardial infarction and cardiac tissue engineering
2.3.2.1 Myocardial infarction
Heart disease is the main cause of death in the Western world.260 There is therefore here
lies a growing need for innovative therapies.
A healthy heart works like a pump and beats at an average of 100,000 times a day. The
heart is divided into two sides, separated by an inner wall called the septum. Each side
is subdivided into two chambers. The right side of the heart pumps blood to the lungs
to collect the oxygen. The left side of the heart receives the oxygen-rich blood from the
lungs and pumps it into the body.
A heart attack, also called myocardial infarction (MI), follows a sudden blockage of one
or more of the blood vessels supplying the heart or coronary arteries. The blockage leaves
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Figure 2.21: The illustration shows a cross-section of a healthy heart and its inside struc-
tures.261
damaged tissues on the heart which the body does not repair naturally. Instead, a scar is
formed as the mature contracting cardiac cells (cardiomyocytes) have a limited capacity
to multiply.262 Moreover, permanent cell death can occur if the blood flow is not rapidly
restored within the affected area of the heart muscle. This is due to the abrupt decrease
of nutrients and oxygen supply to the heart muscle.
A very alarming condition arises from the presence of these scarred tissues around the
heart, as they are unable to conduct electrical or mechanical stimuli, and this leads to a
reduction of the pumping efficiency of the heart’s main chambers, the ventricles.83 Faced
with this decrease in cardiac pumping efficiency, the heart tries to compensate through
several mechanisms such as vasoconstriction (constriction of blood vessels) in order to
pump more blood into the heart and provide better pumping force. Vasoconstriction
leads to an increase in the blood pressure and heart rate, together with a hypertrophy
(enlargement) of the heart muscle and left ventricles dilation.
Initially, this observed vasoconstriction helps the heart to stabilise. However, in the long
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term, the constriction of blood vessels can lead to further complications and incremental
deteriorations of the heart as they weaken the latter. This subsequent deterioration can
ultimately trigger heart failure.83 More dangerously, if the heart fails to keep blood pres-
sure at the right level throughout the whole body, body function failure can be a result.
Unfortunately for patients, the only therapeutic treatment, at this stage is heart trans-
plant, which often involves a tedious and difficult waiting list. They can also be treated
with mechanical Ventricular Assist Devices (VADs). In this case, they may face possible
complications (bleeding, thrombotic events, infections or failure of the electrical motor).
In the face of these difficulties, one can therefore understand the growing need to find a
way to regenerate damaged tissues. An interesting and promising method involves the
use of cardiac tissue engineered treatments.
2.3.2.2 Cardiac tissue engineering for myocardial infarction
What is cardiac tissue engineering? Cardiac tissue engineering is a highly promis-
ing approach to develop efficient and innovative treatments for heart disease.83 Through
this approach, the aim is to mimic the extracellular matrix (ECM) using natural or syn-
thetic polymeric materials.81 The ECM is an important component of all tissues and
organs within the body, as this non-cellular constituent ensures the initiation of crucial
biochemical and biomechanical cues needed in various tissue processes e.g morphogenesis,
differentiation and homeostasis. Additionally, the ECM acts as an vital physical scaffold
for cells and cells’ constituents.84
The cardiac extracellular matrix is a complex architectural network formed of proteins
which give the heart its strength and elasticity, along with glycoproteins, proteoglycans
and glycosaminoglycans, which are key to the elasticity of the heart.263
Biomimetic materials should resemble the ECM by mimicking its fibrillar architecture
and providing the necessary contact guidance for specific cardiac cells to function.81 The
biomimetic material should also exhibit elastic properties to match the systolic pressure of
the heart. Degradation characteristics are an additional important parameter to consider.
Indeed, degradable materials represent a better alternative to surgery, if the substrate can
2.3. Bioactivity of silicate-based glasses for cardiac tissue engineering 49
be physiologically removed and eliminated by the body system. Finally, tissue engineered
materials should respond positively to the cardiac cell environment and exhibit angiogenic
properties in order that can stimulate the myocardial regeneration. Ultimately, the aim
of these engineered constructs is to support or replace the heart muscle function.
Myocardial tissue properties Myocardial tissue presents a highly hierarchical struc-
ture with aligned fibrous cells embedded into 3D honeycomb-like micro-patterns.264 This
3D pattern represents the extracellular matrix and comprises collagen fibres and other
proteins. The use of a scaffold with a fibrous or porous structure therefore appears as a
sensible structure for organization, survival and function of the cardiac cells.
Regarding the mechanical properties, an effective cardiac patch should have a Young’s
modulus ranging from tens of kPa and 1 MPa, as it has been reported that the left ven-
tricular stiffness is around 10-20 kPa at the beginning of the diastole, and in the range
of 0.2-0.5 MPa at the end of the diastole.265 In other studies, it has been reported that
the native heart tissue has a Young’s modulus ranging from 10-15 kPa.266 In the case
of ischemic tissues (restriction in blood supply to tissues, causing a shortage of oxygen
and glucose needed for cellular metabolism) associated with fibrosis (formation of excess
fibrous connective tissue in an organ or tissue in a reparative or reactive process), the
Young’s modulus increases up to 30-50 kPa.267
2.3.2.3 Current trends and challenges in cardiovascular tissue engineering
The need for cardiac tissue regeneration has emerged following the discovery that my-
ocytes have a limited regenerative capacity, around 1% of the cells per year at 20 years of
age, decreasing to 0.3% by the age of 75.268 Two main challenges emerge when considering
cardiovascular tissue engineering devices: opting for the right type of human cells, and
providing a matrix that resembles the cardiac tissues with suitable mechanical proper-
ties.269
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Cellular therapy and engineered constructs Different general approaches have
been investigated to regenerate the functional myocardium (Figure 2.22).270
• Ventricular restrain (Figure 2.22 bottom-right)
• Cell suspension (Figure 2.22 left)
• Natural or synthetic scaffolds with and without cells (Figure 2.22 top-right)
Figure 2.22: Various approaches to treat myocardial infarction.271
Ventricular restrain has been considered in many studies to evaluate its use to con-
strain the left ventricle (LV). This non-transplant surgical therapy involves the use of
a prosthetic material to envelop the failing heart and mechanically constrain the latter,
and more precisely the left ventricle, at the end-diastole. This constraint prevents fur-
ther remodelling and helps improve the ventricular function.272 However, in recent years,
fewer and fewer studies have focused on using this kind of device as an efficient treatment
for scarred myocardial tissue.273–275 One study has recently been trialling a ventricular
support system, and this has shown promising results in canine models.274 The very
few studies on ventricular restraints demonstrate a decreasing interest, which can be at-
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tributed to the invasive procedure required for this approach, and the availability of less
invasive and more efficient treatments.260
Cell suspensions are used in cardiac cell therapy to heal the scarred tissue. To do this,
cells are implanted into or onto the damaged myocardium using different techniques (in-
tracoronary, intravenous, transendocardial and intramyocardial injections).271 In terms of
cells used, studies carried out on animals and humans using a variety of cell types have
showed promising results, demonstrating that implanted cells can incorporate themselves
into the heart.63,276 However, this method does not provide long lasting effects as cell tend
to migrate away from the site of injection.
Finally, natural or synthetic scaffolds, possibly combined with cells and biodegrad-
able scaffolds with a structural support to manage the tissue regeneration can be used
(Figure 2.22 (top-right)). To engineer these scaffolds, different cell sources and bioreactors
have been studied in order to obtain viable and functional tissue.269 To ensure cardiac
cells to repair or regenerate, a matrix providing similar composition, structure and suit-
able mechanical properties as the cardiac ECM is necessary. This matrix can then be used
to seed cells and create a cardiac tissue construct in vivo. Similarly, the matrix can be
used as an inducer for the cells to grow their own matrix.277 Synthetic or natural biocom-
patible constructs design to mimic the hierarchical structure and mechanical properties
of the heart matrix can be used for this purpose.269 New emerging technologies aim to
combine degradable scaffolds with bioactive particles, which will help the scarred tissue
to regenerate. It is believed that this acellular therapy can support cellular differentiation
and organisation with an adequate micro-environment and architecture. Indeed, cells re-
spond to their environment and one of the key components affecting cell behaviour is the
ECM.269
These different trends reflect two main features that should be considered when designing
a cardiovascular tissue regeneration solution: the importance of considering the ECM
(its molecular composition, hierarchical structure and biomechanics) and considering how
the cells need to remodel the initial matrix and progressively replace the damaged cells.
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Hereafter, challenges lie in the choice of the material (natural, synthetic or a combination
of both, with or without pre-seeded cells) and the type 3D structure of the construct to
support cell viability, vascularisation and matching mechanical properties of myocardium.
Current challenges arising from the mechanical properties The stiffness of the
infarcted myocardial tissue changes shortly after an infarction and becomes stiffer when
a scar is formed; this is also referred to as cardiac remodelling.269,278–280 The design of
cardiac scaffolds should consider variations of mechanical properties with time. Cur-
rently, biomaterial scaffolds for cardiac tissue engineering are designed in many different
forms.260,281 Porous and fibrous scaffolds are often manufactured to provide macroscopic
voids for the migration and infiltration of cells, and to mimic the hierarchy of the native
ECM allowing control over the cellular alignment.260,281,282 Additionally, the fabrication
techniques play an important role in the mechanical properties, as additive manufacturing
or electrospinning can produce various structure exhibiting a certain range of mechanical
properties (stiffness and elastic moduli).269
Natural and synthetic materials for cardiac tissue engineering An additional
important factor is the choice of the material used for the scaffold.283 Natural materials
such as collagen, fibrinogen, chitosan, gelatin, elastin and silk, can trigger signalling path-
ways affecting cells using surface receptor interactions, uptake, and degradation by cell-
instructive enzymes mechanisms.264,269 One of the disadvantages of working with natural
materials are the difficulties encountered when trying to process them without disrupting
potentially important hierarchical features.269 Hydrogels formed from natural materials
have been considered as a potential solution, but they tend to exhibit poor mechanical
properties.284 On the other hand, synthetic materials offer a wide range of tunable prop-
erties in terms of mechanics, chemistry and degradation. However, their biocompatibility
and cellular interaction behaviour should be closely monitored.270,285–290
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2.3.3 Silicate-based bioactive glasses for cardiac tissue engineer-
ing patches
Bioactive glasses have been considered as a use in cardiac patches in combination with
poly(glycerol sebacate)(PGS).291 In this work, PGS was chosen to provide the neces-
sary mechanical flexible support, while the BGs improve the mechanical properties of the
patch and provide a foothold for the cells to develop and differentiate. Those elastomeric
patches were firstly developed by Chen et al.292, with ranging concentration of BGs from
0% to 10%wt, and the study of their degradation behaviour has shown that the addition
of BGs does indeed counteract the acidity caused by the degradation of PGS. Indeed, the
degradation products of PGS lead to an acidic environment and cellular toxicity, espe-
cially when the polymer contains a high amount of unreacted carboxylic acid groups.293
It has been reported that the acidic degradation products of the polyesters lead to an
inflammatory response and therefore limit their ability to be used as a scaffold for cardiac
tissue engineering.292 To tackle this issue, the use of slightly alkaline nano-fillers such as
45S5 Bioglass have been investigated as a solution.
In terms of mechanical properties, the Young’s modulus (describing the tensile elasticity,
or the tendency of the patches to deform) and strain at break of the samples increased
along with the percentage of BGs particles incorporated. Those results confirmed the pos-
itive effects of the addition of BGs into PGS scaffolds.294 Concerning the biocompatibility,
the in vitro proliferation of mouse fibroblasts was investigated and it was observed that
the nanocomposite/PGS samples provided a greater proliferation of the fibroblasts than
on the pure PGS. In the same way, it was concluded that the addition of BG particles led
to the decrease of the cytotoxicity on human embryonic stem cell-derived cardiomyocytes
in comparison to pure PGS. In that sense, the addition of bioglasses which degrade slowly
in vivo could be used as a degradation kinetics regulator to meet the clinical requirements
in terms of tissue regeneration. Those promising results show the potential of the PGS-
BGs scaffold for a use in cardiac tissue engineering with suitable mechanical properties
and better biocompatibility.
54 Chapter 2. Literature Review
2.3.4 Technology for cardiac regeneration and repair
The various requirements for functional cardiac tissue scaffolds have led to the devel-
opment of different fabrication approaches and material utilisations for cardiac tissue
repair.295 Indeed, national statistics show quite dramatic results, with around a million
people affected by heart failure in the UK each year resulting in 36,000 deaths each year.
Additionally, heart disease is nowadays the leading cause of death and disability in the
world, with an estimated 15 million people dying from strokes and heart attack in 2016 ac-
cording to the World Health Organisation260, with the most common cause of heart disease
being myocardial infarction.265,296 Various approaches have been developed to regenerate
the functional myocardium270, such as cell suspension63,276, natural or synthetic scaffolds
with and without cells269 and ventricular restrains.273–275 Biomaterial scaffold architec-
ture plays a key role in most tissue engineering strategy. Indeed, biomimetic materials
should mimic the extracellular matrix of the tissue of interest in order to have the desired
effect on tissue regeneration. The main idea in engineered cardiac tissue is to reconstruct
a structurally similar and functional replica from damaged tissue. The manufactured con-
structs should exhibit sufficient elastic properties, suitable biocompatibility and enhance
cell regeneration.297 Different manufacturing techniques have been developed in order to
obtain satisfactory scaffolds, such as electrospinning298, three dimensional printing299 or
cell sheet technologies.300 In this project, the focus was on fast, efficient and reliable
techniques to manufacture cardiac patches such as electrospinning and three-dimensional
printing. Electrospinning allows the manufacture of a matrix mimicking the extra cel-
lular matrix of the cardiac cells in order to provide a much needed interface for cardiac
cells to attach and grow. Three-dimensional printing is a useful tool to obtain repeatable
mechanical properties over a large number of patches.
2.3.4.1 Electrospinning
Electrospinning has emerged, in the recent years, as an inexpensive, efficient and lead-
ing method to fabricate fibres with diameters down to tens of nanometers.298 With this
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method, fibres, from a rich variety of materials including polymers, composites, and ce-
ramics, are fabricated. This strategy involves the formation of bioresorbable and biocom-
patible materials into 2D scaffolds, that mimic native tissues or organs. An electrospun
scaffold can therefore endorse numerous important roles in tissue engineering, such as
mimicking the extra cellular matrix (ECM), modulating cell proliferation and differenti-
ation (depending on the structure) and being a carrier of bioactive signalling molecules.
Electrospun scaffolds provide a framework for tissue engineering and help to stabilise cells
and protect infiltration from surrounding tissue.297
Overview of the technique The basic electrospinning set-up298 consists of three major
components: a high-voltage power supply, a spinneret (a metallic needle), and a collector
(a grounded conductor)(figure 2.23).The metallic needle is connected to a syringe in which
the polymer solution (or melt) is put. A syringe pump is used to push the solution through
the needle at a constant and selected rate. When a high voltage is applied, the drop of
polymer solution present at the tip of the needle becomes highly electrified. At this point,
the drop experiences two major types of electrostatic forces: the electrostatic repulsion
between the surface charges and the Coulomb force applied by the external electric field.298
As a result, the liquid drop is distorted into a conical object, commonly known as the
Taylor cone. When the strength of electric field becomes greater that a threshold value, the
electrostatic forces overcome the surface tension of the polymer solution and thus trigger
the ejection of a liquid jet from the nozzle. This highly electrified jet then goes through
a stretching and whipping process, which forms a long and thin thread. As this liquid jet
is continuously elongated and the solvent evaporates, its diameter can be reduced from
hundreds of micrometers to as little as tens of nanometres The charged fibres are attracted
by the grounded collector and settle as a randomly oriented, non-woven mat. The main
parameters which are set and greatly influence the shape and size of the fibres are: the
voltage applied, the speed at which the liquid is pushed out of the needle, the distance
between the collector and the metallic needle, and the type of solution electrospun.
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Figure 2.23: Schematic illustration of the basic set-up for electrospinning.298 (2004) Re-
produced with permission of John Wiley and Sons.
Control of the morphology and diameter The morphology and diameter of elec-
trospun fibres can be controlled by a number of processing parameters such as298:
• the intrinsic properties of the solution such as the type of polymer, the conformation
of polymer chain, viscosity (or concentration), elasticity, electrical conductivity, and
the polarity and surface tension of the solvent;
• the operational conditions such as the applied electric field, the distance between
the collector and the metallic needle, the speed at which the liquid is pushed out of
the needle;
• other variables such as the humidity and temperature of the surroundings.
The presence of beads, constituted of a heap of non-fibrous polymeric material, in elec-
trospun fibres is a very common problem.301 This problem was investigated by looking at
the influence of solution properties on the density of beads contained in the electrospun
fibres. It was found that the viscosity, surface tension, and the density of net charges
carried by the liquid jet all influenced the morphology of resultant fibres. However, the
formation of beads could be attributed to the action of three main forces:
• the surface tension tends to convert the liquid jet into one or many spherical droplets
due to the minimization of surface area302;
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• the electrostatic repulsion between charges on the jet surface tends to increase the
surface area, which favours the formation of a thin jet rather than beads;
• viscoelastic force also resists rapid changes in shape and supports the formation of
fibres with smooth surfaces.
To summarize, the formation of beads can be eliminated if the influence of surface tension
is offset by the effects of the last two forces. Indeed, the more viscous the solution, the
less often beads are observed. The addition of salts to increase the net charge density, or
the use of solvents with lower surface tensions could also lead to the effective elimination
of beads.
Electrospinning represents a highly promising technique; however, it presents one ma-
jor drawback, namely that porous scaffolds fabricated by random processes cannot be
produced with complete control of the geometrical parameters, such as pore size, pore in-
terconnection size and porosity.303 However, this issue has been addressed in this project,
as scaffolds with controlled pore and geometrical parameters were fabricated.
Electrospinning for cardiac tissue engineering Electrospinning finds its adequacy
for cardiac tissue engineering because electrospun nano-fibres morphologically mimic the
natural extracellular matrix of the heart, constituted of continuous fibres ranging from
nano to micro scale with high porosity and variable pore size distribution.264
Beyond the morphological similarities between electrospinning and the ECM of the heart,
electrospinning is a versatile method that manufactures a variety of nano-fibrous struc-
tures using a plethora of available materials. Electrospinning is a simple low-cost tech-
nique, and is adaptable to both a biological laboratory and also for industrial applications.
Additionally, advances within the field enable the development of reproducible and varied
constructs. For instance, aligned nano-fibres can be produced using high speed rotating
drums and mandrel collectors and could be used in the repair of myocardial infarctions.304
Collectors can also be designed with a specific structure depending on the targeted appli-
cations e.g valves or blood vessels. For example, a honeycomb micro-frame was used to
electrospin a layer of natural polymeric fibres, which was then cross-linked into a mesh
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with controllable pore size.305,306
2.3.4.2 Three-dimensional Printing
Three-dimensional printing (3DP), also referred to as layered manufacturing, rapid pro-
totyping or additive manufacturing, is an innovative development in the field of manufac-
turing.299 3DP is a technology developed in the early 1990s at Massachusetts Institute of
Technology (MIT, Cambridge, MA).307 Three-dimensional printing builds the solid vol-
ume from a model by successively adding material layer by layer. 3D printing technology
has recently gained greater interest due to the potential applications in tissue engineer-
ing, and the ability to create a 3D object of virtually any shape from a computer assisted
designed (CAD) model.303 There is now increasing interest in 3D-printed biopolymers.
Indeed, combining 3D printing and biopolymers has been shown to have great potential
in tissue engineering applications. The aim of 3D-printed scaffolds for tissue engineer-
ing is to construct a biomimetic structural environment that facilitates the repair and
regeneration of soft and hard tissues.
Overview of the technique Modelling is the first step of 3DP. To do this, virtual
models CAD or animation modelling software and “slices” are designed and computed
into digital cross-sections, so that the printer can successively use them as a guideline
to print.303 A binding material is then deposited on the build bed or platform, until the
material/binder layering is complete and the final 3D model has been printed. During this
step, the machine reads the design and lays down the successive layers of liquid, powder,
or other materials to build the model from a series of cross-sections until the 3D printed
object is finished. Many different ways of 3D printing techniques exist303:
• selective laser sintering (SLS): the slices are written by a carbon dioxide (CO2) laser
beam;
• stereolithography (SLA): thin successive layers are photocrosslinked by ultraviolet
or visible light which induces photopolymerisation of a reactive system according to
a sliced CAD model308;
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• fused deposition modelling (FDM): small temperature-controlled extruder forces
out a thermoplastic filament material and deposits the semi-molten polymer onto
a platform in a layer by layer process. The monofilament is moved by two rollers
and acts as a piston to drive the semi-molten extrusion. At the end of each finished
layer, the base platform is lowered and the next layer is deposited309,
• direct metal laser sintering (DMLS).303
They differ with regard to the materials which can be used and in the way the layers are
deposited to create parts. For bio-polymers, the most commonly used processes are SLS,
SLA, and FDM.303,310
Three-dimensional printing for cardiac tissue engineering Three-dimensional
printing represents a promising technique to overcome the usual limitations of the fab-
rication of 3D constructs for myocardial tissue engineering. Indeed, one of the main
limitations is the availability of oxygen necessary to the survival of cells.311 3D printing is
a technique that allows the manufacture of scaffolds, integrating open pores or channels
that allow oxygen to easily reach the middle region of the construct, and to allow larger
constructs to be built in vitro.312 Another solution investigated was how to increase the
cell density within the construct.313 However, this has proved to be a difficult task. In-
deed, current methods providing proper vascularisation have not reached the metabolic
high-density requirements of these cardiac tissues. This will result in significant cell death,
as cardiomyocytes do not proliferate. To overcome these issues, 3D printing has been con-
sidered for many applications, such as cardiac valve, coronary vasculature and myocardial
tissue printing.314
The biomaterials used to produce scaffold for cardiac tissue engineering can be natu-
ral polymers including collagen, synthetic thermoplastics, such as poly(glycolic acid) or
poly(lactic acid), or elastomers such as poly(glycerol sebacate).82
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2.3.5 Natural materials for cardiac tissue engineering
Natural polymers have intrinsically the necessary biochemical properties for cells attach-
ment and proliferation.264 Additionally, their degradation products are non-toxic and have
a low immune response. The common natural polymers used in cardiac tissue engineering
include collagen, fibrinogen, chitosan, gelatin, elastin and silk.
Among the many materials investigated for the making of cardiac patches, collagen, the
predominant protein in the extracellular matrix260 has been regularly used, both alone
and with cells. For cardiovascular engineering, the collagen forms of interest are the types
I and III which are the main components of myocardial tissue ECM. Collagen has a long-
standing safety record in terms of biological applications.315
Collagen used as 3D printed scaffold was shown to increase angiogenesis.276 The applica-
tion of a 3D printed collagen scaffold, seeded with human mesenchymal stem cells, led to
positive results with a reduction in left ventricle interior diameter in the contraction phase
(systole), an increased anterior wall thickness, and a 30% increase in fractional shortening
(the fraction of any diastolic dimension that is lost in systole). The authors concluded
that pluripotent human mesenchymal stem cells (hMSCs) can be efficiently delivered to
a site of myocardial injury using a collagen cardiac patch, and such delivery results in
improved myocardial remodelling after infarction. Giraud et al.316 showed that the use
of cardiac patches made of a combination of collagen type I and rat skeletal muscle cells,
improves fractional shortening within 4 weeks.
Dvir et al.317 designed cardiac patches with an alginate based scaffold, seeded in neonatal
cardiomyocytes (cardiac muscle cells) and insulin-like growth factor-1 (IGF-1), stromal-
cell derived factor 1 (SDF-1), and vascular endothelial growth factor (VEGF) (figure
2.24). After 28 days, having been vascularized on the omentum (a fold of peritoneum
connecting the stomach with other abdominal organs) and transplanted onto infarcted
rat hearts, the cardiac patches showed structural and electrical integration into the host
myocardium. Additionally, thicker scars were observed which would prevent further dila-
tion of the chamber and ventricular dysfunction.
Collagen, on its own and as part of a blend, has also been electrospun and used to pro-
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Figure 2.24: Construction of a cardiac patch in an alginate-sulphate/alginate scaffold
capable of binding and releasing mixture factors.317 (2009) Reproduced with permission
of The Proceedings of the National Academy of Sciences.
duce a nearly ideal scaffold for tissue engineering.318,319 Collagen electrospun fibres have
been used as supports for cardiomyoblasts culture and for the delivery of human induced
pluripotent stem cells in a mouse mode.
The use of natural polymers presents many advantages and would appear a natural choice
for tissue engineering. However, there are also some major drawbacks: poor mechanical
performances have been reported.265 Most of these polymers require an extra crosslinking
step to become insoluble in aqueous solutions such as culture media. This crosslinking
step may affect not only their 3D structure and porosity, but also their biocompatibility,
due to the introduction of non-biocompatible chemical agents.266
2.3.6 Synthetic polymers of interest for cardiac tissue engineer-
ing
There has been considerable investigation of synthetic polymers as they enable better con-
trol over mechanical and degradation properties of the scaffold. Two types of polymers
can be used as graft for cardiac tissue engineering: polyesters, such as poly(caprolactone),
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poly(lactic acid) and poly(glycolic acid), or elastomers such as polyurethane, poly(ethylene
glycol) and poly(glycerol sebacate). Biocompatible and biodegradable polyesters with
controllable mechanical and morphological properties270,285 are easy to manufacture, pro-
viding structural support to the heart and improving cardiac function of the latter286 by
supporting cell growth287–290.
A biodegradable polymer degrades and is transported away from the site of action in
the body, but is not necessarily removed from the body. The degradation products of
a bioresorbable polymer are completely eliminated from the body with no residual side
effects.88
Elastomers are more flexible and therefore exhibit mechanical properties which are closer
to that of the heart.320 They can exhibit high elasticity to endure strong deformation
forces, prevent the cells from detaching82,321 and can be synthesised with thermorespon-
sive properties.322 Like polyesters, they are biocompatible and biodegradable and can
provide structural support to cells.323–325
2.3.6.1 Poly(Glycerol Sebacate)
PGS is a biodegradable polymer increasingly used in biomedical applications.326 This
crosslinked elastomer is relatively inexpensive to synthesise and exhibits bioresorbable
properties, as it can degrade and the degradation products are eliminated through nat-
ural pathways.327,328 Additionally, the degradation and mechanical properties of PGS
can be customised by the synthesis parameters.329 This semi crystalline polymer has a
crystallisation temperature of -18.50◦C and a melting temperature 9.6◦C.330 PGS has
shown potential application in nerve331, cartilage329, retinal332 and vascular tissue engi-
neering333 along with repair of tympanic membrane perforation334 and drug delivery.335
Recently, due to its potential and low price, it has been investigated for cardiac tissue
engineering.305,336 Indeed, polymeric heart patches have been developed with elastomer
polymers to provide the necessary mechanical support to the left ventricle of the heart.
In this project, PGS was, therefore, used to manufacture cardiac patches to provide the
mechanical properties needed for cardiac tissue engineering.
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Figure 2.25: Reaction scheme for the chemical synthesis of poly(glycerol sebacate).336
(2012) Reproduced with permission of The Proceedings of Elsevier.
Synthesis Poly(glycerol sebacate) is commonly synthesized from glycerol and sebacic
acid336 as shown in figure 2.25. The first synthesis of PGS was performed by Wang et
al..326 The synthesis of PGS can be divided into two main steps: poly-condensation and
crosslinking. In the poly-condensation step, an equimolar mixture of glycerol and se-
bacic acid is reacted at 120◦C and under argon for 24 hours, before reducing the pressure
from 1Torr to 40mTorr over 5h. During the crosslinking step, the mixture is kept under
vacuum (40 mTorr) and 120◦C for 48 hours. The method is the most commonly used
for synthesising PGS. Studies have been conducted to modify the properties of PGS by
changing parameters such as the molar concentration of the reactants329 and the synthesis
temperature337. However, the synthesis method was kept as shown above.
Visually, PGS is a see-through slightly yellow polyester. Figure 2.25 shows its chemical
structure. PGS can be analysed by FTIR and NMR. The level of cross-linking due to
the amount of ester linkage formed during the second step can be controlled (increase
with the curing and temperature) and followed by FTIR. When the curing time increases,
the FTIR spectrum shows a reduction in the carboxylic acid O-H bend at 1418cm−1.338
Additionally, FTIR results show the reduction of the O-H stretch bands at 3300 cm−1,
demonstrating that the acid groups reacted with the alcohol group to form an ester bond.
Mechanical properties The strain-stress of PGS can be measured through tensile
tests; PGS exhibits non-linear stress-strain behaviour which is characteristic of elas-
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Figure 2.26: Tangent modulus (at 10% strain) values for PGS cylinders with various
processing parameters.329 (2010) Reproduced with permission of John Wiley and Sons.
tomeric material.265,339 This elastic characteristic is due to the covalently cross-linked,
three-dimensional network of random coils, with hydroxyl groups attached to its back-
bone; both the cross-linking and the hydrogen bonding interactions between the hydroxyl
groups contribute to its elastomeric properties.340
The mechanical properties of PGS depend on three processing parameters:
• curing temperature: the influence of curing temperature on the mechanical proper-
ties of PGS was studied and Young’s modulus values were of 0.056 MPa, 0.22 MPa
and 1.2 MPa, were recorded for curing temperatures of 110◦C, 120◦C and 130◦C,
respectively.265
• molar ratio of glycerol to sebacic acid; as shown in figure 2.26 increasing the glycerol
molar ratio decreases the tangent modulus and vice versa.329
• curing time: as shown in figure 2.26, the tangent modulus increases with increasing
curing time.329
When synthesised in a 1:1 ratio at 120◦C and cured for 48 hours, PGS materials have
average tensile Young’s modulus in the range 0.0250 to 1.2 MPa, the ultimate tensile
strength is 0.5 MPa and strain to failure greater than 330%.265,331,339 The Young’s mod-
ulus of PGS is between that of ligaments (kPa range)336,341 and the myocardium of the
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human heart, which ranges between 0.02 and 0.5 MPa, and its maximum elongation is
similar to that of arteries and veins, which is up to 260%.
Physiochemical and biodegradation properties Polymer degradation is defined
as “the chemical reaction resulting in a cleavage of main-chain bonds producing shorter
oligomers, monomers, and/or other low molecular weight degradation products.”342
Many studies have been carried out to understand the degradation behaviour of PGS
in vivo and in vitro 339,343 and it was established that PGS undergoes surface degrada-
tion; the main mechanism of degradation being the cleavage of the ester linkages. This
surface degradation process is responsible for a slow loss of mechanical strength (tensile
properties), relative to mass loss (per unit original area). Additionally, while the mass
loss changes linearly with time, some detectable swelling and better retention of geometry
occur. As explained in Part 2.3.7.1, there is a degradation behaviour discrepancy between
in vivo and in vitro experiments due to the action of some enzymes.
One very interesting property concerning PGS is that its degradation kinetics can be
controlled by diverse processing parameters such as the curing time and temperature.265
These parameters were studied in order to match the characteristic of the heart tissue
recovery kinetics and it has been concluded that the degradation kinetics of PGS synthe-
sized at 110◦C was faster than that of PGS synthesized at 120◦C, while PGS synthesized
at 130◦C showed no evidence of degradation.336 Therefore, in this project, PGS was syn-
thesised at 120◦C to obtain an adequate degradations kinetics.
The degradation properties of the polymers have also been studied in vitro and in vivo
and it has been observed that PGS degrades in the body quite rapidly, with a complete
absorption in vivo within 6 weeks, while the injured heart is still in the process of re-
covering.331 In vitro tests shown that the same sized PGS samples remained without any
degradations for longer than three months.293 This difference between in vivo and in
vitro degradations of PGS was caused by the hydrolysis of the ester links in the polymer
chains, similar to the decomposition of fats in the body. It was concluded that the rapid
degradation of PGS in vivo is due to the catalytic function of enzyme esterases, which
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are specialised in catalysing the hydrolysis of fats in the body.82
Biocompatibility The biocompatibility properties of PGS originate from the starting
reactant used in its synthesis. Indeed, glycerol is a basic building block for lipids, while
sebacic acid is a natural metabolic intermediate in the oxidation of medium to long fatty
acid.337,339,344,345 It should be noted that glycerol and all of its copolymers have been ap-
proved by the Food and Drug Administration (FDA).339,346 The degradation products are
therefore metabolised by the body naturally. The synthesis itself is also biocompatible as
no additives, solvents or catalysts are used during the process.336,347,348 However, the bio-
compatibility properties of any material are not only dependent on its chemical products,
but also on factors such as density, surface porosity, surface hydrophilicity, surface energy,
the environment where it is implanted and the material degradation products.349,350
To assess how the cellular behaviour is affected by the degradation products Schwann
cells were exposed to PGS and Poly Lactic-co-Glycolic Acid (PLGA) extracts. PGS is
often compared to PLGA, as the synthetic polymer is often used in tissue engineering ap-
plications and exhibits a resorption time similar to that of PGS. Results showed that cells
cultured in both PGS and PLGA samples had comparable metabolic rates, attachment,
or proliferation and both polymers showed no cytotoxic effects in contact with the cells
as no apoptosis was witnessed.351 PGS showed positive tissue response in comparison to
PLGA as significantly less inflammation and fibrosis, and no detectable swelling was ob-
served with PGS extract during degradation. This study was performed to demonstrate
the good performance of PGS for neural applications.
In vitro tests shown that fibroblast cells in contact with PGS (and PGLA as control)
exhibit a normal morphology and higher cell growth rate.339
In vivo biocompatibility tests were conducted with Sprague-Dawley rats. The study re-
vealed that the inflammatory response of PGS was similar to that of PLGA. Indeed, PGS
induced insignificant fibrous capsule formation.339 A fibrous capsule is a layer of connec-
tive tissue that is formed due to a biological response to an implanted foreign material.351
In terms of cardiac tissue engineering, the focus is on polymers exhibiting adequate bio-
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compatibility with cardiac tissue and extra cellular matrix.
The native myocardium is composed of cardiomyocytes, cardiac fibroblasts (CFs) and en-
dothelial cells.352 In vitro and in vivo biocompatibility of PGS with cardiomyocytes and
CFs was assessed.352,353 The ability of PGS to provide desired attachment of the seeded
cardiomyocytes and retain healthy beating cells in vitro without any detachment of the
cells was assessed.352 This is a necessary property for cardiac tissue engineering.
The behaviour of CFs in contact with PGS has also been studied.353 This study demon-
strated the biocompatibility that PGS exhibits with CFs, making this material more
suitable for use as cardiac biomaterial. In vivo study was also carried out in rats on
infarcted myocardium. After 2 weeks of implantation, the scaffold was vascularised, as-
sessing furthermore the excellent biocompatibility of PGS and cardiomyocyte tissues.
In order to enhance PGS biocompatibility properties and mechanical properties, numer-
ous approaches have been studied354 whether chemical (grafting of hydrophilic groups355),
physical (surface treatment with sodium hydroxide356) or biological modifications (enzyme
treatment, coating with biocompatible molecules such as laminin, fibronectin, fibrin, col-
lagen or elastin.357). Through these different approaches, material-cell interactions can
be improved and this will ultimately broaden the range of applications for PGS-based
scaffolds.
2.3.6.2 Poly(caprolactone)
Poly(caprolactone) (PCL) is a functional polymer that has been studied extensively.358
This polymer is an aliphatic polyester composed of hexanoate repeat units (Figure 2.27).
The physical, thermal and mechanical properties of PCL are functions of its molecular
weight and its degree of crystallinity. PCL can reach a 69% degree of crystallinity.359 PCL
exhibits a slow degradation through the hydrolysis of its ester linkages and the subsequent
elimination of the resulting fragment by macrophages and cells.360
PCL exhibits biocompatibility properties, as its degradation by-products are non-toxic
and usually metabolised and eliminated by organisms in the body.359 Additionally, its
slow degradation ensures that its mechanical properties are maintained over a long period
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of time. PCL has a low glass transition temperature of -60◦C and is therefore in a
constant viscous state at room temperature.297 Consequently, PCL and its copolymer
were extensively used in numerous drug-delivery devices during what has been referred
to as the ’resorbable-polymer-boom’ of the 1970s and 1980s.361
Figure 2.27: PCL structure
Two methods can be used to prepare PCL362:
- The condensation of 6-hydroxycaproic (6-hydroxyhexanoic) acid
- The ring-opening polymerisation (ROP) of -caprolactone.
Physiochemical and biodegradation properties PCL can be degraded by outdoor
living organisms (bacteria and fungi). However, it is not biodegradable in animal and
human bodies due to the lack of necessary enzymes.363 Nonetheless, it does not mean
that PCL is not bioresorbable but rather that the process takes a great amount of time.
The degradation of PCL varies from 2 to 4 years depending on the starting molecular
weight.364 From the in vivo and in vitro studies, it can be concluded that despite PCL
being hydrophobic it endures a slow two-stage degradation process, triggered by the sus-
ceptibility of its ester linkage to hydrolysis.358,359,361,365 The first stage is therefore the
non-enzymatic hydrolytic cleavage of ester groups, followed by the intracellular degrada-
tion when the polymer is more crystalline and of lower molecular weight (less than 3000
Da/dalton). During the second stage, the polymer is fragmented and degraded by phago-
somes of macrophages and giant cells.366
The degradation of PCL first starts with the hydrolytic degradation of its poly(α-hydroxy)
esters via surface degradation pathways. The latter is determined by a diffusion reaction
phenomenon. This surface degradation or erosion begins with the hydrolytic cleavage
of the polymer backbone, but only on its surface.88 The phenomenon occurs when the
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amount of water intrusion into the polymer is smaller than the rate of hydrolytic breakage
and the production of oligomers and monomers. Following this event, a thinning of the
polymer is observed over time, with no impact of the molecular weight on the internal
bulk part of the polymer. This process gives PCL a great advantage when it comes to
drug delivery applications.367,368
Bulk degradation is witnessed when the water diffuses within the entire bulk of the poly-
mer which triggers hydrolysis throughout the entire matrices of the polymer. This phe-
nomenon will lead to the reduction of the average molecular weight due to the scission
of hydrolytic chain.365 An equilibrium for this diffusion-reaction phenomenon is then
achieved. However, if this equilibrium is disrupted, the degradation mechanism could
produce an acidic gradient, via the carboxyl and hydroxyl end group by-products. In-
deed, in the case of bulk degradation, the newly generated carboxyl end group formed
during ester bond cleavage could accumulate. Subsequently, the internal degradation ac-
celerates in comparison to the surface, leaving an outer layer of higher molecular weight
skin with a lower molecular weight, degraded interior. The degradation mechanism then
relies on two molecular weight distributions. When the inner polymer is small enough,
it diffuses expeditiously through the outer layer. An onset weight loss and a decrease of
chain scission is then observed. An inflammatory reaction resulting from the rapid release
of oligomers and acid-by products can then be witnessed.369 Additionally, the physical
shape of PCL has been shown to have no direct effect on the degradation rate, suggesting
the a homogeneous degradation dominates the process.361,370
A long term in vivo (in rats) degradation study of PCL was conducted for 3 years.371 Us-
ing radioactive tritium labelling, the distribution, absorption and excretion of PCL was
traced. Results revealed that PCL capsules with an initial Mn of 66,000 g/mol stayed
intact in shape for up to two years after implantation, and ruptured down to low Mw
(8000 g/mol) pieces after 30 months. The Mw of PCL was shown to decease in a linear
way with time (66,000 g/mol at 0 month, 24,000 g/mol at around 16 months, 15,000
g/mol at 24 months and 8,000 at 30 months).
To investigate the absorption and excretion of PCL (Mw 3000 g/mol), tritium-labelled
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PCL was implanted subcutaneously in rats. The radioactive tracer and excreta were first
detected 15 days post-implantation in both plasma and faeces. After 135 days, the plasma
radioactivity dropped back to null values while 92% of the implanted radioactive tracer
was detected in feces and urine. No significant radioactivity was found in the organs.
Those data shed light on the behaviour of PCL over an extended period of time proving
its bioresorbability and biocompatibility. Most of the polymer was eliminated naturally
and no traces were found in the organs. The degradation properties of PCL match the
requirements for use in cardiac tissue engineering.
Compression tests performed on 3D printing scaffolds (4x4x8 mm, Figure 2.28) showed
that PCL scaffolds have a mechanical behaviour similar to flexible foam.372,373 The stiff-
ness of PCL scaffolds was measured in vitro and in vivo, and it was observed that the
stiffness increased after 3 months and subsequently remained almost unchanged subse-
quently. This was probably due to the simultaneous rise in its crystallinity, around 3-5%,
over the same period. A higher crystallinity and more crystalline regions would enable
the polymeric material to better resist deformation. Depending on the molecular weight
and initial crystallinity, increases in mechanical properties along with crystallinity are
common. The mechanical properties, particularly the stiffness trend of the in vitro and
in vivo PCL scaffolds after 6 months, were very similar.
Figure 2.28: Gross morphology of in vitro degraded PCL scaffolds observed by SEM.359
(2009) Reproduced with permission of John Wiley and Sons.
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Biocompatibility Generally, bioresorbable polymers exhibit favourable biocompatibil-
ity with living tissue.361,374 Inflammation is mostly triggered by the release of low molec-
ular mass molecules through degradation or due to impurities. These released molecules
can be acidic and therefore lead to secondary inflammatory reactions. Another important
factor in the development of inflammation is the site of implementation and its ability to
eliminate by-products. It is therefore crucial to study the degradation rate of the polymer
and the local tissue clearance mechanism.366
Concerning PCL, the short and long term biocompatibility of PCL scaffolds using different
animal models has been studied in vivo and in vitro.375–380 These studies demonstrated
the beneficial biocompatibility properties of PCL and PCL-composites. Biocompatibility
PCL composites for cardiac tissue engineering will be further discussed below.
Surface functionalisation Surface modifications of PCL have been considered in order
to increase biocompatibility of the implants, by improving the hydrophilicity and cellular
compatibility.381 The idea is to control and manipulate the surface properties of the
scaffold without altering the main properties of the latter.368,382 PCL shows poor cell
attachment as it is a hydrophobic polymer demonstrating inadequate wettability. Various
surface modifications can therefore be of interest to improve in vivo integration of PCL-
based scaffolds383such as
• physical modifications: encouraging cell attachment by coating the surface with
various materials, such as extracellular matrix proteins, collagen and laminin using
physical adsorption.384;
• chemical modifications: plasma treatment represents an effective way of increasing
the hydrophilicity of PCL. PCL/ hydroxyapatite scaffolds were modified by air or
argon plasma, leading to an improved cell adhesion and proliferation.385,386 In an-
other study, PCL electrospun nanofibres were modified by immobilisation of type-I
collagen scaffolds using plasma treatment. Collagen immobilization enhanced the
human dermal fibroblasts’ adherence, spreading and proliferation.387;
• surface-initiated atom transfer radical polymerisation (ATPR) to allow the making
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of polymer brushes on different kinds of substrate. It has been shown that gelatin
grafting on to plasma treated PCL nanofibres improves endothelial cell spreading,
proliferation and orientation.388 Additionally, Poly (glycidyl methacrylate) brushes
were used to immobilize the collagen via surface-initiated ATRP on the PCL film
surface. The new functionalised PCL film surfaces showed excellent cell adhesion
features389;
• biological modification: immobilisation of biomolecules such as growth factor to en-
hance cell attachment and proliferation. A study revealed that the immobilization
of laminin-derived sequences onto the surface of PCL scaffolds increased the at-
tachment of adipose-derived stem cells.390 Additionally, bone marrow stromal cells
adhesion was quantitatively increased using surface functionalisation of PCL scaf-
folds with RGD peptides.160
2.3.7 Biomimetic approach with PGS and PCL-based scaffolds
for cardiac tissue engineering
Biomimetic scaffolds represent a promising solution for myocardial tissue engineering.349,353
Indeed, cardiomyocytes have high oxygen demand, as healthy ones are physiologically em-
bedded in a network of capillaries providing unobstructed oxygen supply.391 Additionally,
these biomimetic scaffolds should aim at replicating the complex structure of the cardiac
muscle, made of highly branched and hierarchically fibres embedded in a 3D collagen
network that resembles a honeycomb network.392
As described above, PGS and PCL are two remarkable polymers presenting highly in-
teresting properties for cardiac tissue regeneration. The following section gives a by no
means exhaustive list of PCL, PGS and 3D manufacturing techniques which can produce
biomimetic scaffolds for cardiac tissue engineering.
2.3.7.1 Poly(glycerol sebacate)-based scaffolds
Micro-fabrication techniques were used to develop an innovative accordion-like honeycomb
microstructure using poly(glycerol sebacate) to yield porous, elastomeric 3-D scaffolds
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with controllable stiffness and anisotropy.349
Figure 2.29: Scanning electron micrographs of PGS accordion-like honeycomb scaffolds
fabricated using laser microablation. Scale bars = 200 µm.349 (2008) Reproduced with
permission of Springer Nature.
These micro-fabrication techniques involved the overlapping of two 200 x 200 µm square
pores oriented at 45 degrees in a pattern to leave a planar network of undulated, 50
µm wide struts. The pores were fabricated using lasers. Cultured neonatal rat heart
cells were seeded on these scaffolds, and they demonstrated interesting properties such as
closely matched mechanical properties compared to native adult rat right ventricular my-
ocardium, with stiffness controlled by polymer curing time. Additionally, the heart cell
contractility was achieved by inducing an electric field stimulation (with directionally-
dependent electrical excitation thresholds). Finally, greater heart cell alignment than
isotropic control scaffolds was obtained. Accordion-like honeycombs therefore represent a
solution to overcome principal structural-mechanical limitations of previous scaffolds, pro-
moting the formation of grafts with aligned heart cells and mechanical properties which
are similar to the myocardium.This study provided satisfactory scaffolds with excellent
biocompatibility and ability to promote cardiac tissue regeneration. However, it is debat-
able if the use of such a difficult micro-fabrication technique is suitable for the targeted
purpose: this multi-staged technique does not easily allow the rapid and repeatable man-
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ufacture of the patches, and using only PGS which is viscous at room temperature, the
in-theatre application of the patches might represent a real challenge.
In terms of electrospinning scaffolds, core/shell PGS/gelatin blends393 were electrospun
(Figure 2.30), where PGS was used as a core polymer to impart the mechanical properties
and gelatin as a shell material, in order to achieve favourable cell adhesion and prolif-
eration. The cardiogenic differentiation of mesenchymal stem cells MSCs was confirmed
by employing specific markers. It is acknowledged that the co-culture of mesenchymal
stem cells and cardiomyocytes with a suitable elastomeric biomaterial combination such
as PGS/gelatin has synergistic effects and is more effective than mesenchymal stem cells
and cardiomyocytes alone.
In the work of Kharaziha et al., PGS and gelatin were blended before being electrospun,
resulting in the fabrication of scaffolds that can mimic the left ventricular myocardium
architecture.394 From the in vitro studies using neonatal rat cardiac fibroblast cells (CFs)
and cardiomyocytes, it was found that aligned fibrous scaffold, consisting of 33 wt% PGS,
induced optimal synchronous contractions of cardiomyocytes while significantly enhancing
cellular alignment.
Figure 2.30: Scanning electron microscopy (SEM) images showing the fibre morphology of
(a) gelatin fibres and (b) poly(glycerol sebacate) (PGS)/gelatin core/shell fibres at 5000
x magnification.393 (2011) Reproduced with permission of John Wiley and Sons.
In order to provide better mechanical properties, PGS can also be blended with other
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synthetic polymers. A polyester blend consisted of PGS, poly(3- hydroxybutyrate-co-3-
hydroxyvalerate) (PHBV) and poly(lactic acid)304 was shown to enhance cell viability,
uniform cell distribution and alignment, due to nutrient provision from inside the 3D
structure. Non-linearly elastic biomaterials were fabricated from PGS and poly(lactic
acid) using the core/shell electrospinning technique293 and showed tensile strength, rup-
ture elongation, and stiffness constants comparable to muscle tissue properties. In vitro
evaluations also showed that PGS/PLLA fibrous biomaterials possessed excellent biocom-
patibility.
Similarly, a micro-structured electrospun fibrous blend of PGS and poly(butylene succinate-
butylene dilinoleate) (PBS-DLA)395 of different compositions was examined for its suit-
ability for heart patches. The use of PBS-DLA led not only to an increase of the average
fibre diameter but also to an increase of the elastic modulus as well as the hydrophobicity
of the blended scaffolds. Once tested in vitro, these micro-structured PGS/PBS-DLA
scaffolds provided suitable mechanical strength, flexibility, and guidance for both mouse
myoblast cell line and cardiomyocytes.
2.3.7.2 Poly(caprolactone)-based scaffolds
Electrospun PCL fibres of a 250 nm average diameter have been suspended on a wire
ring, and have been shown to support the attachment and contraction of neonatal rat
cardiomyocytes in vitro(Figure 2.31).270 Indeed after 3 days, cardiomyocytes start to
contract weakly and in an unsynchronized trend. These contractions become stronger
and synchronize as time progresses. Cardiomyocytes have been shown to adhere, to
populate the entire scaffold mesh, and stain positively for cardio-specific proteins.396 This
scaffold was used as a temporary ECM, enabling the cells to adhere, spread, proliferate
and establish electrical communications between layers creating synchronized beating.
It was also reported that this scaffold did not restrict the contractile functions of the
cardiomyocytes.81
With regard to 3D printing, constructs of arbitrary complexity with uniformly dispersed
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Figure 2.31: (a) Gross view of culture system. A thin, non-woven fibrous mesh is sus-
pended across a wire ring. The thickness of the mesh is 10 mm. The wire ring acts as a
passive load to condition cardiomyocytes during in vitro culture. Scale bar=15mm. (b)
SEM micrograph of mesh. The electrospun fibres have an average diameter of 250 nm,
and observed fibre diameters range from 100nm to 5 mm. The pores are interconnected
and are much larger than the fibres. The topography of the non-woven mesh resembles
that of an ECM and facilitates cell attachment. Scale bar=200 mm.270 (2004) Reproduced
with permission of Elsevier.
cells have been studied. For instance, SLS was used to produce structures that were porous
on both the micron and millimetre scale, ensuring efficient mass transport throughout the
structure.312,397 These scaffolds were manufactured using poly(caprolactone) (PCL) which
gave sintered structures with 48% porosity, 34 µm surface roughness, a tensile stiffness
of 0.43 MPa, and a yield strain of 89%. As for biocompatibility, specific viable cells
were maintained for three weeks in culture, and formed muscle fibres in the form of multi-
nucleated myotubes after 11 days. Unfortunately, no further studies were conducted on
the therapeutic performance of those constructs.
PCL fibre scaffolds present a high stiffness and hydrophobicity, which lead to insufficient
cell attachment and proliferation in cardiac tissue engineering.381 Many studies have tar-
geted the improvement of PCL characteristics. For instance, blends of polymers have
been investigated to improve biocompatibility and mechanical properties. A blend of
PCL and collagen types I have been reported to exhibit appropriate mechanical prop-
erties (tensile modulus of 18 MPa and tensile strength of 7.79 MPa) for a blood vessel
conduct.398 PCL/gelatin scaffolds were shown to have a higher tensile strength in compar-
ison to other hydride scaffolds.399 The effect of pore size on cell attachment and migration
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was also studied in vitro and it has been observed that cell migration was predominant in
PCL/gelatin scaffolds. Random and aligned PCL/gelatin nano-fibrous scaffolds were elec-
trospun393 and results indicated that PCL/gelatin nanofibrous scaffolds presented smaller
fibre diameters (239 ± 37 nm for random fibres and 269 ± 33 nm for aligned fibres), in-
creased hydrophilicity, and lower stiffness compared to electrospun PCL nanofibres. The
aligned PCL/gelatin nanofibres presented anisotropic wetting characteristics and mechan-
ical properties, which closely match the requirements of native cardiac anisotropy. In vivo
tests showed that rabbit cardiomyocytes were cultured on electrospun random and aligned
nanofibres. It was concluded that an aligned PCL/gelatin scaffold greatly promoted cell
attachment and alignment because of the biological components and ordered topography
of the scaffolds.
PCL has also been electrospun in a blend with an oligomer hydrogel (bisphenol A ethoxy-
lated dimethacrylate [BPAEDMA]). The elastic modulus of PCL/BPAEDMA nanofibrous
scaffolds was found to decrease with the increase of the oligomer hydrogel. These scaf-
folds were shown to exhibit flexibility and allow adhesion of cells and tunable mechanical
strength. In addition, these elements are both non-toxic and non-immunogenic.
2.3.7.3 Poly(caprolactone) and poly(glycerol sebacate)-based scaffolds
To obtain more efficient cardiac patches in term of biocompatibility and mechanical prop-
erties, both PCL and PGS have been used to manufacture electrospun scaffolds. The idea
here is to balance out each others disadvantages. Indeed, despite the PGS elastomer being
of great interest, its use in tissue engineering application is limited by the challenge of
casting it into micro- and nanofibrous structure. Additionally, PGS mechanical properties
change quite rapidly once implanted in the body. On the other hand, PCL exhibits steady
mechanical properties and does not represent any difficulties in manufacturing as it has
a low melting point and is soluble in many solvents. However, it is quite hydrophobic.
By combining these two polymers, the aim is to obtain a polymer blend that has tunable
and lasting mechanical properties, is easy to process into micro and nano-structures, and
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has sufficient biocompatibility and hydrophilic properties.
Such scaffolds using PGS pre-polymer/PCL blend have been fabricated using the elec-
trospinning technique.305,400 It was shown that the higher the concentration of PGS pre-
polymer, the higher the diameter of fibres in the scaffold and that the fibre diameter
decreased down to a certain threshold of 17.5 kV(Figure 2.32).305 Similarly, it was shown
that a higher PGS pre-polymer concentration led to more suitable mechanical properties
(elastic modulus (EM), ultimate tensile strength (UTS) and ultimate elongation (UE)
explained in Chapter 5) of electrospun PGS(pre-polymer): PCL scaffolds in comparison
with PCL-composite scaffolds. Finally, in terms of biological evaluation, these scaffolds
significantly improved Human Umbilical Vein Endothelial Cell (HUVEC) attachment and
proliferation compared to PCL-only scaffolds.305,400 The work of Rai et al.400 lays down
promising results for the use of these polymer blends. However, this work studies the
pre-polymer PGS (non cross-linked polymer) in the polymer blend and does not seek to
clarify how the use of such non cross-linked polymer influences the mechanical degrada-
tion properties and if it has negative effects once biologically degraded.
A fibrous scaffold of a blend system of PGS and PCL functionalised using chemical
Figure 2.32: Effect of PGS:PCL ratio and voltage on fibre morphology and diameter.305
(2011) Reproduced with permission of John Wiley and Sons.
immobilization of vascular endothelial growth factor (VEGF) was fabricated for cardiac
2.3. Bioactivity of silicate-based glasses for cardiac tissue engineering 79
patch application.400 The electrospun fibres were shown to support the attachment and
growth of seeded myogenic and vasculogenic cell lines. This fabrication technique showed
promising results, as this approach provided a uniform immobilization of VEGF on the
fibres.
2.3.8 Research opportunities to improve cardiac tissue repair
treatments
Bioactive glasses have been reported to have promising interactions with cardiac tissue
and regeneration properties. However, their use for such applications has not been studied
intensively with the aim of improving existing cardiac engineering treatments.
Cardiac patches containing BGs in a PGS polymeric matrix have been fabricated. Un-
fortunately, no study has yet been performed on the degradation processes which are
believed to affect the mechanical properties of the scaffolds and cell behaviour. To what
extent do BGs provide a damping effect on the pH and how does the scaffold behave
once the BGs are fully dissolved? Additionally, it is worth considering if the use of a fast
degrading polymer like PGS could be the most sensible option for cardiac patches.
Various studies used PGS in combination with a slow degrading polymer (PCL). Many
of them used the PGS as a pre-polymer without commenting on any post-crosslinking
procedures, and how crosslinking would affect the mechanical and biological properties.
In terms of manufacturing techniques, 3D printing and electrospinning are two promising
tools, that are both reliable and scalable. 3D printing provides controllable and repeat-
able mechanical properties, while electrospinning assists the manufacture of ECM-like
scaffolds. However, no studies have reported the simultaneous use of both techniques, in
order to combine the advantages of them both.
To treat myocardial scarred tissue, there is is a need to find efficient and promising
treatments, using reliable and scalable technologies and easily produced biocompatible
materials. Here lie the research opportunities to fabricate a new, innovative treatment for
cardiac tissue repair
Chapter 3
Aims and Objectives
Bioactive glasses have demonstrated their considerable suitability for applications in hard
and soft tissue repair.
Fluoridated PBGs are promising materials for dentistry, as they prevent tooth decay,
enhance tooth enamel remineralisation and inhibit bacterial infections. However, pre-
liminary modelling experiments, studying the influence of fluoride ions, have generated
much debate in the litterature. This thesis aims to provide a clear answer regarding the
role played by fluorine in PBGs. In order to achieve this, classical molecular dynamics
simulations have been selected to describe accurately the atomistic structure of F-PBGs,
containing different amounts of fluorine. Additionally, modelling experiments aim to con-
sider, for the first time, the polarisability of both oxygen and fluorine atoms.
Ideally, such computational models should be backed up with experimental data. How-
ever, due to the lack of suitable laboratory equipment, the synthesis of fluoridated phosphate-
based glasses was impossible. Therefore, for the experimental section, the research was
focused on the use of silicate-based glasses for soft tissue engineering. This commercially
available biomaterial has shown promising interactions with soft tissues such scarred car-
diac myocardium. In the field of tissue engineering, multi-material scaffolds combined
with engineering fabrication approaches are of high interest, as they are able to fulfil nu-
merous requirements for the targeted applications. The use of 45S5 silicate-based glasses,
within a polymeric matrix, has been reported in cardiac tissue applications, but it has
yet to be addressed extensively.291,294,305,400
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The aim of this research is therefore to apply modelling techniques considering the polar-
isability of oxygen and fluorine atoms, in order to resolve current debates in the literature.
Additionally, the experimental section aims to investigate polymer-bioactive glass com-
posites using different manufacturing methods to determine their potential application in
cardiac regenerative medicine. The specific objectives are:
• to improve the modelling of F-containing bioactive phosphate glasses, developing a
novel force field including the polarisability of the oxygen and fluorine atoms, and
to analyse the chemical structure of F-containing PBGs using molecular dynamics
to conclude on the bioactivity of FPBGs;
• to provide new experimental insights and understanding of how a multi-material
strategy (biocompatible polymers and bioactive glass-based scaffolds) used in com-
bination with multi-manufacturing techniques, 3D printing and electrospinning, can
be used to design effective and innovative scaffolds for tissue engineering.
Chapter 4
Atomistic structure of
phosphate-based glasses containing
fluoride
4.1 Introduction:
Bioactivity of fluoridated phosphate-based glasses
In this chapter, bioactive glasses containing fluoride which are beneficial in dentistry are
studied.18,45,46 Fluoride induces the enhancement of tooth enamel remineralisation, the
inhibition of enamel demineralisation and bacterial infections. Fluoride ions cause fluoro-
apatite to form in physiological solutions.118,121 This fluoridated form of hydroxyapatite,
which is the main component of the tooth, is more stable against acid attacks than hy-
droxyapatite.182 Fluoridated PBGs are promising materials for dentistry, as they prevent
tooth decay, enhance tooth enamel remineralisation and inhibit bacterial infections.
Through this study is shown how the addition of fluoride influences the bioactivity of
PBGs.401 To obtain the most accurate and detailed representation of its structural or-
ganisation, the structure of F-PBGs was studied using computer simulations. Recently,
the role played by fluoride ions on the bioactivity of F-PBGs has been debated in the
literature and previous studies have concluded opposite results. In order to provide a
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clear answer, classical molecular dynamics simulations was used to describe accurately
the atomistic structure of F-PBGs containing different amounts of fluorine. This work
provides a new insight into the physical chemistry of fluorinated phosphate-based glasses
(F-PBGs). In this study and for the first time, the polarisability of both the oxygen and
fluorine has been taken into account in order to obtain a detailed atomistic description of
the system along with the Qn distribution which is vital to understand the bioactivity of
the glasses.
4.2 Materials and methods: Computational proce-
dure
The use of polarisable force fields is crucial to obtain a correct description of medium
range structure and hence the bioactivity.227 The role of the force field is to model accu-
rately the atomistic structure of P2O5(50−x/2)-CaO(50−x/2)-CaF2(x) with x = 0,2,5 using the
molecular dynamics code219,220 DL POLY Classic.257 The amount of CaF2 is increased,
while the network connectivity is kept constant to remove any effect of changing the NC
on bioactivity. The extent of any fluoride clustering and its effect on the bioactivity of
fluoridated PBGs is discussed in this chapter.
4.2.1 Polarisable force field development: Potential models
In this work, the force field developed was based on the Born-Mayer ionic model402, which
is based on the assumption that the ions, in the glass, interact via long-range Coulombic
internal forces, short-range two- and three-body interactions. The short-range interactions
between ions i and j are expressed through the Buckingham potential, which accurately
describe the interaction. The Coulombic energy is expressed as
UCoulombij =
qiqj
4piorij
(4.1)
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where qi is the charge of ion i and 0 is the permittivity of free space. Finally, the
three-body interactions are included through a harmonic potential:
V =
1
2
kijk(θijk − θ0)2 (4.2)
where kijk and θijk respectively represent the strength of the bond-bending term, and the
bond angle between the three ions i, j and k.
4.2.2 Implementation of the core shell model
The force field developed takes into consideration the polarisation of the oxygen and
fluoride atoms, using the shell model.240 In the shell model, the polarisabilty is included
by splitting the atom’s total charge into a core of charge (Z+Y) and a shell of charge (-Y).
Atoms such as the oxygen are usually represented through the shell model to take into
account the high polarisability of the oxygen atoms. The shell model was also applied
to fluoride ions to represent their polarisability. The polarisability of fluoride ions sits in
between that of the oxygen and the sodium (Table 4.1). Applying the core-shell model to
the fluoride ions could therefore be of interest to develop a more accurate force field.
The next step was to determine which values for Fcore and Fshell to select. The gulp
program provides a option which is called ”Split” which varies specified core-shell charge
split during fitting. However, the GULP manual does not give clear enough information
on the way to use this option and no examples were found. Therefore, it was decided to
write the input file using data reported in the literature.
The Database of Published Interatomic Potential Parameters provided many different
potential and values for Fcore and Fshell shown in Table 4.2.
The values for the core and shell charges for the oxygen were kept at the values derived by
Table 4.1: Electronic Polarisability in Units of 10−24cm3
Name O2− F− Na+
Electronic Polarisability in Units of 10−24cm3 3.88 1.04 0.179
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Table 4.2: Fcore, Fshell and spring values
Reference Fcore (e) Fshell (e) Spring (eV A˚
−2
)
Atwood 1978403 404 0.6810 -1.6810 41.76
Binks 1994405 0.378 -1.378 24.36
Diller 1979406 .339 -1.339 37.98
Jackson 2000407 0.59 -1.59 20.77
Catlow 1977408 1.380 -2.380 101.200
Catlow et al.408 (Table 4.3) for transferability of the potential and since these potentials
were used to described one of the crystal (CaF2) that was chosen, among other to fit
the force field describing F-PBGs. Ionic charges were used to represent the calcium and
phosphorus ions. The adiabatic shell model is used in this work to avoid significant
exchange of kinetic energy between the core-shell unit and the rest of the system.
Table 4.3: Ion charges used in this work
Ion Core (e) Shell (e) Core-shell Interaction (eV A˚
−2
)
Ca +2.000
P +5.000
O222 +0.8482 -2.8482 74.92
F408 +1.380 -2.380 101.200
4.2.3 Empirical Fitting
4.2.3.1 Crystal Data and creation of the Gulp files
The potential, for every atoms composing the crystal structure, were empirically fitted.
To do so, crystal data, from various crystals of interest, were selected. The crystals
used for the empirical fitting are: the phosphorus pentafluoride PF5, the phosphorus
oxide triofluoride POF3, the calcium fluoride CaF2, the disodium fluorotrioxophosphate
Na2PO3F , the calcium fluorooxophosphate Ca5FO12P3. The crystal data were found on
the Physical Sciences Data-science Service data base. The GULP input files were created
using these crystal data.
86 Chapter 4. Atomistic structure of phosphate-based glasses containing fluoride
4.2.3.2 Methodology
During the fitting, one or two parameters are varied at a time. Following that, the
simulation was ran using GULP and an Output file was generated. Results were judged
satisfactory when the sum of squares values, based on parameters such as the lattice
parameters, was the closest to 0 and some lattice vector recalculated within 2-3 % of the
experimental values. This value was set as there are no set values for what can be an
acceptable error. A 2 to 3 % error will not necessarily affect the results since the glass
itself has a density error when it is produced, and the MD simulation also introduce an
error itself (error in trajectory averages on both truncation and sampling errors).409 The
accuracy of the potential fitting is determined by the percentage of errors between the
optimised lattice structure and the experimental data, summed over all lattice parameters,
corresponding to minimising F in the equation 2.16. Therefore, this percentage of error
that was set should be used with cautions as a 2-3 % was judged acceptable but a 3 %
error on each lattice parameter and in the same direction would be unacceptable as it
would lead to an too large error overall.
4.2.4 Already existing Fluoroapatite Potential
Mkhonto et al 410 derived a potential model for fluoroapatite Ca10(PO4)6F2 fitted to struc-
ture, elastic constant and vibrational frequencies of the phosphate groups. They also used
existing calcite and fluorite potential models.411 The aim of this study was to model the
effect of water on the surface structure and morphology of fluoroapatite by introducing
a novel model. The derived potentials were calculated in compatibility with existing po-
tentials for calcite and fluorite. The Ca-F and Ca-O parameters in the fluoroapatite,
the oxygen and fluoride core-shell charges and interactions were taken from the litera-
ture.412,412,413 The other potentials such as the interaction between oxygen and fluoride
ions and between the oxygen and phosphorus within the phosphate group were empiri-
cally fitted using the GULP program to a variety of experimental parameters such as the
elastic constant, bond dissociation energy, vibrational data and crystal structure of the
phosphate group. Some interaction were described by the Morse potential or the Buck-
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ingham potential.
Initially, the Buckingham potential was selected to describe the two-body interactions as
it is a fairly adequate potential to describe interactions within ionic solid. The values
presented differed largely for the ones initially selected.221,222,414 However, the fit of the
potential, using those data which seemed thorough, was attempted. The Morse potential
is interesting to work with as it takes into account physical and concrete properties such
as the dissociation energy D or the equilibrium separation.
Unfortunately, the study did not fit any parameters for the phosphorus fluoride interac-
tion. The idea was therefore to simultaneously fit a Morse potential for the P-F bond
using GULP and to run an MD simulations with DL POLY without any fluoride in order
to compare the results to already existing ones.225
4.2.4.1 Morse potential for the P-F bond
In order to fit a Morse potential to a diatomic bond, three parameters are required to be
set :
• The dissociation energy D in eV is 439kj/mol = 4.55eV ;415
• The equilibrium separation r0 is equal to 158-153 pm416 so the mean as the value
which is 155.2 pm was used;
• The last parameters is called α and is variable which can be determined by spec-
troscopic data. After conducting some research we decided to fit this last potential
empirically using GULP due to the lack of data on this parameter.
4.2.4.2 DL POLY simulation without fluoride-Phosphate interaction
A simulation was ran using the potential from the work of Mkhonto et al 410, in order to
determine the accuracy of those potential the idea was to compare the results to already
existing ones.225 It then came to attention that, in the potential parameters used in this
work, the value used as charge for the phosphorus was equal to 1.180 instead of 5.00. This
false value for the phosphorus core is not explained in the review. However, due to the
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absence of response after contacting the author, it was decided to not to use this value
for the phosphorus as the charge was wrong and carry on fitting them from bulk crystals.
4.2.5 Potential fitting using already existing potentials
4.2.5.1 Phosphate potential
The fitting the potential was first attempted using existing phosphate potentials222 which
were developed for the study of phosphate-based bioglasses. The idea behind the use of
those potentials was to obtain a fairly transferable force field. The Buckingham potential
parameters was fitted for the following interactions:
• Cacore-Fshell
• Fshell-Fshell
• Pcore-Fshell
• Oshell-Fshell
They were fitted empirically to the structures and elastic constants of relevant crystals us-
ing the energy minimization code GULP233:phosphorus pentafluoride PF5, phosphorus ox-
ide triofluoride POF3, calcium fluoride CaF2, disodium fluorotrioxophosphate Na2PO3F,
and calcium fluorooxophosphate Ca5FO12P3.
4.2.5.2 Phosphate and fluoride potentials
To gain a better transferability of the force field, already existing potentials, developed for
phosphate glasses221,222,414 and fluoroapatite408,410, were used. The P-Fs, P-Fs-P, Fs-P-Fs
and Fs-P-Os interactions (where e.g., Fs is the shell on the fluoride atom) were fitted
empirically to the structures and elastic constants of relevant crystals (Ca5FO12P3, PF5,
POF3 and CaF2).
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Table 4.4: Two-body potential fitting results using
existing fluoride potential and phosphate glass poten-
tial.222,410,412,413
Interactions Aij(eV) ρij Cij(eV.A
−6)
Os-Fs 583833.70 0.2116 7.68
Fs-Fs 99731834.0 0.1201 17.02
Na-Fs 1254.0 0.2745 0.00
Ca-Fs 1272.80 0.29971 0.00
P-Os 1020.00 0.34322 0.030
Os-Os 22764.30 0.14900 27.88
Na-Os 56465.3453 0.193931 0.00
Ca-Os 2152.3566 0.309227 0.099440
Table 4.5: Three-body potential fitting re-
sults using existing fluoride potential and
phosphate glass potential.222,410,412,413
Interactions k (eV.rad−2) θ (deg)
Os-P-Os 3.3588 109.470
P-Os-P 7.6346 141.179333
4.2.6 Classical molecular dynamics simulations
Once the potential was derived and gave satisfactory results, the classical molecular dy-
namics simulations were performed using the DL POLY code.257 Three different compo-
sitions (Table 4.6) in the (P2O5)(50−x/2)(CaO)50−x/2(CaF2)x system were modelled: one
with 0 mol% of CaF2 (referred to as F0), one with 2 mol% of CaF2 (F2) and one with 5
mol% of CaF2 (F5). The amount of CaF2 was increased while the ratio of the number of
oxygen atoms to the number of phosphorus atoms, and hence the network connectivity,
were kept constant. The densities of the compositions of fluoridated phosphate glasses
modelled (Table 4.6) were not available in the literature, glass properties databases or ex-
perimentally achievable. We have therefore estimated the densities using already exiting
density data on calcium phosphate bioglasses.225,417–420
At the start, the configuration for the various compositions consisted of quasi-randomly
placed atoms in a cubic box positioned so that two atoms would not be found within
80-90 % of their expected interatomic separation. The molecular dynamics runs were
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Table 4.6: Simulated compositions with the corresponding densities
and cell sizes.
P2O5 CaO CaF2 Density Number of atoms Cell size
mol% mol% mol% (g cm−3) (A˚)
F0 50.0 50.0 0.0 2.589 2000 30.96
F2 49.0 49.0 2.0 2.592 1800 29.90
F5 47.5 47.5 5.0 2.597 1700 29.34
then performed in a constant volume and temperature canonical (NVT) ensemble. The
different simulations were run using a well-established and reliable methodology to model
glasses174,210,214,221,222,229. For each composition the initial configuration was run at 2500K
until the system reaches an equilibrium. Following that, the system was gradually cooled
down from 2500K to 300K ensuring that the system reached thermal equilibrium for each
of the temperatures (2500K, 2000K, 1500K, 1000K, 650K and 300K). Each step was run
for 40ps which corresponds to an overall cooling rate of 9-10K/ps. This cooling rate has
been shown to give reliable results in terms of medium-range structure.229 In this work
all data are taken from averages of five independent simulations for each composition.
4.3 Results and discussion
4.3.1 Polarisable force field development
4.3.1.1 Fitting potential results using existing phosphate potentials
The optimised potentials, using existing phosphate potentials222 and lattice parameters of
the recalculated structures, are shown in Tables 4.7 and 4.8. The results obtained on the
crystal structure for the POF3, shows a high percentage of error on the z direction. This
could be explained by the layered structure of the crystal on the z direction. The results
obtained for the CaF2 crystals, were highly unsatisfactory with a mean error percentage
of 31.17 %. As shown in Figure 4, the conjecture was that the structure probably requires
a Ca-Ca interaction to correctly reproduce the structure, however this interaction is not
consistent with the potential used in phosphate glasses as there are very weak Ca-Ca
4.3. Results and discussion 91
Table 4.7: Two-body potential fitting results using ex-
isting phosphate glass potential.222
Interactions Aij(eV) ρij Cij(eV.A
−6)
Pc-Fs 488.18 0.3483 1.05
Os-Fs 0.000003 0.3362 22.10
Fs-Fs 1127.70 0.2753 11.19
Nac-Fs 1594.2 0.2555 0.00
Cac-Fs 3141.93 0.0058 0.00
Pc-Os 1020.00 0.34322 0.030
Os-Os 22764.30 0.14900 27.88
Nac-Os 56465.3453 0.193931 0.00
Cac-Os 2152.3566 0.309227 0.099440
Table 4.8: Three-body potential fitting re-
sults using existing phosphate glass poten-
tial.222
Interactions k (eV.rad−2) θ (deg)
Os-P-Os 3.3588 109.470
P-Os-P 7.6346 141.179333
P-Fs-P 7.6346 141.179333
Fs-P-Os 27.853756 109.470
Fs-P-Fs 0.652140 109.470
P-Fs-P 7.6346 141.179333
interactions in PBG. It was therefore decided to discarded the crystal. Na2POF3 (Figure
4.1)was a crystal investigated in a first place, however fitting with other crystals led to
a crash of the program. The rest of the crystal gave unsatisfactory results, with mean
percentages of error of 2.26, 3.89 and 6.53 for respectively Ca5FO12, NaF and PF5. Those
results were not satisfactory and therefore, were not kept for the following steps. In a
new attempt, already existing fluoride potential, and phosphate potentials were used as
a starting point to fit the Buckingham parameters.
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Table 4.9: Percentage of difference between the recalcu-
lated structure and data along with the mean % values.
Crystal a(A˚) b(A˚) c(A˚) Mean % of error
PF5 -4,74 -4,74 10.11 6.53
POF3 3.95 3.95 6.42 4.77
CaF2 -31.17 -31.17 -31.17 -31.17
Ca5FO12P3 2.30 2.30 2.17 2.26
NaF -3.89 -3.89 -3.89 -3.89
Figure 4.1: View of the crystal structure of Na2POF3
4.3.1.2 Fitting results Using existing phosphate and fluoride potentials
The optimised potentials are given in Tables 4.10 and 4.11, and the lattice parameters
of the corresponding crystal structures, optimised with the potentials, are presented in
Table 4.12. The results obtained on the optimised structures of Ca5FO12P3, POF3 and
CaF2 were in good agreement with the experimental lattice parameters, with an average
error of 2.67, 1.28 and 0.51 % respectively. PF5 showed a higher percentage of error
between the optimised structure and the experimental data. However, when the small
amount of fluoride put in our models (with a maximum of 5 mol%) is taken into account,
a configuration where five fluoride atoms are bonded to one phosphorus atom is very
unlikely, hence this error was deemed unimportant and the use of such potentials was
chosen for the subsequent molecular dynamics simulations.
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Table 4.10: Two-body Buckingham potential terms
Interactions Aij(eV) ρij(A˚) Cij(eV A˚
−6)
P-Fs 1089.25 0.2568 7.28
Os-Fs
410 583833.70 0.2116 7.68
Fs-Fs
410 99731834.0 0.1201 17.02
Ca-Fs
410 1272.80 0.29971 0.00
P-Os
222 1020.00 0.34322 0.030
Os-Os
222 22764.30 0.14900 27.88
Ca-Os
222 2152.3566 0.309227 0.099440
Table 4.11: Three-body harmonic potential terms
Interactions k (eV rad−2) θ (deg)
Os-P-Os
222 3.3588 109.470
P-Os-P
222 7.6346 141.179333
P-Fs-P 7.6346 141.179333
Fs-P-Os 27.853756 109.470
Fs-P-Fs 0.652140 109.470
Table 4.12: Percentage difference in lattice parameters be-
tween the optimised structure and experimental data
Crystal a(A˚) b(A˚) c(A˚) Average
POF3 1.90 1.90 0.50 1.28
CaF2 -0.51 -0.51 -0.51 -0.51
Ca5FO12P3 3.94 3.94 0.13 2.67
PF5 -15.59 -15.59 5.95 12.38
4.3.2 Analysis of the structure of F-PBGS through molecular
dynamics simulations
The potential developed in part 4.3.1.2 gave the most satisfactory results in terms of
the lattice parameters of the corresponding crystal structures optimised with the poten-
tial. The molecular dynamics simulations was therefore carried out using this values.
Through this project, the aim was to gain further understanding of the atomic structure
of fluoridated phosphate-based glasses and on how the addition of fluoride will effect the
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bioactivity. Figure 4.2 shows a picture of the F0 composition. All results shown in the fol-
lowing sections were calculated from the average of 5 simulations, for each compositions.
Figure 4.2: View of the F0 composition. The colours are: phosphorus (green), oxygen
(red) and calcium (blue).
4.3.2.1 Short-range structure of the bioglasses
For all the compositions, the partial pair-correlation function gP−O(r) (Figure 4.3) showed
the presence of two kinds of phosphorus bonding with bond lengths around 1.47 A˚ and 1.61
A˚. Those bond lengths respectively correspond to the double and single bond between
the phosphorus and the oxygen atoms. The pair-correlation functions (Figure 4.3 (top))
overlap for the F0, F2 and F5 compositions, which proves that the P-O bonding does
not depend on composition, and those results are in agreement with previous simulations
of fluoride-free phosphate glasses.222 Neutron diffraction experiments421 indicated that
the P-O distance depends on the ratio y = n(M2/µ)/n(P2O5) where n(x) is defined by
the molar amount of the species x and µ represents the charge of the modifier M . For
y = 1.04 (our composition) the corresponding P-NBO and P-BO bond lengths should be
around 1.51 A˚ and 1.62 A˚ respectively, with which we are in good agreement.
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Figure 4.3: Partial pair-correlation functions gP−O(r) (top) and gP−F (r) (bottom) for the
F0 (black), F2 (red) and F5 (blue) compositions
4.3.2.2 Fluoride interaction with the phosphorus
In the F2 and F5 compositions, the partial pair-correlation functions gP−F (r)(Figure 4.3)
show its first peak at a distance of 4.5-4.6 A˚. Typical P-F chemical bonds, in crystals such
as PF5, are usually around 1.5 A˚. No fluoride atoms bonding to the phosphorus atoms
were observed. The only atoms coordinated to the phosphorus were the oxygen atoms.
99.6 % of the phosphorus atoms are coordinated to four oxygen atoms for all the different
compositions. (The remaining 0.4 % are coordinated to three or five oxygen atoms).
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Figure 4.4: Partial pair-correlation functions gCa−O(r) (top) and gCa−F (r) (bottom) for
the F0 (black), F2 (red) and F5 (blue) compositions
4.3.2.3 Calcium association with the oxygen and the fluoride
The partial pair correlation functions gCa−O(r) and gCa−F (r) (Figure 4.4) were analysed
and showed that the Ca-O and Ca-F bond lengths are 2.31 A˚ and 2.21 A˚ respectively.
Those values represented were characteristic Ca-O and Ca-F distances for F-PBGs.225 It
was therefore concluded that the calcium atom bonded chemically to both fluoride and
oxygen atoms. To determine which of the latter calcium atom predominantly binds, the
Ca-F and Ca-O coordination numbers were calculated. For Ca-F they were respectively
0.19 and 0.56 for the F2 and F5 compositions and the Ca-O. CNs were 6.763 ± 0.002, 6.57
± 0.01, 6.05 ± 0.01 respectively for F0, F2 and F5. Additionally, the Ca-O coordination
number decreased with increasing CaF2 content while the coordination number of Ca-
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F increases. The fluoride atom replaced the oxygen atom in the calcium atom’s first
coordination shell and the phosphate’s coordination shell was not affected .
4.3.2.4 Clustering
Visualisation of the F2 and F5 composition showed clustering formed of fluoride and
calcium atoms (Figure 4.5). These clusters led to the segregation of the glass network
into modifier-rich (soluble in an aqueous environment) and network-rich regions (poorly
soluble in an aqueous environment). As observed in silicate glasses422, these clusters
could lead to the formation of a discontinuous apatite layer on the surface of the bioactive
glasses once implanted in the body. A decrease of the bioactivity of the glasses will result
from this uneven apatite layer.
The clustering ratio of the different models can be defined as the ratio RX−Y of the
observed total number of atoms of species Y found within a coordination sphere of an
atom of species X (NX−Y,MD) compared to that expected if the atoms were homogeneously
dispersed (NX−Y,hom). It can be calculated using the following formulas423–426
RX−Y =
NX−Y,MD
NX−Y,hom
=
CNX−Y + δ(X−Y )
4
3
pir3c
NX
Vbox
(4.3)
where δ(X−Y ) is 1 if X = Y and 0 otherwise and rc is a cut-off distance at which the X-Y
coordination number of interest CNX−Y is calculated. NX represents the total number of
X atoms contained in the whole simulation box of volume Vbox. The clustering ratios for
the fluoridated phosphate glasses were calculated with rc=4 A˚ which correlated with the
first coordination shell of the central atom of species X since it is where the nanoscale
aggregation would appear (Table 4.13). For each composition, clustering of Ca, F, P, and
O were calculated at the beginning (2500K) and at the end (300K) of the simulation.
Clear evidence of substantial fluoride clustering throughout the simulation was observed
(Figure 4.5). During the simulation, there was an increase of the clustering ratio for the
F-F and Ca-F interactions and a small decrease for the P-F interactions. These results
were in agreement with the pair-correlation functions and visualisation. They also showed
that the high level of fluoride clustering observed at the end of the simulation is a result
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Figure 4.5: View of a representative F5 composition (top) with shrunk oxygen and phos-
phorus atoms and clusters highlighted (bottom) at 300K. The colours are: phosphorus
(green), oxygen (red), calcium (blue) and fluoride (pink).
of the quench: that fluoride atoms form clusters during the cooling. Previous ab initio
simulations225 concluded different results in terms of phosphorus to fluoride bonding.
The observed phosphorus to fluoride bonding in that study is probably due to the small
size of the model (197 to 363 atoms) which might not be large enough to observe the
fluoride-fluoride and fluoride-calcium interactions and the larger cooling rate necessary
for ab initio simulations.
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Table 4.13: F-F, Ca-F, Ca-Ca and P-F clustering ratios
F2 F5
2500K 300K 2500K 300K
F-F 7.22 ± 0.09 10.64 ± 0.24 3.42 ± 0.02 6.98 ± 0.23
Ca-F 1.06 ± 0.01 1.12 ± 0.01 0.99 ± 0.01 1.28 ± 0.02
Ca-Ca 1.37 ± 0.01 1.201 ± 0.002 1.401 ± 0.002 1.209 ± 0.002
P-F 0.97 ± 0.01 0.874 ± 0.005 0.99 ± 0.01 0.69 ± 0.01
4.4 Conclusion
This study presents classical MD simulations of fluoride containing phosphate-based
glasses in the system CaF2-P2O5-CaO.
401 A novel empirical force field was developed
with ionic charges and the use of a shell model for polarisation effects.
The empirical fitting was performed using relevant bulk crystals: Ca5FO12P3 , POF3,
NaF, CaF2, Na2PO3F, PF5 with the Buckingham potential. The potential fitting was
performed using already existing phosphate and fluoride potential and gave transferabil-
ity to the force field developed. The systems composed of P2O5(50−x) CaO(50−x)CaF2(x);
x=0,2,5 were studied. The classical MD simulation results showed that the addition of
fluoride led to the re-polymerization of the network into glass network modifier-rich (sol-
uble) and network-rich (poorly soluble) regions, as it has also been reported for fluoride
containing silicate glasses.18 The analysis of the results indicated that the fluoride prefer-
ably bonded to the calcium and the oxygen was bonded to the phosphorus through single
and double bonds. Additionally, no phosphorous to fluoride bonding was observed in the
simulated systems and the phosphorus bonds with the oxygen creating single and double
bond with the latter. Thereupon, the addition of fluoride in phosphate glasses was shown
to lead to a decrease of the bioactivity. Despite studies showing that the rate at which the
apatite layer is formed can be accelerated by a small addition of fluoride13,118,185,213, the
apatite layer will not be homogeneous due the variation of dissolution in the modifier-rich
(soluble) and network-rich (poorly soluble) regions. This will ultimately have deleterious
effect on the bioactivity of the glass once implanted. Previous ab-initio simulations225
concluded on different results in terms of phosphorus to fluoride bonding. The observed
phosphorus to fluoride bonding in this study is probably due to the small size model(197
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to 363 atoms). Further studies could be undertake in order to determine the minimum
energy pathway leading to the formation of fluoride/calcium rich cluster.
The minimum energy pathway (MEP) refers to the lowest energy path leading to the rear-
rangement of a group of atoms from one stable position to another427. The determination
of the MEP constitutes a real challenge in theoretical and condensed matter chemistry.
MEP can also be referred to as ”reaction coordinates”428 and refers to various chemical
transitions such as reactions, changes in conformation of molecules, or diffusion processes
in solids. For the atom to go from one stable position to another, the system goes up to
what is called an energy barrier that has to be activated in order to overcome the saddle
point energy or potential maximum energy along the MEP. This energy barrier is of high
importance to estimate the transition rate.429 Calculations had been started using already
existing atomistic conformations.
The NEB method was developed to find a MEP between a pair of initial and final states,
both of which are local minima on the potential energy surface. Through this method, all
point on the path is at an energy minimum in all directions. The NEB is a chain-of-states
method through which a string of images (geometric configurations of the system) is used
to describe a reaction pathway430.
Chapter 5
Multi-layered patches containing
silicate-based glasses for cardiac
tissue engineering
5.1 Introduction
The various requirements for functional cardiac tissue scaffolds have led to the devel-
opment of different fabrication approaches and material utilisations for cardiac tissue
repair.295 Indeed, national statistics show quite dramatic results, with around a million
people affected by heart failure in the UK each year resulting in 36,000 deaths each year.
Additionally, heart disease is nowadays the leading cause of death and disability in the
world with an estimated 15 millions people dying from strokes and heart attack in 2016
according to the World Health Organisation.260 The most common cause leading to heart
diseases being myocardial infarction.265,296 Various approaches have been developed to re-
generate the functional myocardium270 such as cell suspension63,276, natural or synthetic
scaffolds with and without cells269 and ventricular restrains.273–275 Biomaterial scaffold
architecture plays a key role in most tissue engineering strategy. Indeed, biomimetic ma-
terials should mimic the extracellular matrix of the tissue of interest in order to have
the desired effect on tissue regeneration. The main idea in engineered cardiac tissue is
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to reconstruct a structurally similar and functional replica from damaged tissue. The
manufactured constructs should exhibit sufficient elastic properties, suitable biocompat-
ibility and enhance cell regeneration.297 Different manufacturing techniques have been
developed in order to obtain satisfactory scaffolds such as electrospinning298, three di-
mensional printing299 or cell sheet technologies.300 In this project, the focus was put onto
fast efficient and reliable techniques to manufacture cardiac patches that are electrospin-
ning and three-dimensional printing. Electrospinning allows the manufacture of a matrix
mimicking the extra cellular matrix of the cardiac cells which is a much needed interface
for cardiac cells to attach and grow. Three-dimensional printing is a useful tool to obtain
repeatable mechanical properties over a large number of patches.
5.1.1 Native myocardium and cardiac structure
Native myocardium is made of cardiomyocytes, cardiac fibroblast (CFs) and endothe-
lial cells. The myocardium is highly organised.431 Cardiomyocytes are self-beating cells
which contract more than three billion times in the average human lifespan, pumping over
7000 L of blood per day through 100,000 miles of blood vessels.80 In terms of structural
properties, cardiomyocytes are aligned parallel to the heart wall. They are cylindrical
rod-shaped muscle cells which are typically around 100-150 µm by 20-35 µm and govern
the function of the myocardium. Cardiomyocytes are interconnected by intercalated disks
(constituted of different types of cells junction) which maintain the electromechanical in-
tegrity of the heart.
CFs constitute over 50% of the cells of the heart432 and are key to regulating the my-
ocardial function and structure. Their role is to contribute to the structural, biochemical,
mechanical and electrical properties of the myocardium. Indeed, they help regulate the
turnover of the ECM as well as controlling proliferation and interaction with myocytes.
CFs therefore affect the cardiomyocytes behaviour.339,432,433 CFs also play an important
role in the remodelling of infarcted myocardium.434
After a cardiac infarction, several changes occur in the structure and function of the
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heart, referred to as cardiac remodelling. This process happens at a genetic, cellular and
intracellular level and has been shown to start shortly after the myocardial infarction and
carries on years after.278–280 To maintain cardiac output, the loss of contractile tissue is
compensated by hypertrophy of myocytes and stabilisation of the infarct area through the
development of scar tissue.435 Cardiomyocytes undergo elongation or hypertrophy due to
an increase in the left ventricular volume and stress in the cardiac wall.436 This over-
stretch of the ventricle and cardiomyocytes further impairs contractable properties of the
heart and contributes to the expansion of the scarred region.437 The ECM also undergoes
remodelling. Indeed, shortly after the infarction, a new ECM is formed with increased
fibrillar collagen (type I and III). Vascular remodelling occurs to increase the blood flow
reaching the ventricle.
5.1.2 Polymers-Bioactive glasses composites scaffolds
PGS and PCL are the two biodegradable polymers that were used to manufacture the
cardiac patches along with water soluble 45S5 BGs. However, they tend to exhibit dif-
ferent degradation rates. Indeed, PGS degrades relatively faster than PCL as it can be
resorbed within 60 days in the body while PCL undergoes slow degradation with implants
remaining in the body for up to 2 years.364,438 Additionally, the processing methods used
to fabricate the scaffolds plays an important role in the degradation behaviour. There-
fore the degradation process of the engineered cardiac patches had to be assessed. The
pH, weight loss, water absorption should be measured as they are key features describ-
ing the efficiency of the patches. Indeed, the pH has to be adequate for the cells as an
acidic environment leads to a decrease of the contractile capacity of the cardiac muscle.439
Additionally, weight loss and water absorption give information on how the degradation
mechanism of this polymer blend affects its physical properties. Finally, those information
in combination with mechanical properties after degradation helped assessing how long
the patch will ensure its role.
On top of degradation and mechanical properties, cardiac patches are required to pro-
vide suitable surface chemistry for cell attachment, proliferation and differentiation along
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with a 3D porous open network to promote sufficient vascularisation for the transport of
nutrients and metabolic waste in order to promote cell growth. In vitro biological study
therefore assessed to which extent the manufactured cardiac patches fill in those require-
ments. Cardiomyocytes require high oxygen supply (27.6 nmol mg protein−1 min−1).
Engineering patches providing an high enough supply of oxygen and nutrients constitute
therefore a real challenge and have to be tested.
5.1.3 Mechanical properties in cardiac tissue engineering
The aim of the engineered cardiac patches is to help the scarred tissue of the myocardium
to regenerate. To achieve successful manufacturing of a cardiac patch for myocardial
tissue regeneration, matching the properties of the scaffold and native myocardium is es-
sential.336 Cardiac muscle fibres are in highly vascularised and hierarchical systems, em-
bedded within a 3D collagen network (made of different level of organisation) resembling
a honeycomb.440 This collagen organisation ensures sufficient cardiomyocyte contraction
during systole whilst protecting the cells from over-extension during diastole. Therefore,
maintenance of a robust, elastic material is necessary for the cardiac pump function.441,442
This structural organisation leads to anisotropy in the electrical and mechanical properties
of the heart.349,392
The Young’s modulus (measure of stiffness) of the heart muscle ranges from 10 to 20
kPa at the beginning of diastole to 200 to 500 kPa at the end of diastole.443–447 The
tensile strength of the human myocardium varies between 30 to 70 kPa.265,400,448 Many
studies have tried and replicate similar experimental mechanical properties. Recently,
the influence of the addition of a heart patch exhibiting a Young’s modulus going up to
200% of the average myocardium’s has been studied using theoretical simulations.449 In
these simulations, the use of such non-contractile patches has been shown to help reduce
the wall stress proportionally along with the infarct expansion and global left ventricle
remodelling. Those findings were also corroborated by recent studies which confirmed
that the use of a stiffer and thicker materials lowered infarct expansion, left ventricle
remodelling and bettered global left ventricle function.265,400,450,451
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Myocardial infarction is followed by the development of scar tissue due the cardiac re-
modelling. This scar presents mechanical properties that affect the heart function. The
evolution of the scar mechanics and structure along with the left ventricular structure has
been studied in rat models.452 The study revealed that over 1, 2, 3, and 6 weeks, the heal-
ing infarct in rats exhibited structural and mechanical isotropy and that the increasing
amount of collagen played an important role in the mechanical properties as it influenced
cardiac remodelling. Finite Element Modelling showed that the infarct region is stiffer
(higher Young’s modulus) than healthy myocardium tissue and that a re-orientation of
the collagen fibres occurs within 1 week.453,454
5.1.4 Aims and objectives
This project targeted the design cardiac patches for myocardial tissue regeneration.455
This cardiac patches aimed at being bioresorbable and biocompatible with a control-
lable degradation and resorption rate to match cell/tissue growth in vitro/vivo, and also
provided suitable surface chemistry for cell attachment, proliferation, and differentiation.
Additionally, these patches were manufactured into a three-dimensional and highly porous
scaffold with an interconnected porous network for cell growth, flow transport of nutrients,
and metabolic waste and have suitable mechanical properties to match the tissues at the
site of implantation. To do so, two manufacturing techniques were combined: 3D printing
and electrospinning with the use poly(glycerol sebacate) and poly(caprolactone). Those
polymers have been used in combination with bioactive glass 45S5 which has gained more
and more interest as a use in soft tissue regeneration. This innovative cardiac patches
have been mechanically tested to match the properties of the cycling beating heart.
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5.2 Material and methods
5.2.1 Instrumentation
5.2.1.1 Infrared
Infrared spectra were recorded on neat compounds using a Fourier Transform Infrared
Spectrophotometer Shimadzu FTIR-8400S, equipped with an ATR diamond and irradi-
ating between 7800cm−1 and 350cm−1. Only relevant absorbances are reported. The
data were recorded through the software IRsolution.
5.2.1.2 NMR spectroscopy
1H nuclear magnetic resonance (NMR) spectra were recorded, in commercial deuterated
solvents, on a JEOL ECS-400 spectrometer (1H at 399.782 MHz, 13C at 100.525 MHz),
a Bruker Advance Ultra-Shield 400 spectrometer (1H at 400.134 MHz, 13C at 100.624
MHz) at 293 K. Chemical shifts were expressed as δ in parts per million (ppm) and were
adjusted to the chemical shift of the residual NMR solvent resonance peak (CDCl3,
1H: δ
= 7.26 ppm). 1H coupling constants (J) were reported in Hertz (Hz). Information about
multiplicity are abbreviated as follows: s = singlet, d = doublet, t = triplet, q = quartet,
quin = quintet, m = multiple
5.2.1.3 SEM characterisation
The surface micro-structure of samples was characterized in a field emission gun (FEG)
scanning electron microscope (SEM) (model LEO 1530VP).The samples were Au/Pd-
coated and observed at an accelerating voltage of 5 kV.
5.2.1.4 X-Ray Diffraction
Powder X-ray diffraction data were collected using the Bruker D8 Advance diffractometer
in reflection geometry, Cu Kα (1.54060 A˚) radiation (Chemistry Department, Loughbor-
ough University). The sample was prepared as substrate. A small amount of sample
was ground in acetone. The suspension was dropped with a pestle onto a silicon sample
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substrate to produce a thin smear. The data were collected over the 2θ range of 5 to 60◦
with a step size of 0.014 and a count time of 5.5 s per step. Therefore, the data were
collected for a total measurement time of approximately 6 hours 11 min. t, app.m =
apparent multiplet, dd = doublet of doublet, etc.
5.2.2 Polyglycerol sebacate synthesis
The polymer was synthesized according to the work of Wang et al.326 in two steps and
by polycondensation. A round-bottom flask equipped with a N2 bubbler and a Dean-
Stark trap was charged with a 1:1 molar ratio of anhydrous glycerol (Sigma Aldrich,
purity 99%) and recrystallized sebacic acid (Sigma Aldrich, purity 99%). Bubbling N2
was passed through the mixture for 10 min then it was heated up to 120◦C and maintained
at this exact temperature for 24h before the pressure was reduced from 1 torr to 40 mtorr
over 5 h. The reaction mixture was kept at 40 mtorr and 120◦C for 48 h. PGS was
characterised using IR and NMR.
5.2.3 Silicate-based bioactive glasses characterisation
The bioglass 45S5 R© was purchased from XL Tech science and characterised using SEM
and XRD. Analysis to determine if the BGs could be electrospun in a polymer blends or
3D printing were ran.
5.2.4 Electrospinning of the PCL/PGS solution
PCL with a molecular weight of 80 kDa (Aldrich,) and the synthesised PGS were dissolved
in a 7:3 mixture of dichloromethane and methanol to obtain a 13 and 14 wt% solutions.
The polymer solution was delivered with a syringe pump (NE-300 syringe pump from
New Era Pump Systems) at a flow rate of 0.8 ml/min to a stainless steel needle (inner
diameter=1 mm; 100 Sterican 21G) connected to a high voltage power supply (Linari
Engineering). At a voltage of 8 kV, a fluid jet was ejected from the needle, and the
resulting electrospun mesh was collected on aluminium sheet placed at 15cm from the
needle. The scaffolds were stored at room temperature for several days.
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5.2.5 3D printing of the PCL/PGS/BGs scaffolds
To determine the most suitable composition for cardiac tissue engineered patches, various
polymeric compositions were manufactured to obtain adequate mechanical properties.
The following compositions were prepared and investigated for the purpose of cardiac
tissue regeneration:
• Composition 1 : Poly(caprolactone)
• Composition 2 : Poly(caprolactone), Bioglass (5 wt%)
• Composition 3 : Poly(caprolactone), Bioglass (10 wt%)
• Composition 4 : Poly(caprolactone) : Poly(glycerol sebacate) (1:1)
• Composition 5 : Poly(caprolactone) : Poly(glycerol sebacate) (1:1), Bioglass (5
wt%)
• Composition 6 : Poly(caprolactone) : Poly(glycerol sebacate) (1:1), Bioglass (10
wt%)
• Composition 7 : Poly(caprolactone) : Poly(glycerol sebacate) (2:1), Bioglass (10
wt%)
• Composition 8 : Poly(caprolactone) : Poly(glycerol sebacate) (1:2), Bioglass (5
wt%)
The aim was to understand the influence of all of the polymers, composites and composi-
tions on the mechanical properties. For the preparation of solutions, various procedures
were tested in order to obtain an homogeneous solution with no agglomerated particles
and appropriate for 3D printing.
The initial idea consisted in 3D printing at a high temperature (above 200◦C). Indeed,
PCL is a polymer with a low melting point and the idea was to prepare an homogeneous
solution at high temperature and 3D print it through an high temperature extrusion pro-
cess and direct deposition. Three PCL polymers with various molecular weight (Mw) and
degree of polymerisation (Mn) were investigated:
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• PCL80000 : Mn= 80,000
• PCL45000 : Mn= 45,000
• PCL10000 : Mn= 10,000
PCL80000 had too high of a molecular weight to be melted and extruded through high
temperature extrusion process. Even at a temperature of 260◦C the polymer was too
viscous to be extruded and also to be mixed with PGS and BGs. A lower molecular
weighted PCL was then trialled. The PCL 45000 was 3D printable at high pressure and
high temperature 220◦C which could, however, lead to the degradation of the polymer.
Additionally, an homogeneous solution with PGS and BGs was not obtainable. PCL10000
was easily 3D printable, however the scaffold obtained were excessively brittle to be used
as cardiac patches.
Another idea was to use a filament made from PCL, PGS and BGs and 3D print it through
fused deposition method (FDM). PGS is highly viscous but, unfortunately, liquid at room
temperature which did not allow us to use this method.
Finally, the idea was set on using direct deposition method with a solution of dissolved
polymers and suspended BGs particles. PCL and PGS are soluble in Chloroform and
Dichloromethane. However, those solvents are highly dangerous in terms of toxicity and
have supposed carcinogenic properties. Acetone, a benign solvent was then selected.
PCL and PGS have a relatively good solubility in acetone. To increase their solubility
the solution were prepared at temperature varying between 30 and 50◦C.
Solutions for the various compositions were prepared as follow with the amount shown in
Table 5.1: For the solutions containing bioglasses, BGs was dry ball milled using an agate
ball mill and the desired amount was added to 5 g of acetone with 50 µL of Dimethyl
Sulfoxide (DMSO). The solution was then left under vigorous agitation for 1 hour and
then filtered with a 150 µm sieve. the rest of acetone was then used to rinse. The solution
was then heated up to 40◦C. The necessary amount of PGS was then added. Following
the complete dissolution of PGS, PCL was added slowly before leaving on a stirrer at
40◦C overnight.
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Table 5.1: Composition of the solutions for 3D printing
Composition PCL(g) PGS(g) BGs(g) Acetone(g) DMSO µL
1 2.5 - - 7.5 -
2 2.5 - 0.132 8 50
3 2.5 - 0.278 8.5 50
4 2.5 2.5 - 10
5 2.5 2.5 0.556 10 50
6 2.5 2.5 0.265 10 50
7 5.0 2.5 0.835 10 50
8 2.5 5.0 0.395 8.5 50
The solutions were placed in a syringe as shown in Figure 5.1. The samples were 3D
printed at a temperature of 37◦C.
Figure 5.1: Solution of composition 6 ready to be 3D printed
For repeatability and good comparison of the mechanical properties of all the composition,
the inner structure properties of the scaffold were kept similar with the parameters shown
in table 5.2.
The scaffolds were 3D printed on top of aluminium foil as shown is picture 5.2. In terms of
3D printing procedure, the pressure, speed time for pre flow and post flow were adjusted
and optimised to obtain the desirable inner structure with no contact between two strands
in the same layer as shown in figure 5.3.
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Table 5.2: 3D printing parameters
Parameters Layer 1 Layer 2
Hatch Type Line Line
Distance from contour (mm) 0.30 0.30
Angle (◦) 0.0 90.0
Distance between strands (mm) 1.45 1.45
Strand Shift X axis (mm) 0.00 0.70
Strand Shift Z axis (mm) 0.00 0.00
Figure 5.2: 3D printing on aluminium foil
Figure 5.3: Final 3D printing on aluminium foil
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5.2.6 Manufacturing of the hybrid cardiac patches
Once all the components of the cardiac patches were manufactured separately successfully,
the focus was put on understanding how to best combined them. Two methods were
investigated:
• 3D printing of the solution on top of the electrospun scaffold (order 1)
• Electrospinning on top of the already 3D printed and dried scaffolds (order 2)
Two samples following the protocol explained in Section 5.2.5 were manufactured and
analysed through FEG-SEM where the cross-section and view from both sides was ob-
served.
5.2.7 Characterisation of the thermal properties
A DSC Q200 V24 differential scanning calorimeter was used for this study. Polymeric
samples were put in DSC aluminium pans. Following this the pan was hermetically sealed
and placed to the sample holder of the instrument
To determine the precise weight of polymer used for the experiment, the pans and seals
were weighed before the addition of the polymer. The polymer was then placed in the
pans which were subsequently sealed and weighed again. Assuming no weight loss occurred
during this process, the exact weight was then recalculated. Thus 6.7 mg of PCL-PGS,
4.9 mg of PGS and 10.1 mg of PCL were used as samples with an empty DSC pan used
as control. The latter was weighted, sealed, and of similar weight. The experience was
performed under nitrogen.
To determine both exothermic and endothermic changes the heat/cool/heat program was
used. Through this procedure, the sample was initially heated up to 160◦C at a ramp of
10◦C/min and kept at 160◦C for 1.00 min in order to obtain a amorphous dispersion of
the polymer chains at a liquid state. The samples were then cooled down to -70◦C at a
pace of 20◦C/min which allowed the observation of the endothermic peak corresponding
to the crystallisation of the polymer chains. Once the temperature reached -70◦C, this
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temperature was ensured for 1min then followed by an increase of temperature up to
160◦C at a ramp of 10◦C/min to observe the exothermic peak representing the fusion
5.2.8 Mechanical testing
Mechanical properties of the samples were determined using tensile techniques. The
material’s mechanical strength was measured, along with its ability to resist loads without
failure due to excessive stress or deformation. Typical point of interests to determine a
material strength are:
• Ultimate Tensile Strength (UTS) or peak stress, which describes the strength at the
maximum load.
• Young’s modulus (E), representing the elastic strength of the material
• Elongation, which is the maximum extension a material can take without breaking.
To determine the mechanical properties of polymeric materials, the strain () as a function
of the stress (δ) applied to a specific sample is measured. At low strain, most solids
materials exhibit an elastic deformation. In this zone, the stress (δ) is proportional to the
strain ():
δ = E ·  (5.1)
where E refers to the Young’s modulus of the plastic and measures the stiffness of the ma-
terial. This equation is known as Hooke’s law which implies a proportionality between the
applied stress (or load) and the resulting observed strain (or elongation) up to a certain
limits called the proportional limit.456 Beyond this elasticity limit, the material will not
return to its original shape and size once the strain is removed and will endure permanent
deformations. If the yield is increased pass this point, the material will reach the yielding
point, where an increase in strain occurs without an increase in stress. This point marks
the begin of plastic deformation of the material. Following this the material will reach its
breaking point.
Some polymers exhibit an orientation and alignment of their chains in the direction of
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the load, leading to an increase in the material’s strength and stiffness. This phenomenon
is referred to as ”strain hardening” and ”stress induced crystallization”.457 On the other
hand, amorphous polymers, after reaching this stage, can exhibit true strain softening,
where a brittle fracture is characterised by no observed yielding point.458
Temperature greatly affects the mechanical properties of polymers, indeed, above the
glass transition temperature a sudden change of mechanical behaviour can be witnessed
and the polymeric materials can change from brittle to ductile.458 PGS and PCL are
both above their Tg at room temperature (and subsequently at body temperature), it
has been reported, using simulations and experimental measurements, that increasing the
temperature of an amorphous polymer induces a decrease in elastic moduli.459,460
During this project, uniaxial tensile tests were performed on the multi-layered scaffold.
20x40 mm rectangular strips were cut from each scaffold. The thickness of the scaffold was
measured using a Digital Vernier Caliper. Each scaffold was strained to the breaking point
at a constant speed of 10 mm/min using a microtensile tester (Instron 5944). Samples
were mounted in tensile grips 13 mm from each sample end, leaving an approximate gauge
of 16 mm. The stress and strain were analysed using a Instron Bluehill Inc software. The
Young’s modulus was calculated from the slope of the stress-strain curve.
5.2.9 In vitro degradation tests
The in vivo degradation behaviour of the multi-layered scaffolds was evaluated in phosphate-
buffered saline (PBS) solution under static conditions at 40 ◦C for 5 months. Multi-layered
scaffold containing no BGs were used as controls for the study. The pH, water absorption,
weight loss were measured. To determine initial dry weight, the samples were weighed
with a 0.1 mg resolution balance (Sartoruis, CP3245). Each sample was then placed in
the well of a 24-well cell culture plate (Fisher Scientific, 10380932). Following this, 2.5
mL of phosphate buffered saline (PBS), pH 7.4 (ThermoFisher Scientific, 10380932) was
added to each well, ensuring that the scaffolds were fully immersed in the solution. The
plates were then sealed with para-film (Heathrow Scientific Moisture Proof Sealing) and
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Figure 5.4: Preparation of the scaffold for the degradation tests
incubated (Gallenkamp) at 40◦C for the duration of the experiment. At multiple time
points, samples (n=5) were removed from solution and sponged gently to remove excess
water. Each sample was then weighed to determine the wet weight. The samples were
then washed with deionised water, and left to dry overnight, before weighing again to de-
termine the degraded dry weight. The percentage water absorption (WA) of each sample
was calculated using the following formula:
Water absorption(%) =
(Wet weight - Degraded dry weight)
Degraded dry weight
· 100. (5.2)
The percentage weight loss of each sample was calculated using the formula:
Weight loss(%) =
(Initial dry weight – Degraded dry weight)
Initial dry weight
· 100. (5.3)
where degraded dry weight refers to the weight of the sample after being removed from
the PBS solution and dried. At each of the time points and for each samples (n=5),
the pH of the PBS solution was measured following the removal of the samples from the
wells.(Hanna instruments, H198103).
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5.2.9.1 Mechanical tests
The variation of the mechanical properties was also measured. To do so, 20x40 mm
rectangular samples (n=8) were cut from the 3D printed scaffolds. The samples were
placed in Petri dishes, and immersed in PBS to ensure coverage of the samples as shown
in Figure 5.5. The samples were put in the oven for 1 and 2 months at 40◦C. Following
this incubating period the mechanical tests were performed. A microtensile tester (Instron
5944) was used to measure tensile strain; following the same experimental parameters as
shown in section 5.2.8.
Figure 5.5: Preparation of the scaffold for the mechanical degradation tests
5.2.9.2 Thermal characterisation : DSC
Five-month degraded scaffolds of composition C4-EM, C5-EM and C9-EM were removed
from the PBS solution and then thoroughly rinsed with deionised water before being dried
over night. Once those samples were dried, DSC thermal testing were conducted on them
to try and determine any shifts in polymer composition during the degradation process.
The same protocol as described in section 5.2.7 page 112 was used and 5.9mg, 7.1mg and
8.2 mg of samples of composition C4-EM, C5-EM and C9-EM respectively were tested.
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5.2.10 In vitro viability and toxicity cell studies
5.2.10.1 3T3 cell cultures
3T3 fibroblast were harvested and cultured from mice. After thawing, the 3T3 cells
were grown in Alpha MEM Medium (BioWhittaker R© Reagents, Lonza Walkerville Inc,
United States). Cell culture media was complemented with 10% foetal bovine serum
(Sigma Aldrich; UK), 1% antibiotic and antimycotic (100 µg/ml penicillin, 100 mg/ml
streptomycin, and 0.25µg/ml amphotericin B; Sigma Aldrich; Uk) and 1% of L-Glutamine
(Sigma Aldrich; Uk). Cell cultures were maintained in T75cm2 flasks (Costar, Corning
Inc., Corning, NY, USA) in standard culture conditions of 37◦C and 5% CO2, cells were
passaged every 2 days after harvesting them by trypsinization using 0.05% Trypsin-EDTA
solution (Gibco R©, Fisher Scientific UK) at 80–90% culture confluence and further sub
cultivated into culture flasks.
5.2.10.2 Preparation of 96-well plates for cell culture
3T3 cells were counted using the Trypan blue (Sigma-Aldrich R©, UK) and a hemocy-
tometer. The cells were seeded in 96 well flat bottom plates using a pipette. To do so, a
solution of 1 million cell per mL of media was prepared after cell counting and 0.01mL of
this solution (containing 10 000 cells) was deposited in 36 wells of the 96 well plate and
completed with 0.190 mL of media.
5.2.10.3 Indirect In Vitro toxicity and cell viability assay
To determine the viability and cytotoxicity of the 3D printed samples, three 1 cm square
scaffolds were cut from three different 3D printed scaffolds for each of the following com-
positions: C4-EM, C9-EM and C10-EM. Scaffolds were sterilised using UV and EtOH as
this has been reported to have an important effect on cell viability.461–463 The scaffolds
were covered with 2.5 mL of media and placed in an incubator under standard culture
conditions of 37◦C and 5% CO2. 2.5 mL of only media without scaffold or cells were
incubated alongside. After 1, 3 and 7 days, the 0.2 mL of media covering the scaffold was
taken using a pipettes and placed on top of the cells in the 96 well plates. Negative con-
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trol cells were incubated in culture media Alpha MEM, the second negative control cells
were incubated with cell culture media placed alongside the incubated immersed scaffolds.
Positive control cells were killed just 20 min before testing the viability using Industrial
Methylated Spirit (IMS). Following this step the cells were incubated for 24 hours and
viability was measured using the PrestoBlue Cell Viability Reagent Protocol and assessed
using fluorescence measurements. All of the conditions were tested in triplicate wells.
After being incubated for 24 hours, media and IMS were slowly aspirated using a aspi-
rating pipette linked to an aspirator. 0.1 ml of an 1/10 presto in media solution was
deposited in each well plate containing cells and on 3 wells containing no cells to measure
the background fluorescence of the presto blue. The well plate was covered in aluminium
foil and placed in an incubator for 30 min. Following that, fluorescence/viability was
assessed using a plate reader. The following parameters were used during the reading, the
96 well plate was agitated for 5s, measurements of fluorescence were done at an excitation
of 560 nm and a emission of 590 nm. Measurements obtain for NC1 were assimilated with
100% viability. Viability values for other samples were normalised from this value.
5.3 Results and discussion
5.3.1 Poly(glycerol sebacate) characterisation
The structure of PGS was characterised by NMR and IR. FTIR analysis (Figure 5.6)
confirmed the formation of ester bonds in the PGS, shown by the intense peak at 1732
cm−1. The two absorption maxima around 2928 cm−1 and 2854 cm−1 were attributable
to the methylene group, and the broad peak observed around 3600 cm−1 was due to
hydrogen bonded hydroxyl groups or can also be due to the humidity in the room.400 IR
spectrum showed that the PGS was successfully synthesized.
IR (νmax/cm−1, neat):2928, 2854, 1732, 1257, 1232, 1161, 1126, 1093, 1047 1H NMR
(400 MHz, CDCl3) δ (ppm):1.246–1.297 (s, 20 H) 1.62–1.16 (m, 10 H) 2.29–2.356 (m, 10
H) 3.69–3.73 (m, 2 H) 4.11–4.31 (m, 6 H); Impurities 2.17 due do traces of acetone from
cleaning the glass.
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Figure 5.6: FTIR poly(glycerol sebacate)
The full spectrum of 1H NMR spectrum in shown in figure 5.7 was analysed using already
existing data from the literature.347,464 As we could expect three signals belonging to
the sebacic unit between 1.2 and 2.5 ppm; signals for the methylene protons of glycerol
between 3.5 and 4.4 ppm; and signal for the methylene protons of the three glycerides
between 4.8 and 5.5 ppm, as shown in Figure 5.7. The small peaks present at δ = 5.088
ppm and 5.255 ppm correspond to some traces of non cross-linked polymer chains.
5.3.2 Silicate-based bioactive glasses characterisation
The particles used in the manufacturing of the cardiac patches should exhibit the following
requirements:
• Amorphous structure throughout all of the particles
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Figure 5.7: 1H-NMR spectra with attributed signals
• Particle size smaller than needle size used in 3D printing or electrospinning (Syringe
nominal inside diameter of 0.514mm)
• Avoid any agglomeration of the particles within the solution to obtain homogeneous
and repeatable 3D printed scaffolds
The XRD spectrum (Figure 5.8) performed on the bioglasses showed the presence of a
crystalline phase materialised by a sharp peak. In 45S5 bioglasses, formation of sodium
calcium silicate crystals such as Na2CaSi2O6 or Na2Ca2Si3O9) is highly common.
465 Un-
fortunately, the percentage of crystalline phase present within the glass could not be
assessed and quantified with certainty. However, data in the literature revealed that this
crystalline phase in bioglass is a very common problem which can be due to various fac-
tors such as the presence of water or during the sintering process.465,466 Crystallisation
occurring within the amorphous phase of bioactive glasses decreases the formation of the
hydroxyapatite layer.465 Additionally, it is argued that this crystalline phase can decrease
the bioactivity of the glass.465,467–469
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However, in the case of this project, using bioactive glasses containing an unmeasured and
controllable level of crystalline phase would have negative effects on the data recorded as
it would influence them in an unpredictable and unrepeatable way. The company pro-
viding the bioglass was then contacted to obtain another batch. However, obtaining a
replacement batch was a long process. Therefore, preliminary work was undergone with
this batch while waiting for a replacement.
Figure 5.8: XRD 45S5 R©X-Ray Diffraction
The SEM picture (Figure 5.9) shows no sign of agglomeration of the particles but put
in evidence the size dispersion of the particle which can go from 30 µm to 150 µm.
The dispersion can cause problem in terms of 3D printing as they can block the nozzle
preventing the 3D printing of defect-less scaffolds. The particle were deemed to large to be
used with an electrospinning technique. The particles sizes were reduced and homogenized
by ball milling. Following that the size dispersion was observed once more using FEG-
SEM. The purchased bioglass were milled with 10 wt.% of acetylene acetate by a planetary
high-energy ball-milling (Fritsch, pulverisette 7). Zirconia balls and a zirconia vial were
used in the wet ball milling process. The rotating speed and ball-milling time were fixed at
450 rpm and 23 repetitions of 15min. The samples were then separated from the Zirconia
balls and washed with Ethyl Acetate. The solutions was then centrifuged for 15 min at
an rpm of 800. The supernatant solvent was removed and the wet bioglass were dried in
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Figure 5.9: FEG-SEM Bioglass 45S5 R©
an oven at 50◦ over night.
Analysis of the particles Once dried the particle were analysed by SEM and XRD.
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Figure 5.10: FEG-SEM Bioglass 45S5 R©after Wet Ball milling and drying
SEM images showed a significant decease of particle size however, they tended to agglom-
erates. Forming entities of diameter varying between 10 and 120 µm. This decrease of
particle size insured the possibility to 3D print using an 23 Ga needle (230 µm in diame-
ter). However, due to the small size, the particle led to the formation of more aggregates
which would ultimately lead to anisotropy in the 3D printed scaffold. This feature would
then decrease the repeatability and efficiency of the experiment. To assert the good re-
peatability of the experiment, a small amount of Dimethyl Sulfoxide (DMSO) was used
to help prevent the particle from agglomerating. Indeed, DMSO has often been used as
a functional solvent to stabilise and disperse particles.470,471 DMSO is as a polar, aprotic
solvent, with good solvating strength.472 This green solvent with low toxicity can help
nanoparticle solvating and stabilization.
The XRD results showed a reduction of the crystalline phase which was due to the decrease
of the crystalline material within the particle. This is a result of the milling procedure
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Figure 5.11: FEG-SEM Bioglass 45S5 R©after Wet Ball milling and drying
indeed, wet milling has the ability to decrease the crystallinity of a material.473–475
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5.3.3 Electrospinning of the PCL/PGS solution
The morphological assessment of the scaffolds done through FEG scanning electron mi-
croscopy (SEM) (Figures 5.12 and 5.13) demonstrated that the fibres obtained had contin-
uous morphology without any observed beads. FEG-SEM images showed scaffolds made
of 3D meshes interconnected fibres. The average diameter was 5.50 ± 0.4 µm and 6.57 ±
0.65 µm respectively for fibres electrospun from solution with 14 and 13 wt% concentra-
tion.
PGS/PCL fibres glued together at some intersections and formed a physical link. This
was attributed to the presence of PGS which is a highly viscous polymer at room temper-
ature. This property was deemed of great interest for the multi-layered cardiac patches
as it ensured a perfect contact between the 3D printed layer and the electrospun one and
prevent the separation of the two scaffolds in simulated body fluids and once implanted
in the body.
Figure 5.12: FEG-SEM 13%wt of polymer (1:1 PGS/PCL) in DCM/MeOH (7:3)
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Figure 5.13: FEG-SEM 14%wt of polymer (1:1 PGS/PCL) in DCM/MeOH (7:3)
5.3.4 3D printing of the PCL/PGS/BGs scaffolds
3D printed scaffolds made of two bio-polymers and bioactive glasses 45S5 for cardiac tissue
engineering were manufactured. An homogeneous solution of the polymers, with good
particle dispersion to prevent any uneven scaffold distribution and any blockage during the
3D deposition, was successfully obtained. The 3D scaffolds present satisfactory structures
following the set geometrical dimensions form the CAD file with adequate repeatability
over multiple scaffold which were visually assessed. The next step was to determine how
to assemble the two-layered scaffolds.
5.3.5 Manufacturing of the hybrid cardiac patches
Figure 5.15 shows the cross section and view from both sides of the samples prepared
following ”order 1”. The addition of the liquid solution of solvent/polymer mixture on
top of the electrospun scaffold (Figure 5.14) led to the loss of 3D mesh architectural
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structure of the underlying scaffold. Indeed, the viscous but liquid 3D printed solution
infiltrated and filled in the open-structure of the pores as clearly illustrated in figure 5.15
in the view from the electrospun side and from the cross-section where two intertwined
scaffolds were clearly demonstrated. The view from the 3D printed side showed a good
satisfactory structure in the manufactured layers. The two scaffolds appeared to be in
perfect contact. However, the infiltration of the 3D printed layer within the electrospun
scaffold would lead to the annihilation the mesh open structure of the electrospun scaffold
which aimed at mimicking the ECM of the cardiac cells. This would therefore alter the
role of the electrospun scaffold. Additionally, this intertwined scaffolds could lead to an
uneven and non repeatable porosity in the combined scaffolds and also alter the mechanical
properties of the scaffold. This manufacturing method was therefore deemed inadequate.
Figure 5.14: Order 1: Experimental set-up
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Figure 5.15: Order 1: View form the electrospun side, cross-section and view from the
printing side using FEG-SEM of scaffold made of PGS/PCL(1:1) electrospun mat and
PCL/PGS(1:1)BGs(5 wt%) 3D printed layers
In the case where the mixture of PGS/PCL was electrospun on top of the 3D printed
scaffold (Figure 5.16), surface analysis showed that both of the scaffold presented no
alterations after being combined (Figure 5.17). This was a necessary property to ensure
good interaction with the cells once implanted and even mechanical properties. The 3D
printed scaffolds exhibited a good satisfactory structure. When looking at the cross-
section it appeared from the SEM that the two scaffolds may not have been in sufficient
contact to prevent a separation of the layers once implanted. Indeed, it appeared that
the contact was only ensured by a few fibres stuck to the 3D printed scaffold. To gain an
initial idea on the scaffold behaviour in an aqueous environment and of a separation of
the layers would occur, samples were placed in deionised water at room temperature and
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Figure 5.16: Order 2: Experimental set-up
at 37◦ under agitation for a week. The sample showed no separation of the two layers
which led to the selection of this manufacturing technique for the following tests and
optimisation.
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Figure 5.17: Order 2: View form the electrospun side, cross-section and view from the
printing side using FEG-SEM of scaffold made of PGS/PCL(1:1) electrospun mat and
PCL/PGS(1:1)BGs(5 wt%) 3D printed layers
The fabrication and analysis of the scaffolds led us to select the second order as man-
ufacturing approach. The first technique led to the formation of intertwine layers with
infiltrated solution within the electrospun scaffold that would ultimately alter the poros-
ity, interaction with the cells and also the mechanical properties. The second approach
gave good intact layers and the ability of the two layers to remain in contact has been
tested. The cohesion of the layers on a longer time scale and the separation of the scaf-
folds during the degradation tests in simulated body fluid was also tested and is discussed
below.
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5.3.6 Optimisation of the scaffolds: use of different bioglasses
The 45/70 µm particle batch was analysed through SEM. Analysis (Figure 5.18) showed
no sign of agglomeration of the particles and demonstrated the highly satisfactory size
dispersion of the particle which ranged from 45 µm to 75 µm with perfectly round-shaped
spheres. The observed dispersion and particle shapes were of great interest for the 3D
printing step as no blockage of the nozzle was observed during 3D printing and ensured
defect-less scaffolds. The particle sizes measured were small enough to be electrospun
through a 21G needle. The electrospinning of a solution of the polymer mixture con-
taining various amounts of bioglasses was therefore attempted. The electrospun scaffold
morphology was assessed using FEG-SEM. Particle analysis performed using the software
Figure 5.18: FEG-SEM Bioglass 45S5 R©45/70 µm
ImageJ (Figure 5.19) showed a recalculated particle size of an average of 55.2 ± 30 µm
(Figure 5.20).
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Figure 5.19: Particle Size Analysis (ImageJ), the particle are recognised using a threshold
(top) and associated with a diameter (bottom)
Figure 5.20: Particle size distribution
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The XRD measurements (Figure 5.21) performed on the bioglasses showed the absence of
a crystalline phase. This 45/70 µm particle batch showed highly satisfactory properties.
Indeed, the sample presented an amorphous structure within the glasses.
Figure 5.21: XRD 45S5 R©with size:45-75/microm X-Ray Diffraction
5.3.6.1 Preparation of the scaffolds
Electrospun The samples were prepared as described above: 2 compositions were stud-
ied one with 5% of BGs and one with 10%. Both electrospun samples were morphologically
assessed using FEG-SEM. The images are presented in Figures 5.22 and 5.23. The scaf-
folds showed satisfactory electrospun fibres with no beads. Diameter of the fibres was
calculated using the software ImageJ. The average diameter of the fibres was 2.05 ± 0.17
µm and 1.32 ± 0.10 µm respectively for the solution containing 5 and 10 wt%. However,
despite covering a large portion of the samples no particles of BGs was observed.This
absence of particle in the scaffold could either be due to the needle getting blocked by too
large agglomerates or the particles being to heavy to fly the short distance between the
needle and the collector.
In order to determine which mechanism was preventing the BGs to reach the scaffold the
experience was performed again. This time, a piece of foil was placed right under the
needle and the collector distance was shorten from 15 cm down to 8cm. The experiment
was run for 30 minutes and the samples were analysed using an optical microscope. Once
again, no particle of BGs was observed in the electrospun sample and the foil placed
under the needle showed droplets of dry polymers containing what appeared to be bright
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Figure 5.22: FEG-SEM 14%wt of polymer (1:1 PGS/PCL) in DCM/MeOH (7:3) and
with added Bioglass 45S5 R©45/70 µm (5 wt%)
white bubbles. To determine if those bright spots could be particles observed using a
optical microscope, a droplet of the mixture contained in the syringe was placed on a
foil sheet and also observed under the light of the microscope. The observed image also
picture droplets of see-through polymer circling what appears to be bright white droplets.
The assumption that the BGs were to big to reach the collector and therefore falling on
the floor was selected. The sample was then observed trough SEM and it confirmed our
hypothesis that the particles were too large and heavy to reach the collector and therefore
fell off somewhere between the syringe and collector as shown in Figure 5.24.
3D printed Solution for 3D printing were prepared as follow: the solution for the
various compositions were prepared as shown in Table 5.3: The desired amount of BGs
was suspended in 10g of acetone with 50 µL of Dimethyl Sulfoxide (DMSO). The solution
was then left under vigorous agitation for 1 hour. The solution was then heated up to
40◦C. The necessary amount of PGS was then added. Following the complete dissolution
of PGS, PCL was added slowly before leaving on a stirrer at 40◦C overnight.
The solutions were placed in a syringe and 3D printed at a temperature of 37◦C following
the inner structure properties shown in table 5.2. Figure 5.25 shows a microscopic image
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Figure 5.23: FEG-SEM 14%wt of polymer (1:1 PGS/PCL) in DCM/MeOH (7:3) and
with added Bioglass 45S5 R©45/70 µm (10 wt%)
Table 5.3: Composition of the solutions for 3D printing
Composition PCL PGS (g) BGs (g) Acetone (g) DMSO µL
Optimisation 1 (Opt1) 2.5 2.5 0.265 8 50
Optimisation 2 (Opt2) 2.5 2.5 0.556 8 50
of the multi-layered scaffold demonstrating highly symmetrical structure manufactured.
FEG-SEM was used to characterise the samples and demonstrated the great regularity of
the 3D scaffolds. The presence of particle was also observable when their amount equals
10 wt% as shown in figure 5.26.
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Figure 5.24: Droplets collected under the syringe during the electrospinning of the solution
containing 14%wt of polymer (1:1 PGS/PCL) in DCM/MeOH (7:3) and with added
Bioglass 45S5 R©45/70 µm (10 wt%)
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Figure 5.25: Microcopy images of the multi-layered scaffol: (a) and (b) are of composition
C9 and (c) and (d) are of composition C10 with the view from the printed side (left) and
from the electrospun side (right)
Figure 5.26: FEG-SEM of the 3D printed scaffolds with 5 wt% of BGs (top) and 10 wt%
of BGs(bottom)
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The use of the 45/75 µm 45S5 Bioglass R© allowed the improvement of the printing process.
Firstly, the use of spherical non aggregated particle ensured a better dispersion of the
latter in solvents which subsequently provided geometrically repeatable scaffolds. To
obtain an adequate dispersion of the fine particles, a smaller amount of acetone was used
which maintained a high enough viscosity for the particles to stay dispersed throughout
the entire 3D printing process. Additionally, less 3D printing related problems such
blocked nozzle occurred. So far, the use of the 45/75 µm 45S5 Bioglass R© constituted
a real optimisation in comparison with the first BGs used as they are amorphous with
small variation in sizes and they allowed the development of a simpler procedure for the
manufacturing of the 3D printing scaffolds.
The composition containing the 45/75 µm 45S5 Bioglass was refereed to as Composition
9 (C9) for the one containing 5 wt% of BGs and Composition 10 (C10) for the one
containing 10 wt% of BGs.
5.3.7 Characterisation of the thermal properties
Figure 5.27: Endothermic values on the PCL, PGS and, PCL-PGS compositions
Figure 5.27 shows the calculated endothermic values for the PCL, PGS and, PCL-PGS
compositions. Thermal analysis demonstrated the absence of chemical interactions be-
tween the polymers once blended. Indeed, the results show no significant variations in
the glass-transition temperature (Tg) and melting temperature(Tm). FTIR used in com-
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bination with DSC has been shown to be a powerful analytical tool.476 Those results are
in agreement with IR spectrum measurements as shown in Figure 5.28.
FTIR analysis (Figure 5.28) of the different composition confirmed the absence of in-
teraction between the different component. Comparison with the literature enabled the
attribution of the intense peaks around 1700 cm−1 to the ester bonds. While, two absorp-
tion maxima around 2900 cm−1 and 2850 cm−1 were attributable to the methylene group,
and the broad peak observed around 3600 cm−1 was due to hydrogen bonded hydroxyl
groups or can also be due to the humidity in the room.400,461,477 PGS and PCL being two
polymer exhibiting very similar chemical functions (ester bonds, ester bonds and hydroxyl
group, the absence of any new absorption peak in both multi-layer and electrospun scaf-
fold along with the DSC data. The small adsorption peak observed around 2340 cm−1
was due to the presence of CO2 during the sample acquisition.
478
Figure 5.28: IR spectrum of the PCL, PGS and, PCL-PGS compositions
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Table 5.4: Selected Compositions for the 3D printed layer
Composition PCL/PGS Ratio Bioglass Percentage (wt%)
C1 (1:0) 0
C2 (1:0) 5
C3 (1:0) 10
C4 (1:1) 0
C5 (1:1) 5
C6 (1:1) 10
C7 (2:1) 10
C8 (1:2) 5
C9* (1:1) 5
C10* (1:1) 10
* Compositions C9 and C10 were prepared using 45-75 µm
Bioglass
5.3.8 Mechanical characterisation
The aim was to produce a patch with satisfactory mechanical properties in order to provide
a suitable treatment for scarred myocardial infarction. Therefore, selection of the material
composition was firstly made. Testing the mechanical properties of several compositions
helped better understand the effect of each component on the mechanical properties.
Mechanical properties served as a first selection as the myocardium’s properties have
been intensively studied and mechanical requirements of a scaffold play a crucial role in
cardiac tissue regeneration.265,400,443–448 Additionally, it is a efficient and straight forward
screening method.
The tested compositions are detailed in Table 5.4
All compositions were tested with and without electrospun mat, which was made of PCL
and PGS in a 1:1 ratio. For better clarity, the samples were tested with electrospun
mat of composition X, referred to as CX-EM, where EM stands for electrospun mat and
the ones without any electrospun mat referred to as CX where X is the composition as
detailed above. Using tensile testing, the effects of polymer content, the electrospun mat
and amount and size of BGs were assessed.
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5.3.8.1 Influence polymer content
To study the influence of the polymer used, the compositions C1, C4, C5, C7 and C8
showed interesting data. Figure 5.29 shows the results obtained for the measure of the
Young’s modulus(E), Failure at strain (FS) and UTS when the amount of PGS is varied
with the polymer blend.
The addition of PGS led to a decrease of all three measurements. For the compositions
Figure 5.29: Influence of polymer on the mechanical properties with the study of compo-
sitions C1 (PCL), C4(PCL-PGS(1:1)), C5 (PCL-PGS(1:1)-5wt%BGs), and C7 (PCL-
PGS(1:2)-5wt%BGs)
C1, and C4 containing no BGs, the largest drop in the mechanical properties was witnessed
with an decrease from 573 ± 143 MPa to 102 ± 4 MPa for the Young’s modulus, from
142 ± 57 % to 23 ± 2% for the failure at strain and from 2.61 ± 0.82 MPa to 0.82 ±
0.04 MPa for the UTS respectively for C1 and C4. This trend was further present in the
composition C7 where the polymer blend contains twice as much PGS with a E going
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down to 44 ± 2 MPa, a FS to 9.2 ± 1.0 % and an UTS to 0.22 ± 0.01 MPa.
The addition of PGS led to a more flexible cardiac patch that also tend to break at shorter
elongation. PGS being a elastomer, more flexible patches were obtained. However, the
addition of PGS did not enable the patch to sustain more elongation before breaking.
This was attributed to the polymer blend and the absence of chemistry bonds between
PGS and PCL as shown in the DSC measurements (Figure 5.27). Indeed, a mixture of
two polymers composed of large macro molecular chains is obtained (chains which are
cross-linked for PGS) that possibly do not mix at a macro level and therefore the mix
appears to be non miscible at a macro level and would explain why the PCL scaffold (C1)
could sustain a larger elongation as shown in Figure 5.30 and not the composition C4,
C5, C7 and C8.
Figure 5.30: Scaffold of composition C1 being elongated under tensile stress
Additionally, PGS sheets (cross-linked at 120◦ as was the PGS used in this study) have
been shown to exhibit lower E (0.22± 0.03 MPa), FS (2.56± 0.26%) and UTS (0.39± 0.03
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MPa), while PGS pre-polymer films demonstrated the following mechanical properties E
(1.2 ± 0.3 MPa), FS (45 ± 8 %) and UTS (0.32 ± 0.04 MPa).400 In this study, they
produced blends of PGS ans PCL through electrospinning that demonstrated an increase
in stiffness and elongation. Indeed, the E went up from 6 ± 2 MPa to 8 ± 2 MPa
respectively for the PCL fibres to the PCL-PGS fibres along with the E that went from
116 ± 30 % to 142 ± 29% and the UTS from 2.0 ± 0.7 MPa to 3.0 ± 0.5 MPa. These
results could be explained by the use of the pre-polymer which is not cross-linked and
therefore constituted of smaller polymer chains. The study does not present any thermal
analysis which could help understand if chemical bonds are created between the two
polymers.
5.3.8.2 Influence electrospun mat (EM)
Following the study of the influence of the polymer content (see section 5.3.8.1), the effect
of the addition of the electrospun mat (EM) on the mechanical properties was investi-
gated. Firstly, the mechanical properties of the EM on its own were tested. It should be
noted that these results have to be taken with caution, as during the realisation of the
tests, the samples used were extremely thin (a few mm) and their thickness and width
were altered whilst being removed from the aluminium foil and mounted on the tensile
machine. However, results showed that PCL-PGS(1:1) electrospun mat exhibited a E of
66 ± 16 MPa and demonstrated a high FS of 72 ± 6 % and UTS of 4.5 ± 1.1 MPa. These
results appear quite surprising considering this sample exhibits a very narrow thickness
(a few mm) but could be elongated up to 73 ± 6 % and required a high UTS to break.
At this point the material was beyond its elasticity limits. The hypothesis here is that
the EM experienced strain hardening or stress induced crystallisation where the polymer
undergoes a re-orientation and alignment of their chains in the direction of the loading
increasing their strength and stiffness, which could explain the high values of FS and
UTS.
The mechanical properties of PGS/PCL EM were investigated on the work of Rai et
al.400 were a 15 wt% polymer solution (PGS pre-polymer/PCL (2:1 weight ratio)) in
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DCM/MeOH (7:3 volume ratio) was electrospun at a flow rate of 1.6 ml.h−1 at a distance
of 15 cm and voltage of 15kV. This samples showed a Young’s modulus of 0.02–0.5 MPa
and tensile strength = 3–15 kPa. In the work of Vogt et al.461, 1:1 blends of PCL and
PGS (using PGS prepolymer and mildly crosslinked PGS) in acetic acid with a concen-
tration of 27.6 wt%. The electrospun scaffold were obtained at flow rate of 1.1 ml.h−1 at
a distance of 11 cm and voltage of 15kV. Mechanical characterisation of the EM for the
composition using mildly crosslinked PGS showed an E of 7.1 ± 0.8 MPa, an UTS of 5
± 1 MPa and a FS of 333 ± 48 %.
With regards to this data, the obtained values were significantly higher (for E and UTS)
and were explained by the use of a fully polymerised PGS. Additionally, the FS values
obtained were smaller than the one in the work of Vogt et al.461 which was once again
explained by the use of cross-linked PGS leading to a more difficult dissolution.
When the EM was added to the 3D printed scaffolds, all of the compositions showed an
increase of the E; as shown in Figure 5.31. This increase in stiffness could be explained by
the presence of the thicker scaffold combined of two layers which then presented a higher
stiffness. An increase in the ultimate tensile strength with the addition of the EM was
also observed with a 36 % increase for C4, 80 % for C5 and 38 % for C9. This was a
subsequent effect of the hardening the EM experienced toward the end of the test. Figure
5.32 shows how the multi-layered scaffold behave under elongation. In most cases the 3D
printed layer was the first one to break, followed by the breaking of the EM showed in
the stress-strain measurements with a sudden drop in stress. The failure at strain did not
seem to show any correlates with the addition of the EM; going from 23 ± 2 down to 6.0
± 0.2 % for C4, from 9.0 ± 0.7 up to 11.3 ± 0.5 % for C5 and from 9.0 ± 1.O down to
4.6 ± 0.4 % for C9. The FS was therefore not influenced by the addition of the EM.
The electrospun fibres acted as a reinforcement for the assembled patches due to the ex-
cellent fibre–fibre bonding and strong interfacial adhesion between the electrospun layer
and the 3D-printed one. Similar mechanical behaviour, even though for a different scaf-
fold architecture, has been recorded for three-layer systems made of porous PGS tubes
wrapped with PCL electrospun fibres and reinforced by PCL rings (tensile load at break
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Figure 5.31: Influence of the electrospun on the mechanical properties with the study of
compositions EM (Electrospun Mat), C4 and C4-EM(PCL-PGS(1:1)), C5 and C5-EM
(PCL-PGS(1:1)-5wt%BGs), C9 and C9-EM (PCL-PGS(1:1)-5wt% [45-75µm]-BGs) and
C8 (PCL-PGS(1:2)-5wt%BGs)
of around 5.5 N), where PGS significantly contributed to the elastomeric response.479 The
use of electrospun sheets to increase tensile strength in composites has been described in
the literature for microfibre-based netting materials.480–482
5.3.8.3 Influence of bioactive glasses
Finally, the influence of the addition of BGs on the mechanical properties was then as-
sessed. Scaffolds with various types and amounts of BGs were manufactured. Two types
of BGs were used; Type 1 refers to the first BGs used and wet ball milled as detailed in
section 5.3.2 page 122 and type 2 the [45-75 µm]-BGs used as optimisations.
In terms of the amount of BGs, Figure 5.33 shows that increasing of the amount of BGs
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Figure 5.32: Schematic: Multi-layered scaffold behaviour under elongation
led to an statistically significant increase in the E for most compositions. Indeed, for the
patches made solely out of PCL, E gradually increased from 572 ± 143, 1030 ± 113 to
1128 ± 42 MPa respectively for the compositions containing 0, 5 and 10 wt% of BGs.
The same observation was made for the PCL-PGS compositions containing type 1 and
2 BGs. Indeed, E gradually increased with the addition of BGs (101 ± 4, 126 ± 7 and
279 ± 34 MPa respectively for the C4, C5 and C6 compositions and 241 ± 17 and 311
± 39 MPa respectively for the C9 and C10 compositions). The addition of BGs led to
a stiffer and thicker scaffold. However, this increase in stiffness was accompanied by an
important decrease in the FS(120 ± 44 down to 4.0 ± 1.3 MPa respectively for C2 and
C3; 23 ± 2, 9.1 ± 0.7 and 2.7 ± 0.5% respectively for C4, C5 and C6; 9.0 ± 1.0 and 4.1
± 1.1 MPa for C9 and C10). Increasing the amount of BGs made the scaffolds less elastic
as it introduced inhomogeneities within the structure. Indeed, a mixture of polymers is
obtained containing highly brittle micro particles of solid inorganic material. In terms
of UTS, the data presented no significant changes. In other terms, the incorporation of
5wt% of bioactive glass microspheres in the PCL–PGS matrix gave a significant reduc-
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Figure 5.33: Influence of the bioactive glasses on the mechanical properties with the
study of compositions C1 (PCL), C2 (PCL-5wt%BGs), C3 (PCL-10wt%BGs), C4 (PCL-
PGS(1:1)), C5 (PCL-PGS(1:1)-5wt%BGs), C6 (PCL-PGS(1:1)-10wt%BGs), C9 (PCL-
PGS(1:1)-5wt% [45-75µm]-BGs) and C10 (PCL-PGS(1:1)-10wt% [45-75µm]-BGs)
tion in the sample extension before failure, with no statistically significant changes in the
maximum load.
The main structural differences between type 1 and type 2 BGs, as they have been shown
using SEM in section 5.3.2 and section 5.3.6, were the morphology and size dispersion.
Type 1 after being ball-milled presented agglomerated particle of a few micrometers
shaped-like flakes; Type 2 presented sphere like particles with size varying between 45
and 75 µm.
An increase, by a factor 2, from type 1 to type 2 in E was observed for composition C5
and C9. C6 and C10 showed no statistical differences in term of E values. No significant
statistical variations were observed for FS while the UTS increased by a 0.2 MPa for C5
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and C9. Once again, no statistical differences were observed for C6 and C10 for the UTS
values.
5.3.8.4 Conclusion on the mechanical properties
When the fibres were deposited onto the 3D printed PCL-PGS scaffolds, a significant rise
in the Young’s modulus of the composite scaffolds was observed: from 102 ± 5 MPa for
C4 samples to 250 ± 12 MPa for C4-EM ones. The increase in stiffness can be associated
with the excellent adhesion between the 3D-printed layer and the electrospun one, and
makes the electrospun/3D-printed samples of potential interest as engineered scaffolds for
soft tissue engineering. The effect of the electrospun fibres on the mechanical properties
of the scaffolds was evident also for samples containing BG microspheres. 3D-printed
scaffolds with 5 and 10 wt% of BGs had E values of 126 ± 7 MPa and 280 ± 20 MPa,
respectively; the deposition of the electrospun mats determined an increase in Young’s
modulus up to 241 ± 17 MPa for C9-EM and 311 ± 20 MPa for C10-EM. A comparison
between composite 3D-EM samples shows that 5 wt% of BGs had no significant impact
on the stiffness, differently from 10 wt% BGs that induced a 30% increase in the Young’s
modulus. Similar values of elastic modulus in tension have been reported for polymer-
BGs scaffolds for bone tissue engineering, including: 60 µm-thick PCL films containing
50 wt% of 45S5 bio-glasses (approx.200 MPa)483, electrospun mats (80 µm thick) of
polyvinyl alcohol and 45S5 BGs (approx. 250 MPa)484, and polydimethylsiloxane-BGs-
PCL monoliths (230–330 MPa)485.
5.3.8.5 Comparison with the mechanical properties of the heart: Pre-selection
of the compositions
Engineered heart patches should sustain systolic (contractive) forces and also withstand
diastolic (expansive) loads. The stress-strain profile obtained are reflecting elastomeric
materials as they exhibit no discontinuity in the curve. In overall, the scaffolds made of
both PCL and PGS were found to be less stiff and tough that the PCL based scaffolds
and the addition of BGs was found to increase this stiffness.
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The following compositions were selected following the mechanical tests:
• Composition 4 (C4-EM): Poly(caprolactone) : Poly(glycerol sebacate) (1:1)
• Composition 5 (C5-EM): Poly(caprolactone) : Poly(glycerol sebacate) (1:1), Bio-
glass (5 wt%)
• Composition 9 (C9-EM): Poly(caprolactone) : Poly(glycerol sebacate) (1:1), 45-75
µm-Bioglass (5 wt%)
• Composition 10 (C10-EM): Poly(caprolactone) : Poly(glycerol sebacate) (1:1), 45-75
µm-Bioglass (10 wt%)
Composition 4 was used as reference. All of the other compositions exhibited E ranging
from 126 to 310 MPa and tensile strength ranging from 610 to 820 kPa. Those values
were relatively high for the purpose of cardiac patches. However, understanding how
the mechanical properties could change once implanted in the body is crucial data. As
those samples were composed of 5 to 10 wt% of BGs which exhibit rapid dissolution once
exposed to an aqueous environment and therefore their dissolution could drastically influ-
ence the mechanical properties. The latter should also decrease along with the recovery
of the heart. Additionally, it should be noted that those mechanical tests were performed
at room temperature and not at 37◦C as the tensile test equipment used could not ensure
a controlled temperature on the samples. Mechanical strength and E have been shown to
decrease with the increase of temperature for polymers.486 Indeed, it has been reported
that, an increase in temperature of an amorphous polymer leads to a decrease in elastic
moduli.459,460
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5.3.9 In vitro degradation tests: hybrid patches with and with-
out BGs
5.3.9.1 pH, weight loss and water absorption
Measurements of pH, weight, loss and water absorption are shown in Figure 5.34. During
degradation, several physical and chemical interactions such as swelling of the polymers
and decrease in cross-linking density occured.
In terms of pH measurement, the highest pH drop was observed for the composition C4
which did not contain any BGs as it decreased down to 5.9 after 6 hours. PGS under-
goes degradation through the hydrolysis of the ester bonds which produces an carboxylic
group.343,487 This in addition with the presence of unreacted carboxylic acid group on
the backbone of PGS contributes to the pH drop observed for all samples. The conjunc-
ture was thereafter that the presence of BGs helped regulating the acidity and pH of
the media. It appeared that the type 1 BGs helped damping the pH drop in a better
way. This observation can be attributed to their size as they were only a few micrometers
and agglomerated, they therefore exhibited a higher surface exposition and were dissolved
more rapidly. Releasing the alkaline entities which are, according to the model developed
by Hench, Si(OH)4
24 and forming an alkaline hydroxyapatite layer. This is an impor-
tant results as BGs will therefore help counteract the acidic degraded by products and
be doing so increase the beneficial effect of the patches for the purpose of cardiac tissue
engineering.
The patches containing 5 wt% of type 2 BGs showed a largest drop in pH amongst the
BGs-containing scaffolds with a pH of 6.06 after 6 hours. The values of the pH of C9 were
inferior to that of C10 suggesting that increasing the amount of BGs helped counteract
the acidity of the degradation by product of PGS. For composition C10, latency period
was observed where the pH drops down to 6.24 after 1 hour before gradually going back
to 7.0 after 1 day suggesting that the gradual dissolution of the BGs, started after 1 hour
of immersion of PBS was enough to counteract the acidity.
Over 60 days, the pH of composition C4 was observed to exhibit an non-linear profile
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constituted of sudden increase and drops in values. This was attributed to the types
BGs used which were formed of micro-particles that tended to agglomerate forming a
large diversity in size measurements. This contributed to an uneven 3D printed scaf-
folds and dissolution of the glass. This other composition shows a more linear decrease
of pH over time reflecting a better controlled dissolution over the engineering scaffolds.
This was due to the use of spherical BGs leading to a better distribution with the scaffolds.
Weight Loss exhibited higher values for the compositions containing BGs at 60 days.
This results were explained by the dissolution of the BGs leaving a suspected porosity
(confirmed by following SEM analysis in section 5.3.9.2, page 153 ) within the scaffold
that provided a greater surface of contact between the polymers and aqueous solution.
However, the weight loss for the composition C5 was smaller than C4 for the first 6 hours;
the peak in weight loss (8.53 ± 0.02 %) simultaneously corresponds to a sudden increase
in pH (7.06 ± 0.08) and water absorption(43.5 ± 0.03 %). This underlines the following
mechanism: the particle dissolution was followed by an increase of pH leading to more
weight loss and water absorption.
The weight loss and water absorption profile of composition C9 and 10 followed a same
pattern with a highest peak at 6 hours with a subsequent linear decrease over 60 days.
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Figure 5.34: pH, weight loss and water absorption measurements on the multi-layered
scaffolds of composition C4 (PCL-PGS(1:1), C5 (PCL-PGS(1:1)-5wt%BGs), C9 (PCL-
PGS(1:1)-5wt% [45-75µm]-BGs) and C10 (PCL-PGS(1:1)-10wt% [45-75µm]-BGs) in
PBS
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Influence of the electrospun scaffold Similar tests were conducted on the 3D scaffold
on a shorter period of time (13 days). Those tests were performed in collaboration with
a research student: Bridie Catchpole, and helped us understand the influence of the EM
on the degradation properties. Results of the research are detailed in Appendix A.
Results, on the 3D printed scaffold showed, that the PCL scaffolds absorbed the least wa-
ter (16 ± 4.1 %) and did not lose a significant amount of weight over 13 days. This values
were explained by the high hydrophobicity of PCL. The pH of the PBS solution varied
between 6.85 and 7.2. Concerning the polymer blends, results on the water absorption
measurements in the C4 composition scaffolds plateaued after only 3 hours at 29.5 ± 5.1
%. C4-EM also plateaued after 3 hours at 47.33 ± 0.05 %. Despite the use of a PCL of
higher molecular weight (Mw=90000), and therefore more hydrophobic, the multi-layered
scaffold did not seem to exhibit a higher hydrophobicity. Weight loss was 7.7 ± 1.6 % at
13 days while the C4-EM showed a weight loss of 6.4 ± 0.01 % after 14 days.
Concerning the composition containing BGs, percentage water absorption for the C5 com-
position was highest at 24 hours (79.5 ± 4.1 %) against 41.45 ± 0.05 %. These results
contradicted previous observations on the hydrophobicity of the multi-layered patches and
suggested that this difference in water absorption is due to the hydrophobicity brought
by the EM. For C5, weight loss after 13 days was significantly greater than the PGS and
PCL based scaffold at 12.7 ± 1.6 %. At 13 days, pH had gradually decreased to 6.5 with
the C4 composition while the C4-EM exhibited similar values with a pH at 6.76 ± 0.02.
5.3.9.2 SEM
To better understand how the degradation in PBS affects the morphology of the fiber,
FEG-SEM were performed on the degraded scaffolds. Those scaffolds were degraded in
water for 2 and 4 weeks. They were immersed in water and not PBS so that the 3D
architectural structure would not be altered by the ions present in the PBS solution
as those samples would not require to be rinsed in water to remove potential crystals
formed by the phosphate buffer solution. FEG-SEM images (Figure 5.35 and 5.36) showed
how the porosity of the samples increased as the immersion time increased. Indeed,
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porosity increased on the outside and inner structure of the 3D printed scaffold, while
outer porosity appeared on the 3D printed fibres after only 2 weeks in water. Porosity
is beneficial for cell growth, flow transport of nutrients, and metabolic waste which will
ultimately help cells regenerate. However, the appearance of porosity will lower the
mechanical strength. Finally, FEG-SEM allowed to show that the samples retained their
3D architectural structure despite undergoing various degradation processes
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Figure 5.35: FEG-SEM on the degraded scaffolds in deionised water and of composition
C4-EM and C5-EM
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Figure 5.36: FEG-SEM on the degraded scaffolds in deionised water and of composition
C9-EM and C10-EM
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5.3.9.3 Mechanical tests
Mechanical tests on the degraded scaffolds were performed after one and two months
immersed in PBS and using the compositions C4, C9 and C10. The Young’s modulus
Figure 5.37: Mechanical tests on the compositions C4-EM (PCL-PGS(1:1)), C9-EM
(PCL-PGS(1:1)-5wt% [45-75µm]-BGs) and C10-EM (PCL-PGS(1:1)-10wt% [45-75µm]-
BGs) before degradation (CX-EM), after 1 (CX-EM-1) and 2 months (CX-EM-2) in PBS
of all composition decreased quite drastically after one and two months with a highest
drop of 67% in values (81 ± 26 MPa for C10-EM-1) for composition C10-EM after 1
month against 45 % (138 ± 22 MPa) for C4-EM-1. The observed decreased recorded for
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C9-EM-1 was not statistically representative. After two months the highest drop in E was
also witnessed for C10-EM with a decrease of 86 % (36 ± 19 MPa for C10-EM-2) in value
while the values for C4-EM-2 (73 ± 12 MPa) and C9-EM-2 (99 ± 33 MPa) decreased of
71 % and 59 % respectively. The use of a higher amount of larger BGs led to a more
rapid decrease of the scaffold stiffness. During the whole degradation process, E values
for C9-EM were higher than C4-EM while the C10-EM values showed smaller E after 1
month. Therefore the addition of 10 wt% of BGs led to a faster degradation process.
After the dissolution of the BGs the scaffold exhibited a higher porosity that provided
an easier access of the aqueous solution of further degraded the scaffold and accelerating
the degradation process of PGS through the faster breakdown of ester bonds ultimately
leading to the hydrolytic weakening of the material. Another study400 measured the evo-
lution of PGS-PCL-EM mechanical properties for cardiac patch applications. They have
observed a drop in E values after 28 days (from 13.8 ± 6.1 MPa down to 1.4 ± 2.2 MPa).
This observation is supported by the UTS measurements while a linear decrease of UTS
are observed for all compositions. The highest drop in UTS was observed for the C4-EM
composition with a calculated 83 % drop (0.19 ± 0.04 MPa for C4-EM-1) after 1 month
while C10-EM-1 and C9-EM-1 observed a drop of respectively 81 % (0.16 ± 0.04 MPa
for C10-EM-1) and 67 % (0.27 ± 0.04 MPa for C9-EM-1).
The failure at strain showed interesting results where for C4-EM and C9-EM, a decrease
of 60 and 85 % respectively for C4-EM-1 (2.37 ± 0.76 %) and C9-EM-1 (1.31 ± 0.17 %)
was observed. This decrease was then followed by a significant increase in the FS values
where for C4-EM-1 , FS values went from 2.37 ± 0.76 % to 6.06 ± 3.04 % and for C9-EM-
1 , FS values went from 1.31 ± 0.17 % to 2.80 ± 1.15 %. The firstly observed decrease
can be attributed to the BGs which might not have been fully dissolved after 2 weeks
and therefore led to the formation of alkaline zones with the scaffold weakening the later.
Once fully dissolved the scaffold present a better heterogeneity increase the percentage of
elongation of the samples. Additionally, PGS undergoes faster degradation than PCL, the
ratio of polymer within the blend therefore varies and the scaffold contained an increasing
majority of PCL. In this case, the higher porosity of the scaffold resulting from a higher
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amount of BGs dissolved led to a faster dissolution of PGS and therefore a higher ratio
of PCL with the structure. Finally the high percentage of error witnessed for C10-EM at
one and tow month were due to the high brittleness of the samples once degraded were
even a delicate manipulation of the sample led to the insertion of heterogeneity with the
different patches.
5.3.9.4 Thermal Testing: DSC
Figure 5.38: DSC measurements on degraded scaffolds after 5 months in PBS with com-
positions C4-EM, C5-EM and C9-EM compositions
Figure 5.38 can be separated into two zones:
• Zone 1 which is situated around 10◦C and gave valuable insight as to whether the
tested sample contains PGS
• Zone 2, situated in the vicinity of 50◦C corresponded to the Tg of PCL and therefore
helped determine if the samples contains any PCL after degradation.
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Table 5.5: DSC values for Tg and enthalpy for PCL, PGS, PCL-PGS (1:1) and composi-
tions C4-EM-5, C5-EM-5 and C9-EM-5
Composition Zone 1 Zone 2
Beginning of Tg TgC Enthalpy Beginning of Tg Tg Enthalpy
◦C ◦C (J/g) ◦C ◦C (J/g)
PGS 2.31 6.37 22.25 - - -
PCL - - - 51.63 57.43 68.89
PCL-PGS (1:1) -2.44 3.06 7.29 47.24 53.98 29.79
C4-EM-5 2.47 8.60 5.04 50.09 53.12 45.36
C5-EM-5 0.55 5.91 1.17 50.53 53.23 54.25
C9-EM-5 0.39 9.10 7.98 49.64 52.31 44.48
For each composition and each zone, the values for the temperature and measure enthalpy
are listed in Table 5.5. For the thermal tests conducted on the degraded scaffolds after 5
months, PGS has been degrading to various extents in all samples. Compositions C5-EM-
5 seemed to be PGS free after 5 months while compositions C4-EM and C9-EM contained
a certain remaining amount of PGS. PGS therefore dissolved faster in the composition
containing type 1 BGs which are smaller particles. Once those particle were dissolved
they left an open porous network for the PBS to infiltrate the scaffolds and to degrade
polymers. Smaller size particles would most certainly led to the presence of smaller but
more numerous pores which could explain the results on the thermal testing.
Concerning PCL, thermal testing showed us that the polymer was still present in high
quantity within the scaffold. Indeed, PCL degradation rate is much slower (from 2 to 4
years).364 Nonetheless, no significant shifts in the Tg were observed. This can be explained
by the degradation process of PCL undergoing a reduction of the average molecular weight
due to the scission of hydrolytic chain. This would suggests that PCL is undergoing bulk
degradation processes.365
5.3.10 In vitro viability and toxicity cell studies
The normalised results obtained for day 1, 3 and 7 are presented in Figure 5.39. Details
of the values obtained are presented in Appendix B.
All of the three compositions presented viability results above 70% demonstrating satis-
factory biocompatibility with the fibroblast cells. Percentages of viability were above that
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Figure 5.39: Biocompatibility viability assay via indirect contact with 3T3 cells using
ethanol sterilisation
of the control for day one and two.
For day 1, results showed a high survival rate of 124 % ± 4, 126% ± 7 and 129% ± 4
respectively for compositions C4-EM, C9-EM and C10-EM. The highest value of viability
was observed for all compositions at day 2 with a survival rate of 125% ± 11, 137% ± 11,
134% ± 6 respectively for compositions C4-EM, C9-EM and C10-EM.
All three scaffolds present a drop at day 7. Composition C9-EM presented the highest
decrease in viability with 84% ± 9 at day 7. Whilst compositions C4-EM and C10-
EM presented percentage of viability of 103% ± 6 and 123% ± 4 respectively. C10-EM
demonstrated the smallest drop in cell viability at day 7 and, on overall, sustained high
cell viability of a longer period.
These observations can be explained when considering the pH profile (Figure 5.34) match-
ing the release profile of the BGs and degradation of PGS. PGS degradation lead to an
acidic environment which is deleterious for the cells. The addition of alkaline BGs helped
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counteract this acidity and ensuring a suitable environment for cell proliferations.
Viability results demonstrated the positive effect of the addition of BGs in the 3D con-
structs since most cell survival rate were above that of the reference (C4-EM) which did
not contain any BGs. Cell survival dropped under that of reference at day 7 for C9-EM.
This can be explained by the open porous network left after the BGs dissolution which
increase the PGS degradation rate as supported by pH measurements and thermal data.
The addition of 10 wt% of BGs in C10-EM helped sustaining a suitable environment for
cell proliferation for longer as shown by the cell viability percentage over 7 day.
5.3.10.1 Effect of the sterilisation method
Figure 5.40: Results: Biocompatibility viability assay via indirect contact with 3T3 cells
Figure 5.40 presents the normalised results obtained for day 1, 3 and 7 with scaffolds
sterilised using UV. Results showed that cell viability never exceed 50% therefore ren-
dering the scaffolds not biocompatible. These results are in disagreement with what has
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previously been observed using ethanol sterilisations. Figure 5.41 shows a comparison
for both sterilisation techniques and points out the substantial difference induced by the
sterilisation method.
Similar results have been observed in other studies.461–463 However, explanations for such
Figure 5.41: Biocompatibility viability assay via indirect contact with 3T3 cells: Com-
parison between UV and Ethanol Sterilisation
differences in biocompatibility differ. Tallawi et al.462 argues that the increase of biocom-
patibility when using ethanol sterilisation is due to the apparition of pores following the
leaching of unreacted toxic monomers, whereas Liverani et al.463 and Vogt et al.461 debate
that this difference is due to pore formation following the complete dissolution of PGS
from the blend supported by FTIR measurements.
Studies state that immersion in 70% ethanol does not affect the physical properties of the
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PGS film or PGS/polymer blend.461–463 Nevertheless, further tests should be considered to
study the effect of ethanol sterilisation on the scaffolds. Indeed, mechanical properties and
degradation properties are crucial for cardiac tissue regeneration applications. Therefore,
additional mechanical and degradations tests should be performed. FTIR and DSC data
measurements should also be performed on the ethanol sterilised scaffolds to determine
whether, in this study, ethanol dissolves the polymer or the monomer. Finally, FEG-SEM
could be used to observe the pore formation mentioned in different studies.461–463
Cell viability using ethanol sterilisation showed highly satisfactory results demonstrat-
ing the beneficial use of BGs in the various 3D constructs. The use of 10 wt% of BGs
present the longest sustained viability ensuring cell survival rate above 120% over 7 days.
This is due to the BGs counteracting the acidic degradation of PGS ensuring a suited
environment for cell proliferation. These viability study present satisfactory first results.
Indeed, 3T3 fibroblast cells have been used for this study and are commonly used to
obtain preliminary viability data on biomaterials. However, for the purpose of cardiac
tissue regeneration, further studies should be performed using cells belonging to myoblast
cell line (cell found in muscle tissue such as cardiac tissue eg. C2C12).462
Further optimisations could then be undertaken in order to manufacture an electrospun
mat mimicking environmental conditions able to differentiate stem cells into cardiomy-
ocytes into the cardiac lineage cells. Stem cell-derived cardiomyocytes requires complex
signalling pathway and growth factor in additions with environmental conditions to derive
into cardiac lineage cells.488–491 Finally, effect of sterilisation techniques on the scaffolds
chemical and physical properties should be studied furthermore.
5.4 Conclusion
Through this work, the design, fabrication and characterisation of scaffolds meeting vari-
ous requirements for tissue engineering have been demonstrated.455 Electrospinning and
3D printing have been combined to manufacture biocompatible patches of PCL-PGS
blends containing bioactive glasses. To achieve mechanical properties suitable for the my-
ocardium, 3D printing, more precisely fused method deposition, was used to enable the
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manufacture of 3D scaffolds exhibiting tunable mechanical properties dependent on the
polymer blend ratio and amounts of 45-S5 bioglasses.
The scaffolds exhibited multiscale three-dimensional porosity that is known to be benefi-
cial for cell growth and infiltration, the transport of nutrients and metabolic waste (not
demonstrated in this work). In addition, the use of PGS and bioactive glasses allowed con-
trol over degradation and mechanical properties. The strategy used for the fabrication of
the hybrid scaffolds has proved repeatable and effective in achieving excellent adhesion be-
tween the 3D-printed layer, which provided mechanical support to the whole structure. In
addition, the electrospun mat acted as a biomimetic layer. The presence of the PCL-PGS
electrospun network enhanced the stiffness of the scaffolds and gave a 2.5-fold increase
of the Young’s modulus. The addition of the bioactive glasses, although it affected the
mechanical response of the scaffolds only slightly (a 30% increase in elastic modulus for
samples with 10 wt% BGs), impacted the material degradation in vitro and balanced the
acidic character of PGS. The addition of BGs had beneficial effects and helped regulate
the pH therefore helping provide a suitable environment for cell growth and proliferation.
After 3 months of in vitro degradation tests, the pH of the PBS medium, where the scaf-
folds were incubated, dropped to 5.3 (from 7.4) when no BGs were used; while it only
reached values of 6.0 for scaffolds containing 10 wt% BGs. This had a positive effect on
the growth of fibroblasts, whose viability was sustained longer in vitro for scaffolds with
10 wt% BGs. Cell viability showed that the addition of BGs was beneficial in order to
provide a suitable environment for cells. All compositions have been shown to favour cell
proliferations. It was, also, shown that BGs increased the degradation rate of PCL-PGS
scaffolds. This is explained by the open porosity of the scaffold, which is greater once the
BGs are dissolved.
The manufactured scaffold are promising devices for cardiac tissue engineering which could
be further optimised in the future. Through this work, the design of a scaffold meeting
numerous requirements for cardiac tissue regeneration has been achieved.455 The manu-
factured cardiac patches are biocompatible with a controllable degradation depending on
the composition. They also provide a suitable chemistry for cell proliferation (adhesion
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and differentiation to be tested in a further steps) and exhibit three-dimensional porosity
(intra and surface) that increases with the immersion time which is beneficial for cell
growth, flow transport of nutrients and metabolic waste. Finally, mechanical properties
showed high values of more than 200% of the myocardium which will be beneficial for a
healthy recovery of the heart scarred tissue.
Chapter 6
Conclusion
Bioactive glasses (BGs) are biologically active materials, inducing a beneficial response
from the host body once implanted.18,94 They are ideal candidates for various applica-
tions27 such as dentistry19, bone12,13 or cardiac tissue regeneration17. The versatility
and biological properties of such materials have been demonstrated in a plethora of re-
search papers.9,15,16,18,94 The objective of this work was to use modelling and experimental
methods to better understand the behaviour of BGs for tissue engineering applications.
The work comprised the study of the atomistic structure of fluoridated phosphate-based
glasses (F-PBGs) for dentistry applications401, and the development of 45S5 silicates-
based glasses(Si-BGs)-polymer composite scaffolds for cardiac tissue engineering.
Recently, the role played by fluoride ions on the bioactivity of F-PBGs has been debated
in the literature and previous studies have concluded opposite results.210,225 The objective
of this work was to provide a new insight into the physical chemistry of F-PBGs, driving
forward research. In order to provide a clear answer, classical molecular dynamics (MD)
simulations were used to accurately describe the atomistic structure of F-PBGs. To
improve the modelling of FPBGs, the following objectives were achieved:
• development of an accurate force field to describe the atomistic structure of F-PBGs
by integrating, for the first time, the polarisability of both the oxygen and fluoride
atoms;
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• providing novel and interesting insights into the influence of fluorine on phosphate-
based glasses. MD simulations revealed the presence of soluble ionic-rich clusters
formed of fluorine and calcium ions regions and poorly soluble network-rich regions;
• concluding that the effect of the bioactivity and presence of clusters ultimately de-
creased the bioactivity of the glasses. The ionic-rich regions dissolve at a higher rate
than the network-rich regions, leading to an uneven fluoro-apatite layer formation.
This study did not include experimental data on the atomistic structure of F-PBGs, as
their fabrication was not feasible during the project. The experimental part was therefore
oriented toward commercially available silicate-based glasses for cardiac tissue engineer-
ing, using 3D printing and electrospinning.
45S5 silicate-based glasses have shown promising interactions with soft tissues such scarred
cardiac myocardium.17 The use of 45S5 glasses, within a polymeric matrix, has been
reported in cardiac tissue applications but it has not been addressed extensively to
date.291,294,305,400 The experimental part of this project consisted in designing patches
containing 45S5 glasses for tissue regeneration. To provide new experimental insight on
the use of BGs for soft tissue engineering and engineer innovative bioresorbable and bio-
compatible cardiac patches, the following objectives were achieved:
• development of polymer-BGs composite formulations for 3D printing and electro-
spinning and engineering patches using 3D printing (solvent based-extrusion) and
electrospinning techniques;
• development of mechanically suitable cardiac patches;
• manufacturing of cardiac patches presenting tunable degradation properties and
demonstrating satisfactory cell growth and proliferation properties.
This work presented a new and interesting insight on the very promising use of bioac-
tive glasses as a biomaterial for soft and hard tissue engineering. Through this project,
modelling and experimental data have helped us better understand the use of bioactive
glasses for biomedical applications including personalised treatments for patients.
Chapter 7
Future work
The formation of cluster has a significant role in the assessment of the bioactivity. Further
modelling studies could focus on:
• the minimum energy pathway leading to the formation of clusters observed in F-
PBGs. This calculation will shed light on the energetic transitions occurring within
the chemical structure of the glass;
• studying other ions with therapeutic effects such as silver, copper and cobalt which
have known angiogenesis and antibacterial properties.46,60,123–125
Future experimental work should focus on optimising mechanical properties during degra-
dation as well as cardiac cell biocompatibility. These would represent the final steps in
order to obtain an efficient and specific treatment for patient suffering from myocardial
infarction. This work should include:
• testing various thicknesses of patches and PGS curing times to obtain an optimum
composition;
• further in vivo tests with cardiomyocytes, or endogenous cardiac stem cell if the
patches can induce differentiation into cardiomyocytes;
• studying the influence of the sterilisation techniques.
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Appendix A
Degradation studies on the scaffolds
without electrospun mat
In this work, a collaboration with Bridie Catchpole was conducted. The degradation be-
haviour of the compositions C1, C4 and C5 was studied. The solutions were prepared and
3D printed following the protocole decribed in chapter 4. The water absorption, weight
loss and pH were monitored at the following time points: 3 hours, 6 hours, 1 day, 4 days,
8 days and 13 days,where samples (n=5) were removed from solution. Mechanical tests
were also perfomed on 8 samples of each compositions after 12 days at 40◦C.
To determine the percentage water absorption of the three different scaffolds were incu-
bated in PBS, the wet weight was measured following 3 hours, 6 hours, 1 day, 4 days, 8
days and 13 days. This was then compared to the weight of the sample once it had been
left to dry out overnight. Figure A.1 displays the mean percentage water absorption of
each sample (n=5) at each time point. For the PCL scaffolds, there was no significant
water absorption in the first 8 days, with absorption values of 9.5 – 11.2%. At 13 days
the percentage water absorption increased to 16% ± 4.1, with a significance of 0.02.
This contrasted with the PCL-PGS composite scaffolds where water absorption was higher
after only 3 hours (29.5% ± 5.1). This value then remains at a similar level for up to 13
days.
In the C5 (PCL-PGS-5%) BG samples, water absorption was also observed in the first
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3 hours (43.9% ± 4). This observation was followed by a further increase observed at 6
hours (70.4% ± 2.9), with peak water absorption at 24 hours (79.5% ± 4.1). A significant
decrease in water absorption was observed at 4 days (50.1% ± 5.7) compared to at 24
hours. Water absorption then remained at a similar level for the duration of the experi-
ment.
It could also be noted that the water absorption of the samples containing BG was greater
than in the other samples at comparable time points. The scaffolds of composition C4
also absorbed significantly more water than the PCL scaffolds at all time points.
Figure A.1: Percentage water absorption for the compositions C1 (PCL), C4 (PCL-PGS)
and C5 (PCL-PGS-5%wt BG) scaffolds over a 13 day period in PBS. Wet weight was
measured at 3 hours, 6 hours, 1 day, 4 days, 8 days and 13 days for each scaffold (n=5).
The mean and SEM are plotted as line graphs (n=5)
The weight loss of the samples following incubation in PBS was investigated to characterise
their degradation. The scaffolds were dried out overnight and weighed once dry, this
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measurement was then compared to the initial dry weights to obtain a percentage weight
loss figure. The mean percentage weight loss (n=5) for each scaffold following incubation
in PBS for 3 hours, 6 hours, 1 day, 4 days, 8 days and 13 days is displayed in Figure A.2.
Figure A.2: Percentage weight loss for the compositions C1 (PCL), C4 (PCL-PGS) and
C5 (PCL-PGS-5%wt BG) scaffolds over a 13 day period in PBS. Wet weight was measured
at 3 hours, 6 hours, 1 day, 4 days, 8 days and 13 days for each scaffold (n=5). The mean
and SEM are plotted as line graphs (n=5)
The scaffolds of composition C1 did not undergo significant weight loss during the degra-
dation study, with only 0.9% ± 0.5 weight loss at day 13. For the PCL-PGS scaffolds,
a significant weight loss of 5.4% ± 0.5 was observed at day 1, there is then no further
significant increase in weight loss up to day 13 (7.7% ± 1.6). The scaffolds containing
BG lost on average 9.8% ± 1 of their weight within the first 3 hours. This figure then
increased to 15.7% ± 2 at 6 hours. The weight loss then plateaued at a similar level for
the duration of the experiment.
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The PCL and PCL-PGS scaffolds displayed a similar weight loss profile to each other up
to 24 hours, at which point the weight loss of the composite was significantly greater.
The PCL-PGS-5% BG samples exhibited significantly greater weight loss than the other
scaffold types at all time points.
To determine the pH of the degradation products of the three different scaffold types, the
degradation solution was tested following the removal of the samples for weighing at each
of the time points 3 hours, 6 hours, 1 day, 4 days, 8 days and 13 days. The mean pH of
the solution is depicted in Figure A.3 (n=2).
Figure A.3: pH for the compositions C1 (PCL), C4 (PCL-PGS) and C5 (PCL-PGS-
5%wt BG) scaffolds over a 13 day period in PBS. Wet weight was measured at 3 hours,
6 hours, 1 day, 4 days, 8 days and 13 days for each scaffold (n=5). The mean and SEM
are plotted as line graphs (n=5)
A decrease in pH below physiological level was detected in all three sample solutions at 3
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hours. The samples containing BG displayed a steady decrease in pH, to 6.5 at 13 days.
The pH of the PCL degradation solution plateaued at 6.9 from 6 hours to 8 days, with a
slight increase seen at 13 days (pH 7.1) The PCL-PGS scaffold displayed the largest pH
drop (6.4) at the first time point. The pH then continued to decrease over 24 hours (5.5),
remaining at a similar level at 4 days. A further large decrease in pH was observed at 8
days (5).
Following 12 days in the PBS degradation solution, the mechanical properties of the
PCL, PCL-PGS and PCL-PGS-5% BG scaffolds were tested (Figure A.4.). The Young’s
modulus was measured to determine the stiffness of each of the scaffold materials. Results
found that the Young’s modulus of the PCL samples was greater than the modulus of
the samples containing PGS and BG, with a value of 919.3MPa ± 40.1. There was
no statistical significance between the Young’s modulus of PCL-PGS and PCL-PGS-5%
BG at 12 days degradation with mean values of 220.8MPa ± 10.4 and 242.1MPa ± 17
respectively. The PCL samples also possessed a higher failure at strain than the other
two scaffolds, with an elongation at break of 6.2% ± 0.4. This was similar to the failure
strain of the BG-containing samples (5.5% ± 0.2). Both the PCL and PCL-PGS-5% BG
samples have statistically greater elongation at break than the PCL-PGS scaffolds (3.5%
± 0.3).
The ultimate tensile strength (UTS) was again higher for the PCL samples (4.2MPa ±
0.3) than the other scaffolds. As with the Young’s modulus, there was no significant
difference between the UTS of the PCL-PGS and PCL-PGS-5% BG samples (0.9Mpa ±
0.1 and 1.2 MPa ± 0.1).
The results of this study focusing on the 3D printed scaffolds highlighted preliminary
potential advantages of combining BG with a PCL-PGS copolymer. BGs were shown to
influence greatly the degradation rate and water absorption of the copolymer, in addi-
tion to counteracting the acidity caused by PGS degradation. The addition of BG also
increases the ductility of PCL-PGS scaffolds.
234 Chapter A. Degradation studies on the scaffolds without electrospun mat
Figure A.4: Young’s modulus, failure at strain and ultimate tensile strength of the com-
positions C1 (PCL), C4 (PCL-PGS) and C5 (PCL-PGS-5%wt BG) scaffolds over a 13
day period in PBS. Measurements were taken following a 12 day incubation in PBS; mean
and SEM values are displayed as bar charts (n=8)
Appendix B
Biocompatibility Assay via indirect
method using 3T3 fibroblast cells
B.1 Fluorescence Protocol and Parameters
Viability was assessed through fluorescence measurements using PrestoBlue Cell Viability
tests. This reagent uses colourimetric/Fluorometric growth factors in order to evaluate
the viability and proliferation of a various range of cell types. Indeed, as cells prolifer-
ate and grow, their metabolic activity leads to a chemical reduction of their surrounding
environment. PrestoBLue contains a non-toxic chemical reagent called resazurin that
when exposed to the reducing environment of viable cell converts to resofurin which is
an red fluorescent dye. This REDOX reaction allows the metabolism and hence viability
to be monitored by way of change of colour and fluorescence. To measure the fluores-
cence activity, a plate reader was used in combination with the Tecan i-control software.
Measurements were performed using the following parameters:
• Linear Shaking: 5 s
• Linear Shaking Amplitude: 1 mm
• Mode : Fluorescence top reading
• Excitation wavelength :560 nm
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• Emission wavelength : 590 nm
• Excitation bandwidth : 9 nm
• Emission bandwidth : 20 nm
• Gain : 75%
• Room temperature
In the following section is presented the detail of the fluorescence measurements for each
triplicate along with the associated standard error. Samples within each triplicates present
some divergence in values which points towards a certain heterogeneity between different
construct which could represent a point of optimisation. Values obtained for UV sterilised
scaffolds are presented in Table B.1 while the ones obtained for Ethanol sterilised scaffold
in Table B.2.
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